Title of Each Class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
☒ | Accelerated Filer | ☐ | Non-Accelerated Filer | ☐ | |||||||||||||
Smaller Reporting Company | Emerging Growth Company |
Page No. | ||||||||
Item 1. | ||||||||
Item 2. | ||||||||
Item 3. | ||||||||
Item 4. | ||||||||
Item 1. | ||||||||
Item 1A. | ||||||||
Item 2. | ||||||||
Item 3. | ||||||||
Item 4. | ||||||||
Item 5. | ||||||||
Item 6. | ||||||||
ACL | Allowance for Credit Losses | ||||
Ameribor | The American interbank offered rate, a potential replacement for LIBOR, is a benchmark interest rate calculated as a volume-weighted average of the daily transactions in overnight unsecured loans on the American Financial Exchange, LLC, a self-regulated electronic exchange for direct lending by American banks and financial institutions. | ||||
ASC | Accounting Standards Codification | ||||
ASU | Accounting Standards Update | ||||
Bank | First Merchants Bank, a wholly-owned subsidiary of the Corporation | ||||
CARES Act | Coronavirus Aid, Relief and Economic Security Act | ||||
CECL | Current expected credit losses | ||||
CET1 | Common Equity Tier 1 | ||||
Corporation | First Merchants Corporation | ||||
COVID-19 | 2019 novel coronavirus disease, which was declared a pandemic by the World Health Organization on March 11, 2020. | ||||
Economic Impact Payments | Economic stimulus payments of up to $1,200 per adult and $500 per child, subject to eligibility requirements and certain limitations, as established under the CARES Act and distributed by the IRS. | ||||
ESPP | Employee Stock Purchase Plan | ||||
FASB | Financial Accounting Standards Board | ||||
FDIC | Federal Deposit Insurance Corporation | ||||
Federal Reserve | Board of Governors of the Federal Reserve System | ||||
FHLB | Federal Home Loan Bank | ||||
FOMC | Federal Open Market Committee, the monetary policymaking body of the Federal Reserve System. | ||||
FTE | Fully taxable equivalent | ||||
GAAP | U.S. Generally Accepted Accounting Principles | ||||
IRS | Internal Revenue Service | ||||
OREO | Other real estate owned | ||||
PPP | Paycheck Protection Program, which was established by the CARES Act and implemented by the Small Business Administration to provide small business loans. | ||||
RSA | Restricted Stock Awards | ||||
TEFRA | Tax Equity and Fiscal Responsibility Act |
March 31, 2021 | December 31, 2020 | ||||||||||
(Unaudited) | |||||||||||
ASSETS | |||||||||||
Cash and cash equivalents | $ | $ | |||||||||
Interest-bearing deposits | |||||||||||
Investment securities available for sale | |||||||||||
Investment securities held to maturity, net of allowance for credit losses of $ | |||||||||||
Loans held for sale | |||||||||||
Loans | |||||||||||
Less: Allowance for credit losses - loans 1 | ( | ( | |||||||||
Net loans | |||||||||||
Premises and equipment | |||||||||||
Federal Home Loan Bank stock | |||||||||||
Interest receivable | |||||||||||
Goodwill | |||||||||||
Other intangibles | |||||||||||
Cash surrender value of life insurance | |||||||||||
Other real estate owned | |||||||||||
Tax asset, deferred and receivable | |||||||||||
Other assets | |||||||||||
TOTAL ASSETS | $ | $ | |||||||||
LIABILITIES | |||||||||||
Deposits: | |||||||||||
Noninterest-bearing | $ | $ | |||||||||
Interest-bearing | |||||||||||
Total Deposits | |||||||||||
Borrowings: | |||||||||||
Securities sold under repurchase agreements | |||||||||||
Federal Home Loan Bank advances | |||||||||||
Subordinated debentures and other borrowings | |||||||||||
Total Borrowings | |||||||||||
Interest payable | |||||||||||
Other liabilities | |||||||||||
Total Liabilities | |||||||||||
COMMITMENTS AND CONTINGENT LIABILITIES | |||||||||||
STOCKHOLDERS' EQUITY | |||||||||||
Cumulative Preferred Stock, $ | |||||||||||
Authorized - | |||||||||||
Issued and outstanding - | |||||||||||
Common Stock, $ | |||||||||||
Authorized - | |||||||||||
Issued and outstanding - | |||||||||||
Additional paid-in capital | |||||||||||
Retained earnings | |||||||||||
Accumulated other comprehensive income | |||||||||||
Total Stockholders' Equity | |||||||||||
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | $ | $ |
Three Months Ended March 31, | |||||||||||
2021 | 2020 | ||||||||||
INTEREST INCOME | |||||||||||
Loans receivable: | |||||||||||
Taxable | $ | $ | |||||||||
Tax exempt | |||||||||||
Investment securities: | |||||||||||
Taxable | |||||||||||
Tax exempt | |||||||||||
Deposits with financial institutions | |||||||||||
Federal Home Loan Bank stock | |||||||||||
Total Interest Income | |||||||||||
INTEREST EXPENSE | |||||||||||
Deposits | |||||||||||
Federal funds purchased | |||||||||||
Securities sold under repurchase agreements | |||||||||||
Federal Home Loan Bank advances | |||||||||||
Subordinated debentures and other borrowings | |||||||||||
Total Interest Expense | |||||||||||
NET INTEREST INCOME | |||||||||||
Provision for credit losses - loans | |||||||||||
NET INTEREST INCOME AFTER PROVISION FOR CREDIT LOSSES | |||||||||||
OTHER INCOME | |||||||||||
Service charges on deposit accounts | |||||||||||
Fiduciary and wealth management fees | |||||||||||
Card payment fees | |||||||||||
Net gains and fees on sales of loans | |||||||||||
Derivative hedge fees | |||||||||||
Other customer fees | |||||||||||
Increase in cash surrender value of life insurance | |||||||||||
Gains on life insurance benefits | |||||||||||
Net realized gains on sales of available for sale securities | |||||||||||
Other income | |||||||||||
Total Other Income | |||||||||||
OTHER EXPENSES | |||||||||||
Salaries and employee benefits | |||||||||||
Net occupancy | |||||||||||
Equipment | |||||||||||
Marketing | |||||||||||
Outside data processing fees | |||||||||||
Printing and office supplies | |||||||||||
Intangible asset amortization | |||||||||||
FDIC assessments | |||||||||||
Other real estate owned and foreclosure expenses | |||||||||||
Professional and other outside services | |||||||||||
Other expenses | |||||||||||
Total Other Expenses | |||||||||||
INCOME BEFORE INCOME TAX | |||||||||||
Income tax expense | |||||||||||
NET INCOME AVAILABLE TO COMMON STOCKHOLDERS | $ | $ | |||||||||
Per Share Data: | |||||||||||
Basic Net Income Available to Common Stockholders | $ | $ | |||||||||
Diluted Net Income Available to Common Stockholders | $ | $ | |||||||||
Cash Dividends Paid | $ | $ | |||||||||
Average Diluted Shares Outstanding (in thousands) |
Three Months Ended March 31, | |||||||||||
2021 | 2020 | ||||||||||
Net income | $ | $ | |||||||||
Other comprehensive income (loss): | |||||||||||
Unrealized gains/losses on securities available-for-sale: | |||||||||||
Unrealized holding gain (loss) arising during the period | ( | ||||||||||
Reclassification adjustment for losses (gains) included in net income | ( | ( | |||||||||
Tax effect | ( | ||||||||||
Net of tax | ( | ||||||||||
Unrealized gain/loss on cash flow hedges: | |||||||||||
Unrealized holding gain (loss) arising during the period | ( | ||||||||||
Reclassification adjustment for losses (gains) included in net income | |||||||||||
Tax effect | ( | ||||||||||
Net of tax | ( | ||||||||||
Total other comprehensive income (loss), net of tax | ( | ||||||||||
Comprehensive income | $ | $ |
Three Months Ended March 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||
Preferred | Common Stock | Additional | Accumulated Other | ||||||||||||||||||||||||||||||||||||||||||||
Shares | Amount | Shares | Amount | Paid in Capital | Retained Earnings | Comprehensive Income | Total | ||||||||||||||||||||||||||||||||||||||||
Balances, December 31, 2020 | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||||||
( | ( | ||||||||||||||||||||||||||||||||||||||||||||||
Balance, January 1, 2021 | $ | $ | $ | 1005366 | $ | $ | $ | ||||||||||||||||||||||||||||||||||||||||
Comprehensive income: | |||||||||||||||||||||||||||||||||||||||||||||||
Net income | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||
Other comprehensive loss, net of tax | — | — | — | — | — | — | ( | ( | |||||||||||||||||||||||||||||||||||||||
Cash dividends on common stock ($ | — | — | — | — | — | ( | — | ( | |||||||||||||||||||||||||||||||||||||||
Share-based compensation | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||
Stock issued under employee benefit plans | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||
Stock issued under dividend reinvestment and stock purchase plan | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||
Stock options exercised | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||
Restricted shares withheld for taxes | — | — | ( | — | ( | — | — | ( | |||||||||||||||||||||||||||||||||||||||
Balances, March 31, 2021 | $ | $ | $ | $ | $ | $ |
Three Months Ended March 31, 2020 | |||||||||||||||||||||||||||||||||||||||||||||||
Preferred | Common Stock | Additional | Accumulated Other | ||||||||||||||||||||||||||||||||||||||||||||
Shares | Amount | Shares | Amount | Paid in Capital | Retained Earnings | Comprehensive Loss | Total | ||||||||||||||||||||||||||||||||||||||||
Balances, December 31, 2019 | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||||||
Comprehensive income: | |||||||||||||||||||||||||||||||||||||||||||||||
Net income | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||
Other comprehensive income, net of tax | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||
Cash dividends on common stock ($ | — | — | — | — | — | ( | — | ( | |||||||||||||||||||||||||||||||||||||||
Repurchases of common stock | — | — | ( | ( | ( | — | — | ( | |||||||||||||||||||||||||||||||||||||||
Share-based compensation | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||
Stock issued under dividend reinvestment and stock purchase plan | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||
Stock options exercised | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||
Balances, March 31. 2020 | $ | $ | $ | $ | $ | $ |
Three Months Ended | |||||||||||
March 31, 2021 | March 31, 2020 | ||||||||||
Cash Flow From Operating Activities: | |||||||||||
Net income | $ | $ | |||||||||
Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||
Provision for loan losses | |||||||||||
Depreciation and amortization | |||||||||||
Change in deferred taxes | ( | ( | |||||||||
Share-based compensation | |||||||||||
Loans originated for sale | ( | ( | |||||||||
Proceeds from sales of loans held for sale | |||||||||||
Gains on sales of loans held for sale | ( | ( | |||||||||
Gains on sales of securities available for sale | ( | ( | |||||||||
Increase in cash surrender of life insurance | ( | ( | |||||||||
Gains on life insurance benefits | ( | ||||||||||
Change in interest receivable | ( | ||||||||||
Change in interest payable | |||||||||||
Other adjustments | |||||||||||
Net cash provided by operating activities | |||||||||||
Cash Flows from Investing Activities: | |||||||||||
Net change in interest-bearing deposits | ( | ( | |||||||||
Purchases of: | |||||||||||
Securities available for sale | ( | ( | |||||||||
Securities held to maturity | ( | ( | |||||||||
Proceeds from sales of securities available for sale | |||||||||||
Proceeds from maturities of: | |||||||||||
Securities available for sale | |||||||||||
Securities held to maturity | |||||||||||
Net change in loans | ( | ( | |||||||||
Proceeds from the sale of other real estate owned | |||||||||||
Proceeds from life insurance benefits | |||||||||||
Other adjustments | ( | ( | |||||||||
Net cash used in investing activities | ( | ( | |||||||||
Cash Flows from Financing Activities: | |||||||||||
Net change in : | |||||||||||
Demand and savings deposits | |||||||||||
Certificates of deposit and other time deposits | ( | ( | |||||||||
Borrowings | |||||||||||
Repayment of borrowings | ( | ( | |||||||||
Cash dividends on common stock | ( | ( | |||||||||
Stock issued under employee benefit plans | |||||||||||
Stock issued under dividend reinvestment and stock purchase plans | |||||||||||
Stock options exercised | |||||||||||
Repurchase of common stock | ( | ||||||||||
Net cash provided by financing activities | |||||||||||
Net Change in Cash and Cash Equivalents | ( | ( | |||||||||
Cash and Cash Equivalents, January 1 | |||||||||||
Cash and Cash Equivalents, March 31 | $ | $ | |||||||||
Additional cash flow information: | |||||||||||
Interest paid | $ | $ | |||||||||
Loans transferred to other real estate owned | |||||||||||
Fixed assets transferred to other real estate owned | |||||||||||
Non-cash investing activities using trade date accounting | |||||||||||
ROU assets obtained in exchange for new operating lease liabilities | |||||||||||
December 31, 2020 | Impact of CECL Adoption | January 1, 2021 Post-CECL Adoption | |||||||||||||||
Assets: | |||||||||||||||||
Held to maturity securities | ( | ||||||||||||||||
Loans | |||||||||||||||||
Allowance for credit losses - Loans | ( | ( | ( | ||||||||||||||
Net loans | ( | ||||||||||||||||
Tax asset, deferred and receivable | |||||||||||||||||
Liabilities: | |||||||||||||||||
Allowance for credit losses on unfunded loan commitments | |||||||||||||||||
Stockholder's Equity: | |||||||||||||||||
Retained Earnings | ( | ||||||||||||||||
— |
Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | ||||||||||||||||||||
Available for sale at March 31, 2021 | |||||||||||||||||||||||
U.S. Treasury | $ | $ | $ | $ | |||||||||||||||||||
U.S. Government-sponsored agency securities | |||||||||||||||||||||||
State and municipal | |||||||||||||||||||||||
U.S. Government-sponsored mortgage-backed securities | |||||||||||||||||||||||
Corporate obligations | |||||||||||||||||||||||
Total available for sale | $ | $ | $ | $ |
Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | ||||||||||||||||||||
Available for sale at December 31, 2020 | |||||||||||||||||||||||
U.S. Government-sponsored agency securities | $ | $ | $ | $ | |||||||||||||||||||
State and municipal | |||||||||||||||||||||||
U.S. Government-sponsored mortgage-backed securities | |||||||||||||||||||||||
Corporate obligations | |||||||||||||||||||||||
Total available for sale | $ | $ | $ | $ |
Amortized Cost | Allowance for Credit Losses | Net Carrying Amount | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | ||||||||||||||||||||||||||||||
Held to maturity at March 31, 2021 | |||||||||||||||||||||||||||||||||||
U.S. Government-sponsored agency securities | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||
State and municipal | |||||||||||||||||||||||||||||||||||
U.S. Government-sponsored mortgage-backed securities | |||||||||||||||||||||||||||||||||||
Foreign investment | |||||||||||||||||||||||||||||||||||
Total held to maturity | $ | $ | $ | $ | $ | $ |
Amortized Cost | Allowance for Credit Losses | Net Carrying Amount | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | ||||||||||||||||||||||||||||||
Held to maturity at December 31, 2020 | |||||||||||||||||||||||||||||||||||
U.S. Government-sponsored agency securities | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||
State and municipal | |||||||||||||||||||||||||||||||||||
U.S. Government-sponsored mortgage-backed securities | |||||||||||||||||||||||||||||||||||
Foreign investment | |||||||||||||||||||||||||||||||||||
Total held to maturity | $ | $ | $ | $ | $ | $ |
Held to Maturity | |||||||||||||||||
State and municipal | Other | Total | |||||||||||||||
Credit Rating: | |||||||||||||||||
Aaa | $ | $ | $ | ||||||||||||||
Aa1 | |||||||||||||||||
Aa2 | |||||||||||||||||
Aa3 | |||||||||||||||||
A1 | |||||||||||||||||
A2 | |||||||||||||||||
A3 | |||||||||||||||||
Baa2 | |||||||||||||||||
Non-rated | |||||||||||||||||
Total | $ | $ | $ |
State and municipal | |||||
Allowance for Credit Losses: | |||||
Balance, December 31, 2020 | $ | ||||
Impact of adopting ASC 326 | |||||
Provision for credit loss | |||||
Securities charged off | |||||
Recoveries on securities | |||||
Balance, March 31, 2021 | $ |
Less than 12 Months | 12 Months or Longer | Total | |||||||||||||||||||||||||||||||||
Fair Value | Gross Unrealized Losses | Fair Value | Gross Unrealized Losses | Fair Value | Gross Unrealized Losses | ||||||||||||||||||||||||||||||
Investment securities available for sale at March 31, 2021 | |||||||||||||||||||||||||||||||||||
U.S. Government-sponsored agency securities | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||
State and municipal | |||||||||||||||||||||||||||||||||||
U.S. Government-sponsored mortgage-backed securities | |||||||||||||||||||||||||||||||||||
Corporate obligations | |||||||||||||||||||||||||||||||||||
Total investment securities available for sale | $ | $ | $ | $ | $ | $ |
Less than 12 Months | 12 Months or Longer | Total | |||||||||||||||||||||||||||||||||
Fair Value | Gross Unrealized Losses | Fair Value | Gross Unrealized Losses | Fair Value | Gross Unrealized Losses | ||||||||||||||||||||||||||||||
Investment securities available for sale at December 31, 2020 | |||||||||||||||||||||||||||||||||||
State and municipal | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||
U.S. Government-sponsored mortgage-backed securities | |||||||||||||||||||||||||||||||||||
Total investment securities available for sale | $ | $ | $ | $ | $ | $ |
March 31, 2021 | December 31, 2020 | ||||||||||
Investments available for sale reported at less than historical cost: | |||||||||||
Historical cost | $ | $ | |||||||||
Fair value | |||||||||||
Gross unrealized losses | $ | $ | |||||||||
Percent of the Corporation's investments available for sale | % | % |
Available for Sale | Held to Maturity | ||||||||||||||||||||||
Amortized Cost | Fair Value | Amortized Cost | Fair Value | ||||||||||||||||||||
Maturity Distribution at March 31, 2021 | |||||||||||||||||||||||
Due in one year or less | $ | $ | $ | $ | |||||||||||||||||||
Due after one through five years | |||||||||||||||||||||||
Due after five through ten years | |||||||||||||||||||||||
Due after ten years | |||||||||||||||||||||||
U.S. Government-sponsored mortgage-backed securities | |||||||||||||||||||||||
Total investment securities | $ | $ | $ | $ |
Available for Sale | Held to Maturity | ||||||||||||||||||||||
Amortized Cost | Fair Value | Amortized Cost | Fair Value | ||||||||||||||||||||
Maturity Distribution at December 31, 2020 | |||||||||||||||||||||||
Due in one year or less | $ | $ | $ | $ | |||||||||||||||||||
Due after one through five years | |||||||||||||||||||||||
Due after five through ten years | |||||||||||||||||||||||
Due after ten years | |||||||||||||||||||||||
U.S. Government-sponsored mortgage-backed securities | |||||||||||||||||||||||
Total investment securities | $ | $ | $ | $ |
Three Months Ended March 31, | |||||||||||
2021 | 2020 | ||||||||||
Sales and redemptions of investment securities available for sale: | |||||||||||
Gross gains | $ | $ | |||||||||
Gross losses | |||||||||||
Net gains on sales and redemptions of investment securities available for sale | $ | $ | |||||||||
March 31, 2021 | December 31, 2020 | ||||||||||
Commercial and industrial loans | $ | $ | |||||||||
Agricultural land, production and other loans to farmers | |||||||||||
Real estate loans: | |||||||||||
Construction | |||||||||||
Commercial real estate, non-owner occupied | |||||||||||
Commercial real estate, owner occupied | |||||||||||
Residential | |||||||||||
Home equity | |||||||||||
Individuals' loans for household and other personal expenditures | |||||||||||
Public finance and other commercial loans | |||||||||||
Loans | $ | $ |
Term Loans (amortized cost basis by origination year) | |||||||||||||||||||||||||||||||||||||||||||||||
2021 | 2020 | 2019 | 2018 | 2017 | Prior | Revolving loans amortized cost basis | Total | ||||||||||||||||||||||||||||||||||||||||
Commercial and industrial loans | |||||||||||||||||||||||||||||||||||||||||||||||
Pass | $ | $ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||||
Special Mention | |||||||||||||||||||||||||||||||||||||||||||||||
Substandard | |||||||||||||||||||||||||||||||||||||||||||||||
Total Commercial and industrial loans | $ | $ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||||
Agricultural land, production and other loans to farmers | |||||||||||||||||||||||||||||||||||||||||||||||
Pass | |||||||||||||||||||||||||||||||||||||||||||||||
Special Mention | |||||||||||||||||||||||||||||||||||||||||||||||
Substandard | |||||||||||||||||||||||||||||||||||||||||||||||
Total Agricultural land, production and other loans to farmers | $ | $ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||||
Real estate loans: | |||||||||||||||||||||||||||||||||||||||||||||||
Construction | |||||||||||||||||||||||||||||||||||||||||||||||
Pass | |||||||||||||||||||||||||||||||||||||||||||||||
Special Mention | |||||||||||||||||||||||||||||||||||||||||||||||
Substandard | |||||||||||||||||||||||||||||||||||||||||||||||
Total Construction | $ | $ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||||
Commercial real estate, non-owner occupied | |||||||||||||||||||||||||||||||||||||||||||||||
Pass | |||||||||||||||||||||||||||||||||||||||||||||||
Special Mention | |||||||||||||||||||||||||||||||||||||||||||||||
Substandard | |||||||||||||||||||||||||||||||||||||||||||||||
Total Commercial real estate, non-owner occupied | $ | $ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||||
Commercial real estate, owner occupied | |||||||||||||||||||||||||||||||||||||||||||||||
Pass | |||||||||||||||||||||||||||||||||||||||||||||||
Special Mention | |||||||||||||||||||||||||||||||||||||||||||||||
Substandard | |||||||||||||||||||||||||||||||||||||||||||||||
Loss | |||||||||||||||||||||||||||||||||||||||||||||||
Total Commercial real estate, owner occupied | $ | $ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||||
Residential | |||||||||||||||||||||||||||||||||||||||||||||||
Pass | |||||||||||||||||||||||||||||||||||||||||||||||
Special Mention | |||||||||||||||||||||||||||||||||||||||||||||||
Substandard | |||||||||||||||||||||||||||||||||||||||||||||||
Total Residential | $ | $ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||||
Home equity | |||||||||||||||||||||||||||||||||||||||||||||||
Pass | |||||||||||||||||||||||||||||||||||||||||||||||
Special Mention | |||||||||||||||||||||||||||||||||||||||||||||||
Substandard | |||||||||||||||||||||||||||||||||||||||||||||||
Total Home Equity | $ | $ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||||
Individuals' loans for household and other personal expenditures | |||||||||||||||||||||||||||||||||||||||||||||||
Pass | |||||||||||||||||||||||||||||||||||||||||||||||
Special Mention | |||||||||||||||||||||||||||||||||||||||||||||||
Substandard | |||||||||||||||||||||||||||||||||||||||||||||||
Total Individuals' loans for household and other personal expenditures | $ | $ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||||
Public finance and other commercial loans | |||||||||||||||||||||||||||||||||||||||||||||||
Pass | |||||||||||||||||||||||||||||||||||||||||||||||
Total Public finance and other commercial loans | $ | $ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||||
Loans | $ | $ | $ | $ | $ | $ | $ | $ |
December 31, 2020 | |||||||||||||||||||||||||||||||||||||||||||||||
Commercial Pass | Commercial Special Mention | Commercial Substandard | Commercial Doubtful | Commercial Loss | Consumer Performing | Consumer Non-Performing | Total | ||||||||||||||||||||||||||||||||||||||||
Commercial and industrial loans | $ | $ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||||
Agricultural production financing and other loans to farmers | |||||||||||||||||||||||||||||||||||||||||||||||
Real estate Loans: | |||||||||||||||||||||||||||||||||||||||||||||||
Construction | |||||||||||||||||||||||||||||||||||||||||||||||
Commercial real estate, non-owner occupied | |||||||||||||||||||||||||||||||||||||||||||||||
Commercial real estate, owner occupied | |||||||||||||||||||||||||||||||||||||||||||||||
Residential | |||||||||||||||||||||||||||||||||||||||||||||||
Home equity | |||||||||||||||||||||||||||||||||||||||||||||||
Individuals' loans for household and other personal expenditures | |||||||||||||||||||||||||||||||||||||||||||||||
Public finance and other commercial loans | |||||||||||||||||||||||||||||||||||||||||||||||
Loans | $ | $ | $ | $ | $ | $ | 1666062 | $ | $ |
March 31, 2021 | |||||||||||||||||||||||||||||||||||
Current | 30-59 Days Past Due | 60-89 Days Past Due | 90 Days or More Past Due | Total | Loans > 90 Days or More Past Due And Accruing | ||||||||||||||||||||||||||||||
Commercial and industrial loans | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||
Agricultural land, production and other loans to farmers | |||||||||||||||||||||||||||||||||||
Real estate loans: | |||||||||||||||||||||||||||||||||||
Construction | |||||||||||||||||||||||||||||||||||
Commercial real estate, non-owner occupied | |||||||||||||||||||||||||||||||||||
Commercial real estate, owner occupied | |||||||||||||||||||||||||||||||||||
Residential | |||||||||||||||||||||||||||||||||||
Home equity | |||||||||||||||||||||||||||||||||||
Individuals' loans for household and other personal expenditures | |||||||||||||||||||||||||||||||||||
Public finance and other commercial loans | |||||||||||||||||||||||||||||||||||
Loans | $ | $ | $ | $ | $ | $ |
December 31, 2020 | |||||||||||||||||||||||||||||||||||
Current | 30-59 Days Past Due | 60-89 Days Past Due | 90 Days or More Past Due | Total | Loans > 90 Days or More Past Due And Accruing | ||||||||||||||||||||||||||||||
Commercial and industrial loans | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||
Agricultural land, production and other loans to farmers | |||||||||||||||||||||||||||||||||||
Real estate loans: | — | ||||||||||||||||||||||||||||||||||
Construction | |||||||||||||||||||||||||||||||||||
Commercial real estate, non-owner occupied | |||||||||||||||||||||||||||||||||||
Commercial real estate, owner occupied | |||||||||||||||||||||||||||||||||||
Residential | |||||||||||||||||||||||||||||||||||
Home equity | |||||||||||||||||||||||||||||||||||
Individuals' loans for household and other personal expenditures | |||||||||||||||||||||||||||||||||||
Public finance and other commercial loans | |||||||||||||||||||||||||||||||||||
Loans | $ | $ | $ | $ | $ | $ |
March 31, 2021 | December 31, 2020 | ||||||||||||||||
Non-Accrual Loans | Non-Accrual Loans with no Allowance for Credit Losses | Non-Accrual Loans | |||||||||||||||
Commercial and industrial loans | $ | $ | $ | ||||||||||||||
Agricultural land, production and other loans to farmers | |||||||||||||||||
Real estate loans: | |||||||||||||||||
Construction | |||||||||||||||||
Commercial real estate, non-owner occupied | |||||||||||||||||
Commercial real estate, owner occupied | |||||||||||||||||
Residential | |||||||||||||||||
Home equity | |||||||||||||||||
Individuals' loans for household and other personal expenditures | |||||||||||||||||
Loans | $ | $ | $ |
March 31, 2021 | |||||||||||||||||||||||||||||
Commercial Real Estate | Residential Real Estate | Other | Total | Allowance on Collateral Dependent Loans | |||||||||||||||||||||||||
Commercial and industrial loans | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Agricultural land, production and other loans to farmers | |||||||||||||||||||||||||||||
Real estate loans: | |||||||||||||||||||||||||||||
Commercial real estate, non-owner occupied | |||||||||||||||||||||||||||||
Commercial real estate, owner occupied | |||||||||||||||||||||||||||||
Residential | |||||||||||||||||||||||||||||
Home equity | |||||||||||||||||||||||||||||
Individuals' loans for household and other personal expenditures | |||||||||||||||||||||||||||||
Loans | $ | $ | $ | $ | $ |
Three Months Ended March 31, 2021 | |||||||||||||||||||||||||||||||||||
Pre- Modification Recorded Balance | Term Modification | Rate Modification | Combination | Post - Modification Recorded Balance | Number of Loans | ||||||||||||||||||||||||||||||
Commercial and industrial | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||
Real estate loans: | |||||||||||||||||||||||||||||||||||
Residential | |||||||||||||||||||||||||||||||||||
Total | $ | $ | $ | $ | $ |
Three Months Ended March 31, 2021 | |||||||||||
Number of Loans | Recorded Balance | ||||||||||
Real estate loans: | |||||||||||
Residential | $ | ||||||||||
Home equity | |||||||||||
Individuals' loans for household and other personal expenditures | |||||||||||
Total | $ |
Three Months Ended March 31, 2020 | |||||||||||
Number of Loans | Recorded Balance | ||||||||||
Real estate loans: | |||||||||||
Residential | $ | ||||||||||
Total | $ |
Three Months Ended March 31, 2021 | |||||||||||||||||||||||||||||||||||||||||
Commercial | Commercial Real Estate | Construction | Consumer | Residential | Consumer & Residential | Total | |||||||||||||||||||||||||||||||||||
Allowance for credit losses | |||||||||||||||||||||||||||||||||||||||||
Balances, December 31, 2020 | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||
Credit risk reclassifications | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||
Balances, December 31, 2020 after reclassifications | |||||||||||||||||||||||||||||||||||||||||
Impact of adopting ASC 326 | |||||||||||||||||||||||||||||||||||||||||
Balances, January 1, 2021 Post-ASC 326 adoption | |||||||||||||||||||||||||||||||||||||||||
Provision for credit losses | ( | ( | |||||||||||||||||||||||||||||||||||||||
Recoveries on loans | |||||||||||||||||||||||||||||||||||||||||
Loans charged off | ( | ( | ( | ( | ( | ||||||||||||||||||||||||||||||||||||
Balances, March 31, 2021 | $ | $ | $ | $ | $ | $ | $ |
Three Months Ended March 31, 2020 | |||||||||||||||||||||||||||||
Commercial | Commercial Real Estate | Consumer | Residential | Total | |||||||||||||||||||||||||
Allowance for loan losses: | |||||||||||||||||||||||||||||
Balances, December 31, 2019 | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Provision for losses | |||||||||||||||||||||||||||||
Recoveries on loans | |||||||||||||||||||||||||||||
Loans charged off | ( | ( | ( | ( | ( | ||||||||||||||||||||||||
Balances, March 31, 2020 | $ | $ | $ | $ | $ |
December 31, 2020 | |||||||||||||||||||||||||||||
Commercial | Commercial Real Estate | Consumer | Residential | Total | |||||||||||||||||||||||||
Allowance Balances: | |||||||||||||||||||||||||||||
Individually evaluated for impairment | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Collectively evaluated for impairment | |||||||||||||||||||||||||||||
Total Allowance for Loan Losses | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Loan Balances: | |||||||||||||||||||||||||||||
Individually evaluated for impairment | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Collectively evaluated for impairment | |||||||||||||||||||||||||||||
Loans acquired with deteriorated credit quality | — | ||||||||||||||||||||||||||||
Loans | $ | $ | $ | $ | $ |
December 31, 2020 | |||||||||||||||||
Unpaid Principal Balance | Recorded Investment | Related Allowance | |||||||||||||||
Impaired loans with no related allowance: | |||||||||||||||||
Commercial and industrial loans | $ | $ | $ | — | |||||||||||||
Real estate Loans: | |||||||||||||||||
Commercial real estate, non-owner occupied | — | ||||||||||||||||
Commercial real estate, owner occupied | — | ||||||||||||||||
Residential | — | ||||||||||||||||
Individuals' loans for household and other personal expenditures | — | ||||||||||||||||
Total | $ | $ | $ | — | |||||||||||||
Impaired loans with related allowance: | |||||||||||||||||
Commercial and industrial loans | $ | $ | $ | ||||||||||||||
Agricultural land, production and other loans to farmers | |||||||||||||||||
Real estate Loans: | |||||||||||||||||
Commercial real estate, non-owner occupied | |||||||||||||||||
Commercial real estate, owner occupied | |||||||||||||||||
Residential | |||||||||||||||||
Home equity | |||||||||||||||||
Total | $ | $ | $ | ||||||||||||||
Total Impaired Loans | $ | $ | $ |
Three Months Ended March 31, 2020 | |||||||||||
Average Recorded Investment | Interest Income Recognized | ||||||||||
Impaired loans with no related allowance: | |||||||||||
Commercial and industrial loans | $ | $ | |||||||||
Real estate Loans: | |||||||||||
Construction | |||||||||||
Commercial and farmland | |||||||||||
Residential | |||||||||||
Individuals' loans for household and other personal expenditures | |||||||||||
Total | $ | $ | |||||||||
Impaired loans with related allowance: | |||||||||||
Real estate Loans: | |||||||||||
Commercial and farmland | $ | $ | — | ||||||||
Residential | |||||||||||
Home equity | |||||||||||
Total | $ | $ | |||||||||
Total Impaired Loans | $ | $ |
March 31, 2021 | December 31, 2020 | ||||||||||
Amounts of commitments: | |||||||||||
Loan commitments to extend credit | $ | $ | |||||||||
Standby letters of credit | $ | $ |
Three Months Ended March 31, 2021 | |||||
Balances, December 31, 2020 | $ | ||||
Impact of adopting ASC 326 | |||||
Provision for credit losses | |||||
Balances, March 31, 2021 | $ |
March 31, 2021 | December 31, 2020 | ||||||||||
Gross carrying amount | $ | $ | |||||||||
Accumulated amortization | ( | ( | |||||||||
Total core deposit intangibles | $ | $ |
Amortization Expense | |||||
2021 | $ | ||||
2022 | |||||
2023 | |||||
2024 | |||||
2025 | |||||
After 2025 | |||||
$ |
Asset Derivatives | Liability Derivatives | ||||||||||||||||||||||||||||||||||||||||||||||
March 31, 2021 | December 31, 2020 | March 31, 2021 | December 31, 2020 | ||||||||||||||||||||||||||||||||||||||||||||
Balance Sheet Location | Fair Value | Balance Sheet Location | Fair Value | Balance Sheet Location | Fair Value | Balance Sheet Location | Fair Value | ||||||||||||||||||||||||||||||||||||||||
Derivatives designated as hedging instruments: | |||||||||||||||||||||||||||||||||||||||||||||||
Interest rate contracts | Other Assets | $ | Other Assets | $ | Other Liabilities | $ | Other Liabilities | $ | |||||||||||||||||||||||||||||||||||||||
Derivatives not designated as hedging instruments: | |||||||||||||||||||||||||||||||||||||||||||||||
Interest rate contracts | Other Assets | $ | Other Assets | $ | Other Liabilities | $ | Other Liabilities | $ |
Derivatives in Cash Flow Hedging Relationships | Amount of Gain (Loss) Recognized in Other Comprehensive Income on Derivative (Effective Portion) | ||||||||||
Three Months Ended | |||||||||||
March 31, 2021 | March 31, 2020 | ||||||||||
Interest Rate Products | $ | $ | ( |
Derivatives Designated as Hedging Instruments under FASB ASC 815-10 | Location of Gain (Loss) Recognized Income on Derivative | Amount of Gain (Loss) Reclassed from Other Comprehensive Income into Income (Effective Portion) | ||||||||||||||||||
Three Months Ended March 31, 2021 | Three Months Ended March 31, 2020 | |||||||||||||||||||
Interest rate contracts | Interest Expense | $ | ( | $ | ( |
Fair Value Measurements Using: | |||||||||||||||||||||||
March 31, 2021 | Fair Value | Quoted Prices in Active Markets for Identical Assets (Level 1) | Significant Other Observable Inputs (Level 2) | Significant Unobservable Inputs (Level 3) | |||||||||||||||||||
Available for sale securities: | |||||||||||||||||||||||
U.S. Treasury | $ | $ | $ | $ | |||||||||||||||||||
U.S. Government-sponsored agency securities | |||||||||||||||||||||||
State and municipal | |||||||||||||||||||||||
U.S. Government-sponsored mortgage-backed securities | |||||||||||||||||||||||
Corporate obligations | |||||||||||||||||||||||
Interest rate swap asset | |||||||||||||||||||||||
Interest rate swap liability |
Fair Value Measurements Using: | |||||||||||||||||||||||
December 31, 2020 | Fair Value | Quoted Prices in Active Markets for Identical Assets (Level 1) | Significant Other Observable Inputs (Level 2) | Significant Unobservable Inputs (Level 3) | |||||||||||||||||||
Available for sale securities: | |||||||||||||||||||||||
U.S. Government-sponsored agency securities | $ | $ | $ | $ | |||||||||||||||||||
State and municipal | |||||||||||||||||||||||
U.S. Government-sponsored mortgage-backed securities | |||||||||||||||||||||||
Corporate obligations | |||||||||||||||||||||||
Interest rate swap asset | |||||||||||||||||||||||
Interest rate swap liability |
Available for Sale Securities | |||||||||||
Three Months Ended | |||||||||||
March 31, 2021 | March 31, 2020 | ||||||||||
Balance at beginning of the period | $ | $ | |||||||||
Included in other comprehensive income | ( | ( | |||||||||
Principal payments | ( | ( | |||||||||
Ending balance | $ | $ |
Fair Value Measurements Using | ||||||||||||||||||||||||||
March 31, 2021 | Fair Value | Quoted Prices in Active Markets for Identical Assets (Level 1) | Significant Other Observable Inputs (Level 2) | Significant Unobservable Inputs (Level 3) | ||||||||||||||||||||||
Collateral dependent loans | $ | $ | $ | $ | ||||||||||||||||||||||
Other real estate owned |
Fair Value Measurements Using | ||||||||||||||||||||||||||
December 31, 2020 | Fair Value | Quoted Prices in Active Markets for Identical Assets (Level 1) | Significant Other Observable Inputs (Level 2) | Significant Unobservable Inputs (Level 3) | ||||||||||||||||||||||
Impaired loans (collateral dependent) | $ | $ | $ | $ | ||||||||||||||||||||||
Other real estate owned |
March 31, 2021 | Fair Value | Valuation Technique | Unobservable Inputs | Range (Weighted-Average) | |||||||||||||||||||
State and municipal securities | $ | Discounted cash flow | Maturity/Call date | ||||||||||||||||||||
US Muni BQ curve | |||||||||||||||||||||||
Discount rate | |||||||||||||||||||||||
Weighted-average coupon | |||||||||||||||||||||||
Corporate obligations and U.S. Government-sponsored mortgage-backed securities | $ | Discounted cash flow | Risk free rate | ||||||||||||||||||||
plus premium for illiquidity | plus | ||||||||||||||||||||||
Weighted-average coupon | |||||||||||||||||||||||
Collateral dependent loans | $ | Collateral based measurements | Discount to reflect current market conditions and ultimate collectability | ||||||||||||||||||||
Weighted-average discount by loan balance | |||||||||||||||||||||||
Other real estate owned | $ | Appraisals | Discount to reflect current market conditions | ||||||||||||||||||||
Weighted-average discount of other real estate owned balance |
December 31, 2020 | Fair Value | Valuation Technique | Unobservable Inputs | Range (Weighted-Average) | |||||||||||||||||||
State and municipal securities | $ | Discounted cash flow | Maturity/Call date | ||||||||||||||||||||
US Muni BQ curve | |||||||||||||||||||||||
Discount rate | |||||||||||||||||||||||
Weighted-average coupon | |||||||||||||||||||||||
Corporate obligations and U.S Government-sponsored mortgage-backed securities | $ | Discounted cash flow | Risk free rate | ||||||||||||||||||||
plus premium for illiquidity | plus | ||||||||||||||||||||||
Weighted-average coupon | |||||||||||||||||||||||
Impaired loans (collateral dependent) | $ | Collateral based measurements | Discount to reflect current market conditions and ultimate collectability | ||||||||||||||||||||
Weighted-average discount by loan balance | |||||||||||||||||||||||
Other real estate owned | $ | Appraisals | Discount to reflect current market conditions | ||||||||||||||||||||
Weighted-average discount of other real estate owned balance |
March 31, 2021 | |||||||||||||||||||||||
Quoted Prices in Active Markets for Identical Assets | Significant Other Observable Inputs | Significant Unobservable Inputs | |||||||||||||||||||||
Carrying Amount | (Level 1) | (Level 2) | (Level 3) | ||||||||||||||||||||
Assets: | |||||||||||||||||||||||
Cash and cash equivalents | $ | $ | $ | $ | |||||||||||||||||||
Interest-bearing deposits | |||||||||||||||||||||||
Investment securities available for sale | |||||||||||||||||||||||
Investment securities held to maturity | |||||||||||||||||||||||
Loans held for sale | |||||||||||||||||||||||
Loans | |||||||||||||||||||||||
Federal Home Loan Bank stock | |||||||||||||||||||||||
Interest rate swap asset | |||||||||||||||||||||||
Interest receivable | |||||||||||||||||||||||
Liabilities: | |||||||||||||||||||||||
Deposits | $ | $ | $ | $ | |||||||||||||||||||
Borrowings: | |||||||||||||||||||||||
Securities sold under repurchase agreements | |||||||||||||||||||||||
Federal Home Loan Bank advances | |||||||||||||||||||||||
Subordinated debentures and other borrowings | |||||||||||||||||||||||
Interest rate swap liability | |||||||||||||||||||||||
Interest payable | |||||||||||||||||||||||
December 31, 2020 | |||||||||||||||||||||||
Quoted Prices in Active Markets for Identical Assets | Significant Other Observable Inputs | Significant Unobservable Inputs | |||||||||||||||||||||
Carrying Amount | (Level 1) | (Level 2) | (Level 3) | ||||||||||||||||||||
Assets: | |||||||||||||||||||||||
Cash and cash equivalents | $ | $ | $ | $ | |||||||||||||||||||
Interest-bearing deposits | |||||||||||||||||||||||
Investment securities available for sale | |||||||||||||||||||||||
Investment securities held to maturity | |||||||||||||||||||||||
Loans held for sale | |||||||||||||||||||||||
Loans | |||||||||||||||||||||||
Federal Home Loan Bank stock | |||||||||||||||||||||||
Interest rate swap asset | |||||||||||||||||||||||
Interest receivable | |||||||||||||||||||||||
Liabilities: | |||||||||||||||||||||||
Deposits | $ | $ | $ | $ | |||||||||||||||||||
Borrowings: | |||||||||||||||||||||||
Securities sold under repurchase agreements | |||||||||||||||||||||||
Federal Home Loan Bank advances | |||||||||||||||||||||||
Subordinated debentures and other borrowings | |||||||||||||||||||||||
Interest rate swap liability | |||||||||||||||||||||||
Interest payable |
March 31, 2021 | |||||||||||||||||||||||||||||
Remaining Contractual Maturity of the Agreements | |||||||||||||||||||||||||||||
Overnight and Continuous | Up to 30 Days | 30-90 Days | Greater Than 90 Days | Total | |||||||||||||||||||||||||
U.S. Government-sponsored mortgage-backed securities | $ | $ | $ | $ | $ |
December 31, 2020 | |||||||||||||||||||||||||||||
Remaining Contractual Maturity of the Agreements | |||||||||||||||||||||||||||||
Overnight and Continuous | Up to 30 Days | 30-90 Days | Greater Than 90 Days | Total | |||||||||||||||||||||||||
U.S. Government-sponsored mortgage-backed securities | $ | $ | $ | $ | $ |
Accumulated Other Comprehensive Income (Loss) | |||||||||||||||||||||||
Unrealized Gains (Losses) on Securities Available for Sale | Unrealized Gains (Losses) on Cash Flow Hedges | Unrealized Gains (Losses) on Defined Benefit Plans | Total | ||||||||||||||||||||
Balance at December 31, 2020 | $ | $ | ( | $ | ( | $ | |||||||||||||||||
Other comprehensive income (loss) before reclassifications | ( | ( | |||||||||||||||||||||
Amounts reclassified from accumulated other comprehensive income | ( | ( | |||||||||||||||||||||
Period change | ( | ( | |||||||||||||||||||||
Balance at March 31, 2021 | $ | $ | ( | $ | ( | $ | |||||||||||||||||
Balance at December 31, 2019 | $ | $ | ( | $ | ( | $ | |||||||||||||||||
Other comprehensive income (loss) before reclassifications | ( | ||||||||||||||||||||||
Amounts reclassified from accumulated other comprehensive income | ( | ( | |||||||||||||||||||||
Period change | ( | ||||||||||||||||||||||
Balance at March 31, 2020 | $ | $ | ( | $ | ( | $ |
Amount Reclassified from Accumulated Other Comprehensive Income (Loss) For the Three Months Ended March 31, | ||||||||||||||||||||
Details about Accumulated Other Comprehensive Income (Loss) Components | 2021 | 2020 | Affected Line Item in the Statements of Income | |||||||||||||||||
Unrealized gains (losses) on available for sale securities (1) | ||||||||||||||||||||
Realized securities gains reclassified into income | $ | $ | Other income - net realized gains on sales of available for sale securities | |||||||||||||||||
Related income tax expense | ( | ( | Income tax expense | |||||||||||||||||
$ | $ | |||||||||||||||||||
Unrealized gains (losses) on cash flow hedges (2) | ||||||||||||||||||||
Interest rate contracts | $ | ( | $ | ( | Interest expense - subordinated debentures and term loans | |||||||||||||||
Related income tax benefit | Income tax expense | |||||||||||||||||||
$ | ( | $ | ( | |||||||||||||||||
Total reclassifications for the period, net of tax | $ | $ |
Three Months Ended March 31, | |||||||||||
2021 | 2020 | ||||||||||
Stock and ESPP Options | |||||||||||
Pre-tax compensation expense | $ | $ | |||||||||
Income tax expense (benefit) | ( | ||||||||||
Stock and ESPP option expense, net of income taxes | $ | $ | |||||||||
Restricted Stock Awards | |||||||||||
Pre-tax compensation expense | $ | $ | |||||||||
Income tax expense (benefit) | ( | ( | |||||||||
Restricted stock awards expense, net of income taxes | $ | $ | |||||||||
Total Share-Based Compensation | |||||||||||
Pre-tax compensation expense | $ | $ | |||||||||
Income tax expense (benefit) | ( | ( | |||||||||
Total share-based compensation expense, net of income taxes | $ | $ |
Number of Shares | Weighted-Average Exercise Price | Weighted Average Remaining Contractual Term (in Years) | Aggregate Intrinsic Value | ||||||||||||||||||||
Outstanding at January 1, 2021 | $ | ||||||||||||||||||||||
Exercised | ( | $ | |||||||||||||||||||||
Outstanding March 31, 2021 | $ | $ | |||||||||||||||||||||
Vested and Expected to Vest at March 31, 2021 | $ | $ | |||||||||||||||||||||
Exercisable at March 31, 2021 | $ | $ |
Number of Shares | Weighted-Average Grant Date Fair Value | ||||||||||
Unvested RSAs at January 1, 2021 | $ | ||||||||||
Granted | $ | ||||||||||
Vested | ( | $ | |||||||||
Forfeited | ( | $ | |||||||||
Unvested RSAs at March 31, 2021 | $ |
Three Months Ended March 31, | |||||||||||
2021 | 2020 | ||||||||||
Reconciliation of Federal Statutory to Actual Tax Expense: | |||||||||||
Federal statutory income tax at 21% | $ | $ | |||||||||
Tax-exempt interest income | ( | ( | |||||||||
Share-based compensation | ( | ||||||||||
Tax-exempt earnings and gains on life insurance | ( | ( | |||||||||
Tax credits | ( | ( | |||||||||
CARES Act - NOL carryback rate differential | ( | ||||||||||
State Income Tax | |||||||||||
Other | |||||||||||
Actual Tax Expense | $ | $ | |||||||||
Effective Tax Rate | % | % |
Three Months Ended March 31, | |||||||||||||||||||||||||||||||||||
2021 | 2020 | ||||||||||||||||||||||||||||||||||
Net Income | Weighted-Average Shares | Per Share Amount | Net Income | Weighted-Average Shares | Per Share Amount | ||||||||||||||||||||||||||||||
Net income available to common stockholders | $ | $ | $ | $ | |||||||||||||||||||||||||||||||
Effect of potentially dilutive stock options and restricted stock awards | |||||||||||||||||||||||||||||||||||
Diluted net income per share | $ | $ | $ | $ |
(Dollars in Thousands) | Three Months Ended | ||||||||||||||||||||||||||||||||||
March 31, 2021 | March 31, 2020 | ||||||||||||||||||||||||||||||||||
Average Balance | Interest Income / Expense | Average Rate | Average Balance | Interest Income / Expense | Average Rate | ||||||||||||||||||||||||||||||
Assets: | |||||||||||||||||||||||||||||||||||
Interest-bearing deposits | $ | 441,254 | $ | 114 | 0.10 | % | $ | 159,859 | $ | 575 | 1.44 | % | |||||||||||||||||||||||
Federal Home Loan Bank stock | 28,736 | 178 | 2.48 | 28,737 | 299 | 4.16 | |||||||||||||||||||||||||||||
Investment Securities: (1) | |||||||||||||||||||||||||||||||||||
Taxable | 1,494,008 | 6,695 | 1.79 | 1,368,546 | 7,631 | 2.23 | |||||||||||||||||||||||||||||
Tax-Exempt (2) | 1,822,899 | 15,677 | 3.44 | 1,208,717 | 11,816 | 3.91 | |||||||||||||||||||||||||||||
Total Investment Securities | 3,316,907 | 22,372 | 2.70 | 2,577,263 | 19,447 | 3.02 | |||||||||||||||||||||||||||||
Loans held for sale | 16,139 | 156 | 3.87 | 17,217 | 193 | 4.48 | |||||||||||||||||||||||||||||
Loans: (3) | |||||||||||||||||||||||||||||||||||
Commercial | 6,876,818 | 69,174 | 4.02 | 6,235,336 | 76,952 | 4.94 | |||||||||||||||||||||||||||||
Real Estate Mortgage | 975,262 | 9,286 | 3.81 | 870,654 | 10,402 | 4.78 | |||||||||||||||||||||||||||||
Installment | 674,307 | 6,489 | 3.85 | 759,614 | 9,105 | 4.79 | |||||||||||||||||||||||||||||
Tax-Exempt (2) | 693,895 | 6,758 | 3.90 | 643,750 | 6,728 | 4.18 | |||||||||||||||||||||||||||||
Total Loans | 9,236,421 | 91,863 | 3.98 | 8,526,571 | 103,380 | 4.85 | |||||||||||||||||||||||||||||
Total Earning Assets | 13,023,318 | 114,527 | 3.52 | % | 11,292,430 | 123,701 | 4.38 | % | |||||||||||||||||||||||||||
Net unrealized gain on securities available for sale | 55,658 | 48,656 | |||||||||||||||||||||||||||||||||
Allowance for credit losses | (204,353) | (81,160) | |||||||||||||||||||||||||||||||||
Cash and cash equivalents | 165,774 | 159,757 | |||||||||||||||||||||||||||||||||
Premises and equipment | 110,992 | 113,812 | |||||||||||||||||||||||||||||||||
Other assets | 1,093,350 | 1,039,743 | |||||||||||||||||||||||||||||||||
Total Assets | $ | 14,244,739 | $ | 12,573,238 | |||||||||||||||||||||||||||||||
Liabilities: | |||||||||||||||||||||||||||||||||||
Interest-bearing deposits: | |||||||||||||||||||||||||||||||||||
Interest-bearing deposits | $ | 4,616,988 | $ | 3,709 | 0.32 | % | $ | 3,589,240 | $ | 8,276 | 0.92 | % | |||||||||||||||||||||||
Money market deposits | 2,086,322 | 835 | 0.16 | 1,535,844 | 3,783 | 0.99 | |||||||||||||||||||||||||||||
Savings deposits | 1,660,528 | 476 | 0.11 | 1,425,054 | 1,827 | 0.51 | |||||||||||||||||||||||||||||
Certificates and other time deposits | 859,334 | 1,180 | 0.55 | 1,666,642 | 7,862 | 1.89 | |||||||||||||||||||||||||||||
Total Interest-bearing Deposits | 9,223,172 | 6,200 | 0.27 | 8,216,780 | 21,748 | 1.06 | |||||||||||||||||||||||||||||
Borrowings | 675,117 | 3,188 | 1.89 | 748,185 | 4,182 | 2.24 | |||||||||||||||||||||||||||||
Total Interest-bearing Liabilities | 9,898,289 | 9,388 | 0.38 | 8,964,965 | 25,930 | 1.16 | |||||||||||||||||||||||||||||
Noninterest-bearing deposits | 2,344,746 | 1,669,493 | |||||||||||||||||||||||||||||||||
Other liabilities | 161,272 | 122,362 | |||||||||||||||||||||||||||||||||
Total Liabilities | 12,404,307 | 10,756,820 | |||||||||||||||||||||||||||||||||
Stockholders' Equity | 1,840,432 | 1,816,418 | |||||||||||||||||||||||||||||||||
Total Liabilities and Stockholders' Equity | $ | 14,244,739 | 9,388 | $ | 12,573,238 | 25,930 | |||||||||||||||||||||||||||||
Net Interest Income (FTE) | $ | 105,139 | $ | 97,771 | |||||||||||||||||||||||||||||||
Net Interest Spread (FTE) (4) | 3.14 | % | 3.22 | % | |||||||||||||||||||||||||||||||
Net Interest Margin (FTE): | |||||||||||||||||||||||||||||||||||
Interest Income (FTE) / Average Earning Assets | 3.52 | % | 4.38 | % | |||||||||||||||||||||||||||||||
Interest Expense / Average Earning Assets | 0.29 | % | 0.92 | % | |||||||||||||||||||||||||||||||
Net Interest Margin (FTE) (5) | 3.23 | % | 3.46 | % | |||||||||||||||||||||||||||||||
(1) Average balance of securities is computed based on the average of the historical amortized cost balances without the effects of the fair value adjustments. Annualized amounts are computed utilizing a 30/360 day basis. | |||||||||||||||||||||||||||||||||||
(2) Tax-exempt securities and loans are presented on a fully taxable equivalent basis, using a marginal tax rate of 21 percent for 2021 and 2020. These totals equal $4,711 and $3,894 for the three months ended March 31, 2021 and 2020, respectively. | |||||||||||||||||||||||||||||||||||
(3) Non-accruing loans have been included in the average balances. | |||||||||||||||||||||||||||||||||||
(4) Net Interest Spread (FTE) is interest income expressed as a percentage of average earning assets minus interest expense expressed as a percentage of average interest-bearing liabilities. | |||||||||||||||||||||||||||||||||||
(5) Net Interest Margin (FTE) is interest income expressed as a percentage of average earning assets minus interest expense expressed as a percentage of average earning assets. |
Prompt Corrective Action Thresholds | |||||||||||||||||||||||||||||||||||
Actual | Basel III Minimum Capital Required | Well Capitalized | |||||||||||||||||||||||||||||||||
March 31, 2021 | Amount | Ratio | Amount | Ratio | Amount | Ratio | |||||||||||||||||||||||||||||
Total risk-based capital to risk-weighted assets | |||||||||||||||||||||||||||||||||||
First Merchants Corporation | $ | 1,487,455 | 14.33 | % | $ | 1,090,253 | 10.50 | % | N/A | N/A | |||||||||||||||||||||||||
First Merchants Bank | 1,404,801 | 13.49 | 1,093,668 | 10.50 | $ | 1,041,589 | 10.00 | % | |||||||||||||||||||||||||||
Tier 1 capital to risk-weighted assets | |||||||||||||||||||||||||||||||||||
First Merchants Corporation | $ | 1,291,394 | 12.44 | % | $ | 882,586 | 8.50 | % | N/A | N/A | |||||||||||||||||||||||||
First Merchants Bank | 1,273,339 | 12.22 | 885,350 | 8.50 | $ | 833,271 | 8.00 | % | |||||||||||||||||||||||||||
CET1 capital to risk-weighted assets | |||||||||||||||||||||||||||||||||||
First Merchants Corporation | $ | 1,244,967 | 11.99 | % | $ | 726,835 | 7.00 | % | N/A | N/A | |||||||||||||||||||||||||
First Merchants Bank | 1,273,339 | 12.22 | 729,112 | 7.00 | $ | 677,033 | 6.50 | % | |||||||||||||||||||||||||||
Tier 1 capital to average assets | |||||||||||||||||||||||||||||||||||
First Merchants Corporation | $ | 1,291,394 | 9.41 | % | $ | 548,791 | 4.00 | % | N/A | N/A | |||||||||||||||||||||||||
First Merchants Bank | 1,273,339 | 9.31 | 546,920 | 4.00 | $ | 683,650 | 5.00 | % | |||||||||||||||||||||||||||
Prompt Corrective Action Thresholds | |||||||||||||||||||||||||||||||||||
Actual | Basel III Minimum Capital Required | Well Capitalized | |||||||||||||||||||||||||||||||||
December 31, 2020 | Amount | Ratio | Amount | Ratio | Amount | Ratio | |||||||||||||||||||||||||||||
Total risk-based capital to risk-weighted assets | |||||||||||||||||||||||||||||||||||
First Merchants Corporation | $ | 1,475,551 | 14.36 | % | $ | 1,079,015 | 10.50 | % | N/A | N/A | |||||||||||||||||||||||||
First Merchants Bank | 1,412,805 | 13.70 | 1,082,430 | 10.50 | $ | 1,030,886 | 10.00 | % | |||||||||||||||||||||||||||
Tier 1 capital to risk weighted assets | |||||||||||||||||||||||||||||||||||
First Merchants Corporation | $ | 1,282,070 | 12.48 | % | $ | 873,488 | 8.50 | % | N/A | N/A | |||||||||||||||||||||||||
First Merchants Bank | 1,283,922 | 12.45 | 876,253 | 8.50 | $ | 824,708 | 8.00 | % | |||||||||||||||||||||||||||
CET1 capital to risk-weighted assets | |||||||||||||||||||||||||||||||||||
First Merchants Corporation | $ | 1,235,702 | 12.02 | % | $ | 719,343 | 7.00 | % | N/A | N/A | |||||||||||||||||||||||||
First Merchants Bank | 1,283,922 | 12.45 | 721,620 | 7.00 | $ | 670,076 | 6.50 | % | |||||||||||||||||||||||||||
Tier 1 capital to average assets | |||||||||||||||||||||||||||||||||||
First Merchants Corporation | $ | 1,282,070 | 9.57 | % | $ | 536,123 | 4.00 | % | N/A | N/A | |||||||||||||||||||||||||
First Merchants Bank | 1,283,922 | 9.59 | 535,279 | 4.00 | $ | 669,098 | 5.00 | % |
March 31, 2021 | December 31, 2020 | ||||||||||||||||||||||
(Dollars in thousands, except per share amounts) | First Merchants Corporation | First Merchants Bank | First Merchants Corporation | First Merchants Bank | |||||||||||||||||||
Total Risk-Based Capital | |||||||||||||||||||||||
Total Stockholders' Equity (GAAP) | $ | 1,805,856 | $ | 1,836,502 | $ | 1,875,645 | $ | 1,926,269 | |||||||||||||||
Adjust for Accumulated Other Comprehensive (Income) Loss (1) | (35,810) | (38,532) | (74,836) | (77,687) | |||||||||||||||||||
Less: Preferred Stock | (125) | (125) | (125) | (125) | |||||||||||||||||||
Add: Qualifying Capital Securities | 46,427 | — | 46,368 | — | |||||||||||||||||||
Less: Disallowed Goodwill and Intangible Assets | (563,889) | (563,441) | (564,982) | (564,535) | |||||||||||||||||||
Add: Modified CECL Transition Amount | 40,314 | 40,314 | — | — | |||||||||||||||||||
Less: Disallowed Deferred Tax Assets | (1,379) | (1,379) | — | — | |||||||||||||||||||
Total Tier 1 Capital (Regulatory) | 1,291,394 | 1,273,339 | 1,282,070 | 1,283,922 | |||||||||||||||||||
Qualifying Subordinated Debentures | 65,000 | — | 65,000 | — | |||||||||||||||||||
Allowance for Loan Losses Includible in Tier 2 Capital | 131,061 | 131,462 | 128,481 | 128,883 | |||||||||||||||||||
Total Risk-Based Capital (Regulatory) | $ | 1,487,455 | $ | 1,404,801 | $ | 1,475,551 | $ | 1,412,805 | |||||||||||||||
Net Risk-Weighted Assets (Regulatory) | $ | 10,383,360 | $ | 10,415,888 | $ | 10,276,333 | $ | 10,308,855 | |||||||||||||||
Average Assets (Regulatory) | $ | 13,719,785 | $ | 13,672,992 | $ | 13,403,065 | $ | 13,381,969 | |||||||||||||||
Total Risk-Based Capital Ratio (Regulatory) | 14.33 | % | 13.49 | % | 14.36 | % | 13.70 | % | |||||||||||||||
Tier 1 Capital to Risk-Weighted Assets | 12.44 | % | 12.22 | % | 12.48 | % | 12.45 | % | |||||||||||||||
Tier 1 Capital to Average Assets | 9.41 | % | 9.31 | % | 9.57 | % | 9.59 | % | |||||||||||||||
CET1 Capital Ratio | |||||||||||||||||||||||
Total Tier 1 Capital (Regulatory) | $ | 1,291,394 | $ | 1,273,339 | $ | 1,282,070 | $ | 1,283,922 | |||||||||||||||
Less: Qualified Capital Securities | (46,427) | — | (46,368) | — | |||||||||||||||||||
CET1 Capital (Regulatory) | $ | 1,244,967 | $ | 1,273,339 | $ | 1,235,702 | $ | 1,283,922 | |||||||||||||||
Net Risk-Weighted Assets (Regulatory) | $ | 10,383,360 | $ | 10,415,888 | $ | 10,276,333 | $ | 10,308,855 | |||||||||||||||
CET1 Capital Ratio (Regulatory) | 11.99 | % | 12.22 | % | 12.02 | % | 12.45 | % |
Tangible Common Equity to Tangible Assets (non-GAAP) | |||||||||||
(Dollars in thousands, except per share amounts) | March 31, 2021 | December 31, 2020 | |||||||||
Total Stockholders' Equity (GAAP) | $ | 1,805,856 | $ | 1,875,645 | |||||||
Less: Cumulative preferred stock (GAAP) | (125) | (125) | |||||||||
Less: Intangible assets (GAAP) | (571,536) | (572,893) | |||||||||
Tangible common equity (non-GAAP) | $ | 1,234,195 | $ | 1,302,627 | |||||||
Total assets (GAAP) | $ | 14,629,066 | $ | 14,067,210 | |||||||
Less: Intangible assets (GAAP) | (571,536) | (572,893) | |||||||||
Tangible assets (non-GAAP) | $ | 14,057,530 | $ | 13,494,317 | |||||||
Stockholders' Equity to Assets (GAAP) | 12.34 | % | 13.33 | % | |||||||
Tangible common equity to tangible assets (non-GAAP) | 8.78 | % | 9.65 | % | |||||||
Tangible common equity (non-GAAP) | $ | 1,234,195 | $ | 1,302,627 | |||||||
Plus: Tax Benefit of intangibles (non-GAAP) | 5,710 | 5,989 | |||||||||
Tangible common equity, net of tax (non-GAAP) | $ | 1,239,905 | $ | 1,308,616 | |||||||
Common Stock outstanding | 53,954 | 53,922 | |||||||||
Book Value (GAAP) | $ | 33.47 | $ | 34.78 | |||||||
Tangible book value - common (non-GAAP) | $ | 22.98 | $ | 24.27 |
Three Months Ended March 31, | |||||||||||
(Dollars in thousands, except per share amounts) | 2021 | 2020 | |||||||||
Average goodwill (GAAP) | $ | 543,919 | $ | 543,919 | |||||||
Average core deposit intangible (GAAP) | 28,427 | 34,335 | |||||||||
Average deferred tax on CDI (GAAP) | (5,877) | (7,129) | |||||||||
Intangible adjustment (non-GAAP) | $ | 566,469 | $ | 571,125 | |||||||
Average stockholders' equity (GAAP) | $ | 1,840,432 | $ | 1,816,418 | |||||||
Average cumulative preferred stock (GAAP) | (125) | (125) | |||||||||
Intangible adjustment (non-GAAP) | (566,469) | (571,125) | |||||||||
Average tangible capital (non-GAAP) | $ | 1,273,838 | $ | 1,245,168 | |||||||
Average assets (GAAP) | $ | 14,244,739 | $ | 12,573,238 | |||||||
Intangible adjustment (non-GAAP) | (566,469) | (571,125) | |||||||||
Average tangible assets (non-GAAP) | $ | 13,678,270 | $ | 12,002,113 | |||||||
Net income available to common stockholders (GAAP) | $ | 49,469 | $ | 34,263 | |||||||
CDI amortization, net of tax (GAAP) | 1,072 | 1,197 | |||||||||
Tangible net income available to common stockholders (non-GAAP) | $ | 50,541 | $ | 35,460 | |||||||
Per Share Data: | |||||||||||
Diluted net income available to common stockholders (GAAP) | $ | 0.91 | $ | 0.62 | |||||||
Diluted tangible net income available to common stockholders (non-GAAP) | $ | 0.93 | $ | 0.65 | |||||||
Ratios: | |||||||||||
Return on average GAAP capital (ROE) | 10.75 | % | 7.55 | % | |||||||
Return on average tangible capital | 15.87 | % | 11.39 | % | |||||||
Return on average assets (ROA) | 1.39 | % | 1.09 | % | |||||||
Return on average tangible assets | 1.48 | % | 1.18 | % |
(Dollars in Thousands) | March 31, 2021 | December 31, 2020 | ||||||||||||
Non-Performing Assets: | ||||||||||||||
Non-accrual loans | $ | 57,923 | $ | 61,471 | ||||||||||
Renegotiated loans | 655 | 3,240 | ||||||||||||
Non-performing loans (NPL) | 58,578 | 64,711 | ||||||||||||
OREO and Repossessions | 604 | 940 | ||||||||||||
Non-performing assets (NPA) | 59,182 | 65,651 | ||||||||||||
Loans 90-days or more delinquent and still accruing | 1,093 | 746 | ||||||||||||
NPAs and loans 90-days or more delinquent | $ | 60,275 | $ | 66,397 | ||||||||||
(Dollars in Thousands) | March 31, 2021 | December 31, 2020 | |||||||||
Non-performing assets and loans 90-days or more delinquent: | |||||||||||
Commercial and industrial loans | $ | 1,671 | $ | 2,923 | |||||||
Agricultural land, production and other loans to farmers | 1,220 | 1,012 | |||||||||
Real estate loans: | |||||||||||
Construction | 330 | 435 | |||||||||
Commercial real estate, non-owner occupied | 44,239 | 47,548 | |||||||||
Commercial real estate, owner occupied | 2,792 | 3,040 | |||||||||
Residential | 7,185 | 9,034 | |||||||||
Home equity | 2,710 | 2,350 | |||||||||
Individuals' loans for household and other personal expenditures | 128 | 55 | |||||||||
Non-performing assets and loans 90-days or more delinquent: | $ | 60,275 | $ | 66,397 |
March 31, 2021 | |||||||||||
Recorded Balance | Number of Loans | ||||||||||
Commercial and industrial loans | $ | 13,984 | 11 | ||||||||
Real estate loans: | |||||||||||
Construction | 4,360 | 1 | |||||||||
Commercial real estate, non-owner occupied | 43,530 | 10 | |||||||||
Commercial real estate, owner occupied | 1,865 | 6 | |||||||||
Residential | 1,026 | 8 | |||||||||
Individuals' loans for household and other personal expenditures | 291 | 13 | |||||||||
Total | $ | 65,056 | 49 |
Three Months Ended March 31, | |||||||||||
(Dollars in Thousands) | 2021 | 2020 | |||||||||
Net charge-offs (Recoveries): | |||||||||||
Commercial and industrial loans | $ | 484 | $ | 129 | |||||||
Agricultural land, production and other loans to farmers | 1 | 43 | |||||||||
Real estate loans: | |||||||||||
Construction | 2 | (37) | |||||||||
Commercial real estate, non-owner occupied | 2,511 | 19 | |||||||||
Commercial real estate, owner occupied | 638 | 83 | |||||||||
Residential | 72 | (7) | |||||||||
Home equity | (165) | 145 | |||||||||
Individuals' loans for household and other personal expenditures | 78 | 207 | |||||||||
Total net charge-offs | $ | 3,621 | $ | 582 |
(Dollars in Thousands) | Remaining 2021 | 2022 | 2023 | 2024 | 2025 | 2026 and after | ASC 805 fair value adjustments at acquisition | Total | |||||||||||||||||||||||||||||||||||||||
Operating leases | $ | 2,729 | $ | 3,544 | $ | 3,141 | $ | 3,070 | $ | 2,837 | $ | 7,750 | $ | — | $ | 23,071 | |||||||||||||||||||||||||||||||
Securities sold under repurchase agreements | 185,721 | — | — | — | — | — | — | 185,721 | |||||||||||||||||||||||||||||||||||||||
Federal Home Loan Bank advances | 25,072 | 75,097 | 115,097 | 10,097 | 25,097 | 108,877 | — | 359,337 | |||||||||||||||||||||||||||||||||||||||
Subordinated debentures and other borrowings | — | — | — | — | — | 122,012 | (3,573) | 118,439 | |||||||||||||||||||||||||||||||||||||||
Total | $ | 213,522 | $ | 78,641 | $ | 118,238 | $ | 13,167 | $ | 27,934 | $ | 238,639 | $ | (3,573) | $ | 686,568 |
(Dollars in Thousands) | March 31, 2021 | ||||
Amounts of commitments: | |||||
Loan commitments to extend credit | $ | 3,657,931 | |||
Standby and commercial letters of credit | 33,610 | ||||
$ | 3,691,541 |
March 31, 2021 | December 31, 2020 | ||||||||||
Rising 200 basis points from base case | 3.9% | 5.9 | % | ||||||||
Falling 100 basis points from base case | (0.5)% | 0.7 | % |
(Dollars in Thousands) | March 31, 2021 | December 31, 2020 | ||||||||||||
Interest-bearing deposits | $ | 392,806 | $ | 392,305 | ||||||||||
Investment securities available for sale | 2,405,568 | 1,919,119 | ||||||||||||
Investment securities held to maturity, net of allowance for credit losses of $245,000 as of March 31, 2021 | 1,295,289 | 1,227,668 | ||||||||||||
Loans held for sale | 4,430 | 3,966 | ||||||||||||
Loans | 9,318,228 | 9,243,174 | ||||||||||||
Federal Home Loan Bank stock | 28,736 | 28,736 | ||||||||||||
Total | $ | 13,445,057 | $ | 12,814,968 |
Period | Total Number of Shares Purchased (1) | Average Price Paid per Share | Total Number of Shares Purchased as part of Publicly announced Plans or Programs | Maximum Number of Shares that may yet be Purchased Under the Plans or Programs (2) | ||||||||||||||||||||||
January, 2021 | 267 | $ | 40.82 | — | 3,333,000 | |||||||||||||||||||||
February, 2021 | — | $ | — | — | 3,333,000 | |||||||||||||||||||||
March, 2021 | — | $ | — | — | 3,333,000 |
Exhibit No: | Description of Exhibits: | ||||
3.1 | |||||
3.2 | |||||
4.1 | |||||
4.2 | |||||
4.3 | |||||
4.4 | |||||
4.5 | |||||
4.6 | |||||
10.1 | |||||
31.1 | |||||
31.2 | |||||
32 | |||||
101.INS | Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document (2) | ||||
101.SCH | Inline XBRL Taxonomy Extension Schema Document (2) | ||||
101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document (2) | ||||
101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document (2) | ||||
101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document (2) | ||||
101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document (2) | ||||
104 | Cover Page Interactive Data File (formatted as Inline XBRL and included in Exhibit 101) | ||||
(1) Management contract or compensatory plan. | |||||
(2) Filed herewith. | |||||
(3) Furnished herewith. |
First Merchants Corporation | |||||
(Registrant) | |||||
May 10, 2021 | by /s/ Mark K. Hardwick | ||||
Mark K. Hardwick | |||||
Chief Executive Officer | |||||
(Principal Executive Officer) | |||||
May 10, 2021 | by /s/ Michele M. Kawiecki | ||||
Michele M. Kawiecki | |||||
Executive Vice President, Chief Financial Officer | |||||
(Principal Financial and Accounting Officer) |
Service | Annual Amount | Increase from Prior | ||||||||||||
Board Retainer | $ | 115,000 | $ | 20,000 | ||||||||||
Audit Committee Retainer | 5,000 | 5,000 | ||||||||||||
Risk and Credit Policy Committee Retainer | 5,000 | |||||||||||||
Board Chair Supplemental Fee | 50,000 | |||||||||||||
Committee Chair Supplemental Fee: | ||||||||||||||
Audit | 15,000 | * | ||||||||||||
Compensation and Human Resources | 10,000 | |||||||||||||
Risk and Credit Policy | 10,000 | |||||||||||||
Nominating and Governance | 7,500 | |||||||||||||
•Committee Chair does not also receive committee retainer. |
By: /s/ Mark K. Hardwick | ||
Mark K. Hardwick | ||
Chief Executive Officer | ||
(Principal Executive Officer) |
By: /s/ Michele M. Kawiecki | ||
Michele M. Kawiecki | ||
Executive Vice President, | ||
Chief Financial Officer | ||
(Principal Financial and Accounting Officer) |
By: /s/ Mark K. Hardwick | ||
Mark K. Hardwick | ||
Chief Executive Officer | ||
(Principal Executive Officer) |
By: /s/ Michele M. Kawiecki | ||
Michele M. Kawiecki | ||
Executive Vice President, | ||
Chief Financial Officer | ||
(Principal Financial and Accounting Officer) |
CONSOLIDATED CONDENSED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands |
Mar. 31, 2021 |
Dec. 31, 2020 |
---|---|---|
Statement of Financial Position [Abstract] | ||
Allowance for Credit Losses | $ 245 | $ 0 |
Investment securities held to maturity - fair value | $ 1,318,780 | $ 1,280,293 |
Preferred Stock, par value (in dollars per share) | $ 1,000 | $ 1,000 |
Preferred Stock, liquidation value per share (in dollars per share) | $ 1,000 | $ 1,000 |
Preferred Stock, authorized (in shares) | 600 | 600 |
Preferred Stock, issued (in shares) | 125 | 125 |
Preferred Stock, outstanding (in shares) | 125 | 125 |
Common Stock, stated value (in dollars per share) | $ 0.125 | $ 0.125 |
Common Stock, authorized (in shares) | 100,000,000 | 100,000,000 |
Common Stock, issued (in shares) | 53,953,723 | 53,922,359 |
Common Stock, outstanding (in shares) | 53,953,723 | 53,922,359 |
CONSOLIDATED CONDENSED STATEMENTS OF INCOME (Unaudited) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Mar. 31, 2021 |
Mar. 31, 2020 |
|
Loans receivable: | ||
Taxable | $ 85,105 | $ 96,652 |
Tax exempt | 5,339 | 5,315 |
Investment securities: | ||
Taxable | 6,695 | 7,631 |
Tax exempt | 12,385 | 9,335 |
Deposits with financial institutions | 114 | 575 |
Federal Home Loan Bank stock | 178 | 299 |
Total Interest Income | 109,816 | 119,807 |
INTEREST EXPENSE | ||
Deposits | 6,200 | 21,748 |
Federal funds purchased | 2 | 111 |
Securities sold under repurchase agreements | 87 | 352 |
Federal Home Loan Bank advances | 1,442 | 1,774 |
Subordinated debentures and other borrowings | 1,657 | 1,945 |
Total Interest Expense | 9,388 | 25,930 |
NET INTEREST INCOME | 100,428 | 93,877 |
Provision for credit losses - loans | 0 | 19,752 |
NET INTEREST INCOME AFTER PROVISION FOR CREDIT LOSSES | 100,428 | 74,125 |
OTHER INCOME | ||
Net gains and fees on sales of loans | 3,986 | 3,363 |
Increase in cash surrender value of life insurance | 1,189 | 1,360 |
Gains on life insurance benefits | 147 | 0 |
Net realized gains on sales of available for sale securities | 1,799 | 4,612 |
Other income | 232 | 265 |
Total Other Income | 24,091 | 29,799 |
OTHER EXPENSES | ||
Salaries and employee benefits | 38,811 | 39,243 |
Net occupancy | 6,491 | 5,801 |
Equipment | 5,030 | 4,344 |
Marketing | 1,124 | 1,443 |
Outside data processing fees | 4,244 | 4,199 |
Printing and office supplies | 283 | 387 |
Intangible asset amortization | 1,357 | 1,514 |
FDIC assessments | 1,368 | 1,523 |
Other real estate owned and foreclosure expenses | 734 | 505 |
Professional and other outside services | 2,543 | 2,258 |
Other expenses | 4,113 | 4,954 |
Total Other Expenses | 66,098 | 66,171 |
INCOME BEFORE INCOME TAX | 58,421 | 37,753 |
Income tax expense | 8,952 | 3,490 |
NET INCOME AVAILABLE TO COMMON STOCKHOLDERS | $ 49,469 | $ 34,263 |
Per Share Data: | ||
Basic Net Income Available to Common Stockholders (in dollars per share) | $ 0.92 | $ 0.63 |
Diluted Net Income Available to Common Stockholders (in dollars per share) | 0.91 | 0.62 |
Cash Dividends Paid (in dollars per share) | $ 0.26 | $ 0.26 |
Average Diluted Shares Outstanding (in shares) | 54,133,622 | 54,917,760 |
Service charges on deposit accounts | ||
OTHER INCOME | ||
Other income | $ 5,264 | $ 5,970 |
Fiduciary and wealth management fees | ||
OTHER INCOME | ||
Other income | 6,422 | 5,985 |
Card payment fees | ||
OTHER INCOME | ||
Other income | 4,367 | 5,907 |
Derivative hedge fees | ||
OTHER INCOME | ||
Other income | 317 | 1,939 |
Other customer fees | ||
OTHER INCOME | ||
Other income | $ 368 | $ 398 |
CONSOLIDATED CONDENSED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Mar. 31, 2021 |
Mar. 31, 2020 |
|
Statement of Comprehensive Income [Abstract] | ||
Net income | $ 49,469 | $ 34,263 |
Unrealized gains/losses on securities available-for-sale: | ||
OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax | (47,911) | 38,435 |
Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, before Tax | (1,799) | (4,612) |
Tax effect | 10,439 | (7,102) |
Net of tax | (39,271) | 26,721 |
Unrealized gain/loss on cash flow hedges: | ||
Unrealized holding gain (loss) arising during the period | 58 | (1,314) |
Reclassification adjustment for losses (gains) included in net income | 252 | 125 |
Tax effect | (65) | 250 |
Net of tax | 245 | (939) |
Other comprehensive income (loss), net of tax | (39,026) | 25,782 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Total | $ 10,443 | $ 60,045 |
CONSOLIDATED CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($) $ in Thousands |
Total |
Cumulative effect of ASC 326 adoption |
Adjusted balance |
Preferred |
Preferred
Adjusted balance
|
Common Stock |
Common Stock
Adjusted balance
|
Additional Paid in Capital |
Additional Paid in Capital
Adjusted balance
|
Retained Earnings |
Retained Earnings
Cumulative effect of ASC 326 adoption
|
Retained Earnings
Adjusted balance
|
Accumulated Other Comprehensive Income (Loss) |
Accumulated Other Comprehensive Income (Loss)
Adjusted balance
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Beginning balance (in shares) at Dec. 31, 2019 | 125 | 55,368,482 | ||||||||||||
Beginning balance at Dec. 31, 2019 | $ 1,786,437 | $ 125 | $ 6,921 | $ 1,054,997 | $ 696,520 | $ 27,874 | ||||||||
Comprehensive income: | ||||||||||||||
Net income | 34,263 | 34,263 | ||||||||||||
Other comprehensive income (loss), net of tax | 25,782 | 25,782 | ||||||||||||
Cash dividends on common stock | (14,265) | (14,265) | ||||||||||||
Repurchase of common stock (in shares) | (1,634,437) | |||||||||||||
Repurchases of common stock | (55,912) | $ (204) | (55,708) | |||||||||||
Share-based compensation (in shares) | 3,332 | |||||||||||||
Share-based compensation | 1,220 | 1,220 | ||||||||||||
Stock issued under dividend reinvestment and stock purchase plan (in shares) | 15,710 | |||||||||||||
Stock issued under dividend reinvestment and stock purchase plan | 428 | $ 2 | 426 | |||||||||||
Stock options exercised (in shares) | 1,050 | |||||||||||||
Stock options exercised | 7 | 7 | ||||||||||||
Ending balance (in shares) at Mar. 31, 2020 | 125 | 53,754,137 | ||||||||||||
Ending balance at Mar. 31, 2020 | 1,777,960 | $ 125 | $ 6,719 | 1,000,942 | 716,518 | 53,656 | ||||||||
Beginning balance (in shares) at Dec. 31, 2020 | 125 | 125 | 53,922,359 | 53,922,359 | ||||||||||
Beginning balance at Dec. 31, 2020 | 1,875,645 | $ (68,040) | $ 1,807,605 | $ 125 | $ 125 | $ 6,740 | $ 6,740 | 1,005,366 | $ 1,005,366 | 788,578 | $ (68,040) | $ 720,538 | 74,836 | $ 74,836 |
Comprehensive income: | ||||||||||||||
Net income | 49,469 | 49,469 | ||||||||||||
Other comprehensive income (loss), net of tax | (39,026) | (39,026) | ||||||||||||
Cash dividends on common stock | (14,130) | (14,130) | ||||||||||||
Share-based compensation (in shares) | 4,285 | |||||||||||||
Share-based compensation | 1,190 | $ 1 | 1,189 | |||||||||||
Stock issued under employee benefit plans (in shares) | 3,929 | |||||||||||||
Stock issued under employee benefit plans | 144 | 144 | ||||||||||||
Stock issued under dividend reinvestment and stock purchase plan (in shares) | 9,117 | |||||||||||||
Stock issued under dividend reinvestment and stock purchase plan | $ 443 | $ 1 | 442 | |||||||||||
Stock options exercised (in shares) | 14,300 | 14,300 | ||||||||||||
Stock options exercised | $ 171 | $ 2 | 169 | |||||||||||
Restricted shares withheld for taxes (in shares) | (267) | |||||||||||||
Restricted shares withheld for taxes | (10) | (10) | ||||||||||||
Ending balance (in shares) at Mar. 31, 2021 | 125 | 53,953,723 | ||||||||||||
Ending balance at Mar. 31, 2021 | $ 1,805,856 | $ 125 | $ 6,744 | $ 1,007,300 | $ 755,877 | $ 35,810 |
CONSOLIDATED CONDENSED STATEMENTS OF STOCKHOLDERS’ EQUITY (Unaudited) (Parenthetical) |
12 Months Ended |
---|---|
Dec. 31, 2020 | |
Statement of Stockholders' Equity [Abstract] | |
Accounting Standards Update [Extensible List] | us-gaap:AccountingStandardsUpdate201613Member |
CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Mar. 31, 2021 |
Mar. 31, 2020 |
|
Cash Flow From Operating Activities: | ||
Net income | $ 49,469 | $ 34,263 |
Adjustments to reconcile net income to net cash provided by operating activities: | ||
Provision for loan losses | 0 | 19,752 |
Depreciation and amortization | 2,748 | 2,674 |
Change in deferred taxes | (3,079) | (7,662) |
Share-based compensation | 1,190 | 1,220 |
Loans originated for sale | (111,558) | (163,378) |
Proceeds from sales of loans held for sale | 114,383 | 170,307 |
Gains on sales of loans held for sale | (3,289) | (2,931) |
Gains on sales of securities available for sale | (1,799) | (4,612) |
Increase in cash surrender of life insurance | (1,189) | (1,360) |
Gains on life insurance benefits | (147) | 0 |
Change in interest receivable | (714) | 1,412 |
Change in interest payable | 733 | 992 |
Other adjustments | 6,062 | 20,816 |
Net cash provided by operating activities | 52,810 | 71,493 |
Cash Flows from Investing Activities: | ||
Net change in interest-bearing deposits | (501) | (14,681) |
Purchases of: | ||
Securities available for sale | (597,901) | (87,499) |
Securities held to maturity | (135,098) | (126,759) |
Proceeds from sales of securities available for sale | 48,016 | 96,558 |
Proceeds from maturities of: | ||
Securities available for sale | 80,114 | 45,621 |
Securities held to maturity | 66,361 | 49,912 |
Net change in loans | (72,704) | (148,882) |
Proceeds from the sale of other real estate owned | 495 | 303 |
Proceeds from life insurance benefits | 315 | 0 |
Other adjustments | (2,285) | (3,672) |
Net cash used in investing activities | (613,188) | (189,099) |
Net change in : | ||
Demand and savings deposits | 620,609 | 109,276 |
Certificates of deposit and other time deposits | (30,439) | (78,748) |
Borrowings | 8,678 | 180,060 |
Repayment of borrowings | (30,093) | (72,710) |
Cash dividends on common stock | (14,130) | (14,265) |
Stock issued under employee benefit plans | 144 | 0 |
Stock issued under dividend reinvestment and stock purchase plans | 443 | 428 |
Stock options exercised | 171 | 7 |
Repurchase of common stock | 0 | (55,912) |
Net cash provided by financing activities | 555,383 | 68,136 |
Net Change in Cash and Cash Equivalents | (4,995) | (49,470) |
Cash and Cash Equivalents, January 1 | 192,896 | 177,201 |
Cash and Cash Equivalents, March 31 | 187,901 | 127,731 |
Additional cash flow information: | ||
Interest paid | 8,655 | 24,938 |
Loans transferred to other real estate owned | 44 | 761 |
Fixed assets transferred to other real estate owned | 1,167 | 0 |
Non-cash investing activities using trade date accounting | 66,558 | 44,362 |
ROU assets obtained in exchange for new operating lease liabilities | $ 386 | $ 79 |
General |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
General | GENERAL Financial Statement Preparation The Consolidated Condensed Balance Sheet of the Corporation as of December 31, 2020, has been derived from the audited consolidated balance sheet of the Corporation as of that date. Certain information and note disclosures normally included in the Corporation’s annual financial statements, prepared in accordance with accounting principles generally accepted in the United States of America, have been condensed or omitted. These consolidated condensed financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Corporation’s Annual Report on Form 10-K for the year ended December 31, 2020 filed with the Securities and Exchange Commission. The results of operations for the three months ended March 31, 2021, are not necessarily indicative of the results to be expected for the year. Reclassifications have been made to prior financial statements to conform to the current financial statement presentation. These reclassifications had no effect on net income. Material estimates that are particularly susceptible to significant change relate to the determination of the allowance for credit losses and fair value of financial instruments. The uncertainties related to the coronavirus disease 2019 ("COVID-19") could cause significant changes to these estimates compared to what was known at the time these financial statements were prepared. Significant Accounting Policies The significant accounting policies followed by the Corporation and its wholly-owned subsidiaries for interim financial reporting are consistent with the accounting policies followed for annual financial reporting, with the exception of the Corporation's adoption of ASC 326 as described below under the heading "Recent Accounting Changes Adopted In 2021." The Corporation revised certain accounting policies and implemented certain accounting policy elections, related to the adoption of ASC 326 which are described below. All adjustments, which are of a normal recurring nature and are in the opinion of management necessary for a fair statement of the results for the periods reported, have been included in the accompanying Consolidated Condensed Financial Statements. The Corporation adopted FASB Accounting Standards Update (ASU) No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments ("CECL") on January 1, 2021. CECL replaces the previous "incurred loss" model for measuring credit losses, which encompassed allowances for current known and inherent losses within the portfolio, with an "expected loss" model for measuring credit losses, which encompasses allowances for losses expected to be incurred over the life of the portfolio. The new CECL model requires the measurement of all expected credit losses for financial assets measured at amortized cost and certain off-balance sheet credit exposures based on historical experiences, current conditions, and reasonable and supportable forecasts. CECL also requires enhanced disclosures related to the significant estimates and judgments used in estimating credit losses, as well as credit quality and underwriting standards of an organization's portfolio. In addition, CECL includes certain changes to the accounting for investment securities available for sale depending on whether management intends to sell the securities or believes that it is more likely than not they will be required to sell. As of the adoption and day one measurement date of January 1, 2021, the Corporation recorded a one-time cumulative-effect adjustment to retained earnings, net of income taxes, on the consolidated balance sheet of $68.0 million. The allowance increased 57 percent from December 31, 2020, or $74.1 million, because it covered expected credit losses over the life of the loan portfolio, which approximates four years, and it included an allowance on all purchased loans that were previously excluded from the allowance for loan losses calculation. CECL also requires the establishment of a reserve for potential losses from unfunded commitments that is recorded in other liabilities, separate from allowance for credit losses, which was approximately $20.5 million. An allowance for credit losses of $245,000 was recorded on the state and municipal securities classified as held to maturity based on applying the long-term historical credit loss rate, as published by Moody’s, for similarly rated securities. The following table details the impact of the adoption of CECL on the Corporation's balance sheet as of January 1, 2021.
Allowance for credit losses on investment securities available for sale – for investment securities available for sale in an unrealized loss position, the Corporation first assesses whether it intends to sell, or it is more likely than not that it will be required to sell the security before recovery of its amortized cost basis. If either of the criteria regarding intent or requirement to sell is met, the security’s amortized cost basis is written down to fair value through income. For investment securities available for sale that do not meet the aforementioned criteria, the Corporation evaluates whether the decline in fair value has resulted from credit losses or other factors. In making this assessment, the Corporation considers the extent to which fair value is less than amortized cost, any changes to the rating of the security by a rating agency, and adverse conditions specifically related to the security, among other factors. If this assessment indicates that a credit loss exists, the present value of cash flows expected to be collected from the security are compared to the amortized cost basis of the security. If the present value of cash flows expected to be collected is less than the amortized cost basis, a credit loss exists and an allowance for credit losses is recorded, limited by the amount that the fair value is less than the amortized cost basis. Unrealized losses that have not been recorded through an allowance for credit losses are recognized in other comprehensive income. Adjustments to the allowance for credit losses are reported in the income statement as a component of the provision for credit loss. The Corporation has made the accounting policy election to exclude accrued interest receivable on investment securities available for sale from the estimate of credit losses. Investment securities available for sale are charged off against the allowance or, in the absence of any allowance, written down through the income statement when deemed uncollectible or when either of the aforementioned criteria regarding intent or requirement to sell is met. The Corporation did not record an allowance for credit losses on its investment securities available for sale as the unrealized losses were attributable to changes in interest rates, not credit quality. Allowance for credit losses on investment securities held to maturity ("ACL - Investments") – the ACL - Investments is a contra asset-valuation account that is deducted from the amortized cost basis of investment securities held to maturity to present the net amount expected to be collected. Investment securities held to maturity are charged off against the ACL - Investments when deemed uncollectible. Adjustments to the ACL - Investments are reported in the income statement as a component of the provision for credit loss. The Corporation measures expected credit losses on held to maturity debt securities on a collective basis by major security type with each type sharing similar risk characteristics, and considers historical credit loss information that is adjusted for current conditions and reasonable and supportable forecasts. The Corporation has made the accounting policy election to exclude accrued interest receivable on investment securities held to maturity from the estimate of credit losses. With regard to U.S. Government-sponsored agency and mortgage-backed securities, all these securities are issued by a U.S. government-sponsored entity and have an implicit or explicit government guarantee. With regard to securities issued by states and municipalities and other investment securities held to maturity, management considers (1) issuer bond ratings, (2) the financial condition of the issuer, (3) historical loss rates for given bond ratings, and (4) whether issuers continue to make timely principal and interest payments under the contractual terms of the securities. Historical loss rates associated with securities having similar grades as those in the Corporation's portfolio have generally not been significant. Furthermore, as of March 31, 2021, there were no past due principal and interest payments associated with these securities. An allowance for credit losses of $245,000 was recorded on the state and municipal securities classified as held to maturity based on applying the long-term historical credit loss rate, as published by Moody’s, for similarly rated securities. Purchased Credit Deteriorated (“PCD”) – the Corporation has purchased loans, some of which have experienced more than insignificant credit deterioration since origination. PCD loans are recorded at the amount paid. An allowance for credit losses is determined using the same methodology as other loans held for investment. The initial allowance for credit losses determined on a collective basis is allocated to individual loans. The sum of the loan’s purchase price and allowance for credit losses becomes its initial amortized cost basis. The difference between the initial amortized cost basis and the par value of the loan is the noncredit discount or premium, which is amortized into interest income over the life of the loan. Subsequent changes to the allowance for credit losses are recorded through the provision for credit losses. Allowance for Credit Losses - Loans ("ACL - Loans") - the ACL - Loans is a valuation account that is deducted from the loans’ amortized cost basis to present the net amount expected to be collected on loans over the contractual term. Loans are charged off against the allowance when the uncollectibility of the loan is confirmed. Expected recoveries do not exceed the aggregate of amounts previously charged off and expected to be charged off. Adjustments to the ACL- Loans are reported in the income statement as a component of provision for credit loss. The Corporation has made the accounting policy election to exclude accrued interest receivable on loans from the estimate of credit losses. Further information regarding the policies and methodology used to estimate the ACL - Loans is detailed in NOTE 3. LOANS AND ALLOWANCE of these Notes to Consolidated Condensed Financial Statements. Allowance for Credit Losses – Off-Balance Sheet Credit Exposures – the allowance for credit losses on off-balance sheet credit exposures is a liability account representing expected credit losses over the contractual period for which the Corporation is exposed to credit risk resulting from a contractual obligation to extend credit. No allowance is recognized if the Corporation has the unconditional right to cancel the obligation. Off-balance sheet credit exposures primarily consist of amounts available under outstanding lines of credit and letters of credit. For the period of exposure, the estimate of expected credit losses considers both the likelihood that funding will occur and the amount expected to be funded over the estimated remaining life of the commitment or other off-balance sheet exposure. The likelihood and expected amount of funding are based on historical utilization rates. The amount of the allowance represents management’s best estimate of expected credit losses on commitments expected to be funded over the contractual life of the commitment. The allowance for off-balance sheet credit exposures is adjusted through the income statement as a component of provision for credit loss. Impact of COVID-19 On January 30, 2020, the World Health Organization (“WHO”) announced that the outbreak of COVID-19 constituted a public health emergency of international concern. On March 11, 2020, WHO declared COVID-19 to be a global pandemic and, on March 13, 2020, the President of the United States declared the COVID-19 outbreak a national emergency. The health concerns relating to the COVID-19 outbreak and related governmental actions taken to reduce the spread of the virus have significantly impacted the global economy (including the states and local economies in which the Corporation operates), disrupted supply chains, lowered equity market valuations, and created significant volatility and disruption in financial markets. The outbreak has resulted in authorities implementing numerous measures to try to contain the virus, such as travel bans and restrictions, quarantines, shelter in place or total lock-down orders and business limitations and shutdowns. As a result of the shelter in place mandates in effect beginning early in the second quarter of 2020, commercial activity throughout our geographic footprint, as well as nationally, decreased significantly during 2020 and 2021. These containment measures have significantly contributed to rising unemployment and negatively impacted consumer and business spending. Although most states have reopened, albeit under limited capacities and under other social distancing restrictions, commercial activity has not returned to the levels existing prior to the outbreak of the pandemic. While multiple COVID-19 vaccines are now broadly available and vaccination rates are steadily increasing, it is too early to know how effective vaccinations will be in mitigating the adverse social and economic effects of the pandemic. Moreover, certain states and localities have recently experienced significant increases in the number of individuals diagnosed with COVID-19, which, in certain cases, is causing government officials to reinstitute activity restrictions. In addition, variant strains of the COVID-19 virus have appeared, further complicating efforts of the medical community and federal, state and local governments in response to the pandemic. The continued impact of COVID-19 on the Corporation will depend on numerous factors and future developments that are highly uncertain and cannot be predicted with confidence. It is unknown how long the COVID-19 pandemic will last, or when restrictions on individuals and businesses will be fully lifted and businesses and their employees will be able to resume normal activities. Additional information may emerge regarding new developments with COVID-19 and additional actions may be taken by federal, state and local governments to contain COVID-19 or treat its impact. Changes in the behavior of customers, businesses and their employees as a result of COVID-19 pandemic, including social distancing practices, even after formal restrictions have been lifted and vaccination rates have increased, are also unknown. As a result of COVID-19 and the actions taken to contain it or reduce its impact, we may experience changes in the demand for our products and services, changes in the value of collateral securing outstanding loans, reductions in the credit quality of borrowers and the inability of borrowers to repay loans in accordance with their terms. Our commercial and consumer customers are experiencing varying degrees of financial distress, which is expected to continue in 2021, especially if positive cases increase and economic shutdowns continue. These and similar factors and events may have substantial negative effects on the business, financial condition and results of operations of the Corporation and its customers. Guidance on Non-TDR Loan Modifications due to COVID-19 On March 22, 2020, a statement was issued by the Bank’s banking regulators and titled the “Interagency Statement on Loan Modifications and Reporting for Financial Institutions Working with Customers Affected by the Coronavirus” (the “Interagency Statement”) that encourages financial institutions to work prudently with borrowers who are or may be unable to meet their contractual payment obligations due to the effects of COVID-19. Additionally, Section 4013 of the CARES Act further provides that a qualified loan modification is exempt by law from classification as a troubled debt restructure as defined by GAAP, from the period beginning March 1, 2020 until the earlier of December 31, 2020 or the date that is 60 days after the date on which the national emergency concerning the COVID-19 outbreak under the National Emergencies Act (50 U.S.C. 1601 et seq.) terminates. The Interagency Statement was subsequently revised on April 7, 2020 to clarify the interaction of the original guidance with Section 4013 of the CARES Act, as well as setting forth the banking regulators’ views on consumer protection considerations. In accordance with such guidance, the Bank has offered short-term modifications made in response to COVID-19 to borrowers who were current and otherwise not past due. These included short-term, 180 days or less, modifications in the form of payment deferrals, fee waivers, extensions of repayment terms, or other delays in payment that are insignificant. The CAA, as described above, extended the expiration date for COVID-related loan modifications exempt from troubled debt restructuring classification until the earlier of January 1, 2022, or 60 days after the termination of the national emergency. Details of the Corporation's modifications are included in the "LOAN QUALITY" section of Management’s Discussion and Analysis of Financial Condition and Results of Operations included on this Form 10-Q. Recent Accounting Changes Adopted In 2021 The Corporation continually monitors potential accounting pronouncements and the following pronouncements have been deemed to have the most applicability to the Corporation's financial statements: FASB Accounting Standards Updates No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments Summary - The FASB issued Accounting Standards Update (ASU) No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. This new guidance replaces the previous "incurred loss" model for measuring credit losses with an "expected life of loan loss" model, referred to as the CECL model. Under the CECL model, certain financial assets carried at amortized cost, such as loans held for investment and held-to-maturity debt securities, are required to be presented at the net amount expected to be collected. The measurement of expected credit losses is based on information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. This measurement takes place at the time the financial asset is first added to the balance sheet and periodically thereafter. This differs significantly from the “incurred loss” model, which delayed recognition until it is probable a loss had been incurred. The Corporation developed models that satisfy the requirements of the new standard which are governed by a system of internal controls and a cross-functional working group consisting of accounting, finance, and credit administration personnel. The loan portfolio was pooled into ten loan segments with similar risk characteristics for which the probability of default/loss given default methodology was applied. The Corporation utilized a one-year economic forecast period then reverted to historical macroeconomic levels for the remaining life of the portfolio. A baseline macroeconomic scenario, along with other scenarios, were used to develop a range of estimated credit losses for which to determine the best estimate within. The ASU was effective for SEC filers for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. Pursuant to the CARES Act and the related joint statement of federal banking regulators (which also became effective as of March 27, 2020), and consistent with guidance from the SEC and FASB, the Corporation elected to delay implementation of ASU No. 2016-13, which was set to expire on December 31, 2020. However, the CAA (as discussed above) extended the temporary relief from CECL compliance to the earlier of the first day of the fiscal year that begins after the date on which the national emergency concerning COVID-19 terminates, or January 1, 2022. The Corporation elected to delay implementation of CECL following the approval of the CARES Act and, with the enactment of the CAA, the Corporation elected to adopt CECL on January 1, 2021. This allows the Corporation to utilize the CECL standard for the entire year of 2021, while its 2020 financial statements were prepared under the incurred loss model. As of the adoption and day one measurement date of January 1, 2021, the Corporation recorded a one-time cumulative-effect adjustment to retained earnings, net of income taxes, on the consolidated balance sheet of $68.0 million. The allowance increased 57 percent from December 31, 2020, or $74.1 million, because it covered expected credit losses over the life of the loan portfolio, which approximates four years, and it included an allowance on all purchased loans that were previously excluded from the allowance for loan losses calculation. CECL also requires the establishment of a reserve for potential losses from unfunded commitments that is recorded in other liabilities, separate from allowance for credit losses, which was approximately $20.5 million. An allowance for credit losses of $245,000 was recorded on the state and municipal securities classified as held to maturity based on applying the long-term historical credit loss rate, as published by Moody’s, for similarly rated securities. FASB Accounting Standards Updates No. 2019-11 - Codification Improvements to (Topic 326): Financial Instruments - Credit Losses Summary - The FASB issued ASU No. 2019-11, Codification Improvements to Topic 326, Financial Instruments - Credit Losses in order to address issues raised by stakeholders during the implementation of ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses of Financial Instruments. Among other narrow-scope improvements, the new ASU clarifies guidance around how to report expected recoveries. “Expected recoveries” describes a situation in which an organization recognizes a full or partial write-off of the amortized cost basis of a financial asset, but then later determines that the amount written off, or a portion of that amount, will in fact be recovered. While applying the credit losses standard, stakeholders questioned whether expected recoveries were permitted on assets that had already shown credit deterioration at the time of purchase (also known as PCD assets). In response to this question, the ASU permits organizations to record expected recoveries on PCD assets. In addition to other narrow technical improvements, the ASU also reinforces existing guidance that prohibits organizations from recording negative allowances for available-for-sale debt securities. The ASU includes effective dates and transition requirements that vary depending on whether or not an entity has already adopted ASU No. 2016-13. As discussed above, pursuant to the CARES Act, the Corporation elected to defer the adoption of CECL. Additionally, the 2021 Consolidated Appropriations Act ("CAA"), signed into law on December 27, 2020, amended the CARES Act by extending the temporary relief from CECL compliance to the earlier of the first day of the fiscal year that begins after the date on which the national emergency concerning COVID-19 terminates, or January 1, 2022. The Corporation elected to delay implementation of CECL following the approval of the CARES Act and, with the enactment of the CAA, the Corporation elected to adopt CECL on January 1, 2021. The adoption of this standard did not have a significant effect on the Corporation’s consolidated financial statements or disclosures. Accounting Standards Update No. 2019-12 - Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes Summary - The FASB issued ASU No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which is expected to reduce cost and complexity related to the accounting for income taxes. The ASU removes specific exceptions to the general principles in Topic 740 in Generally Accepted Accounting Principles (GAAP). It eliminates the need for an organization to analyze whether the following apply in a given period: • Exception to the incremental approach for intraperiod tax allocation; • Exceptions to accounting for basis differences when there are ownership changes in foreign investments; and • Exception in interim period income tax accounting for year-to-date losses that exceed anticipated losses. The ASU also improves financial statement preparers’ application of income tax-related guidance and simplifies GAAP for: • Franchise taxes that are partially based on income; • Transactions with a government that result in a step up in the tax basis of goodwill • Separate financial statements of legal entities that are not subject to tax; and • Enacted changes in tax laws in interim periods. The ASU is part of the FASB’s simplification initiative to make narrow-scope simplifications and improvements to accounting standards through a series of short-term projects. For public business entities, the ASU is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. Early adoption of the ASU was permitted. The Corporation adopted this standard on January 1, 2021 and adoption of this standard did not have a significant effect on the Corporation's consolidated financial statements or disclosures. New Accounting Pronouncements Not Yet Adopted FASB Accounting Standards Updates - No. 2020-04 - Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting Summary - The FASB issued ASU No. 2020-04 to provide temporary optional guidance to ease the potential burden in accounting for reference rate reform. LIBOR and other interbank offered rates are widely used benchmarks or reference rates in the United States and globally. Trillions of dollars in loans, derivatives, and other financial contracts reference LIBOR, the benchmark interest rate banks use to make short-term loans to each other. With global capital markets expected to move away from LIBOR and other interbank offered rates and move toward rates that are more observable or transaction based and less susceptible to manipulation, the FASB launched a broad project in late 2018 to address potential accounting challenges expected to arise from the transition. The new guidance provides optional expedients and exceptions for applying generally accepted accounting principles to contract modifications and hedging relationships, subject to meeting certain criteria, that reference LIBOR or another reference rate expected to be discontinued. The ASU is intended to help stakeholders during the global market-wide reference rate transition period. Entities may apply this ASU as of the beginning of an interim period that includes the March 12, 2020 issuance date of the ASU, through December 31, 2022. The Corporation expects to adopt the practical expedients included in the ASU prior to December 31, 2022. The Corporation is implementing a transition plan to identify and modify its loans and other financial instruments with attributes that are either directly or indirectly influenced by LIBOR. The Corporation is assessing ASU 2020-04 and its impact on the Corporation's transition away from LIBOR for its loans and other financial instruments. FASB Accounting Standards Updates - Accounting Standards Update No. 2021-01 - Reference Rate Reform (Topic 848): Scope Summary - The FASB has published ASU 2021-01, Reference Rate Reform. ASU 2021-01 clarifies that certain optional expedients and exceptions in Topic 848 for contract modifications and hedge accounting apply to derivatives that are affected by the discounting transition. The ASU also amends the expedients and exceptions in Topic 848 to capture the incremental consequences of the scope clarification and to tailor the existing guidance to derivative instruments affected by the discounting transition. An entity may elect to apply the amendments in this Update on a full retrospective basis as of any date from the beginning of an interim period that includes or is subsequent to March 12, 2020, or on a prospective basis to new modifications from any date within an interim period that includes or is subsequent to the date of the issuance of a final Update, up to the date that financial statements are available to be issued. If an entity elects to apply any of the amendments in this Update for an eligible hedging relationship, any adjustments as a result of those elections must be reflected as of the date the entity applies the election. The amendments in this Update do not apply to contract modifications made after December 31, 2022, new hedging relationships entered into after December 31, 2022, and existing hedging relationships evaluated for effectiveness in periods after December 31, 2022, except for hedging relationships existing as of December 31, 2022, that apply certain optional expedients in which the accounting effects are recorded through the end of the hedging relationship (including periods after December 31, 2022). The Corporation is assessing ASU 2021-01 and its impact on the Corporation's transition away from LIBOR for its loans and other financial instruments.
|
Investment Securities |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investments, Debt and Equity Securities [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment Securities | INVESTMENT SECURITIES The following table summarizes the amortized cost, gross unrealized gains and losses and approximate fair value of investment securities available for sale as of March 31, 2021 and December 31, 2020.
The following table summarizes the amortized cost, gross unrealized gains and losses, approximate fair value and allowance for credit losses on investment securities held to maturity as of March 31, 2021 and December 31, 2020.
Accrued interest on investment securities available for sale and held to maturity of $20.6 million are included in the Interest Receivable line on the Corporation's Consolidated Condensed Balance Sheets. The total amount of accrued interest is excluded from the amortized cost of available for sale and held to maturity securities presented above. In determining the allowance for credit losses on investment securities available for sale that are in an unrealized loss position, the Corporation first assesses whether it intends to sell, or it is more likely than not that it will be required to sell the security before recovery of its amortized cost basis. If either of the criteria regarding intent or requirement to sell is met, the security’s amortized cost basis is written down to fair value through the income statement. For investment securities available for sale that do not meet the aforementioned criteria, the Corporation evaluates whether the decline in fair value has resulted from credit losses or other factors. In making this assessment, the Corporation considers the extent to which fair value is less than amortized cost, any changes to the rating of the security by a rating agency, and adverse conditions specifically related to the security, among other factors. If this assessment indicates that a credit loss exists, the present value of cash flows expected to be collected from the security are compared to the amortized cost basis of the security. If the present value of cash flows expected to be collected is less than the amortized cost basis, a credit loss exists and an allowance for credit losses is recorded for the credit loss, limited by the amount that the fair value is less than the amortized cost basis. Unrealized losses that have not been recorded through an allowance for credit losses is recognized in other comprehensive income. Adjustments to the allowance are reported in the income statement as a component of the provision for credit loss. The Corporation has made the accounting policy election to exclude accrued interest receivable on investment securities available for sale from the estimate of credit losses. Investment securities available for sale are charged off against the allowance or, in the absence of any allowance, written down through the income statement when deemed uncollectible or when either of the aforementioned criteria regarding intent or requirement to sell is met. The Corporation did not record an allowance for credit losses on its investment securities available for sale as the unrealized losses were attributable to changes in interest rates, not credit quality. The allowance for credit losses on investment securities held to maturity is a contra asset-valuation account that is deducted from the amortized cost basis of investment securities held to maturity to present the net amount expected to be collected. Investment securities held to maturity are charged off against the allowance when deemed uncollectible. Adjustments to the allowance are reported in the income statement as a component of the provision for credit loss. The Corporation measures expected credit losses on investment securities held to maturity on a collective basis by major security type with each type sharing similar risk characteristics, and considers historical credit loss information that is adjusted for current conditions and reasonable and supportable forecasts. The Corporation has made the accounting policy election to exclude accrued interest receivable on investment securities held to maturity from the estimate of credit losses. With regard to U.S. Government-sponsored agency and mortgage-backed securities, all these securities are issued by a U.S. government-sponsored entity and have an implicit or explicit government guarantee; therefore, no allowance for credit losses has been recorded for these securities.. With regard to securities issued by states and municipalities and other investment securities held to maturity, management considers (1) issuer bond ratings, (2) historical loss rates for given bond ratings, (3) the financial condition of the issuer, and (4) whether issuers continue to make timely principal and interest payments under the contractual terms of the securities. Historical loss rates associated with securities having similar grades as those in the Corporation's portfolio have been insignificant. Furthermore, as of March 31, 2021, there were no past due principal and interest payments associated with these securities. An allowance for credit losses of $245,000 was recorded on the state and municipal securities classified as held to maturity based on applying the long-term historical credit loss rate, as published by Moody’s, for similarly rated securities. On a quarterly basis, the Corporation monitors the credit quality of investment securities held to maturity through the use of credit ratings. The following table summarizes the amortized cost of investment securities held to maturity at March 31, 2021, aggregated by credit quality indicator.
The following table details activity in the allowance for credit losses on investment securities held to maturity during the three months ended March 31, 2021.
The following tables summarize, as of March 31, 2021 and December 31, 2020, investment securities available for sale in an unrealized loss position for which an allowance for credit losses has not been recorded, aggregated by security type and length of time in a continuous unrealized loss position.
Certain investment securities available for sale are reported in the financial statements at an amount less than their historical cost as indicated in the table below.
In determining the fair value of the investment securities portfolio, the Corporation utilizes a third party for portfolio accounting services, including market value input, for those securities classified as Level I and Level II in the fair value hierarchy. The Corporation has obtained an understanding of what inputs are being used by the vendor in pricing the portfolio and how the vendor classified these securities based upon these inputs. From these discussions, the Corporation’s management is comfortable that the classifications are proper. The Corporation has gained trust in the data for two reasons: (a) independent spot testing of the data is conducted by the Corporation through obtaining market quotes from various brokers on a periodic basis; and (b) actual gains or loss resulting from the sale of certain securities has proven the data to be accurate over time. Fair value of securities classified as Level 3 in the valuation hierarchy was determined using a discounted cash flow model that incorporated market estimates of interest rates and volatility in markets that have not been active. U.S. Government-Sponsored Mortgage-Backed Securities The unrealized losses on the Corporation's investment in mortgage-backed securities were a result of interest rate changes. The Corporation expects to recover the amortized cost basis over the term of the securities. Because the decline in market value is attributable to changes in interest rates and not credit quality, and because the Corporation does not intend to sell the investments and it is not more likely than not that the Corporation will be required to sell the investments before recovery of their amortized cost basis, which may be maturity. As noted in the table above, the mortgage-backed securities portfolio contains unrealized losses of $16.3 million on fifty-five securities in the available for sale portfolio. All these securities are issued by a government-sponsored entity. State and Municipal Securities, U.S. Government-Sponsored Agency Securities and Corporate Obligation Securities The unrealized losses on the Corporation's investments in securities of state and political subdivisions, U.S. Government-Sponsored Agency securities and corporate obligations were caused by interest rate increases. The contractual terms of those investments do not permit the issuer to settle the securities at a price less than the amortized cost basis of the investments. The Corporation does not intend to sell the investments and it is not more likely than not that the Corporation will be required to sell the investments before recovery of their amortized cost basis, which may be maturity. As noted in the table above, the state and municipal securities portfolio contains unrealized losses of $2.7 million on one hundred eight securities in the available for sale portfolio. The U.S. government-sponsored agency securities portfolio contains unrealized losses of $163,000 on two securities in the available for sale portfolio. The corporate obligation securities portfolio contains unrealized losses of $22,000 on one security in the available for sale portfolio. The amortized cost and fair value of investment securities available for sale and held to maturity at March 31, 2021 and December 31, 2020, by contractual maturity are shown below. Expected maturities will differ from contractual maturities because issuers may have the right to call or prepay obligations with or without call or prepayment penalties. Securities not due at a single maturity are shown separately.
Securities with a carrying value of approximately $999.2 million and $890.0 million were pledged at March 31, 2021 and December 31, 2020, respectively, to secure certain deposits and securities sold under repurchase agreements, and for other purposes as permitted or required by law. The book value of securities sold under agreements to repurchase amounted to $178.2 million at March 31, 2021 and $167.3 million at December 31, 2020. Gross gains on the sales and redemptions of investment securities available for sale for the three months ended March 31, 2021 and 2020 are shown below.
|
Loans and Allowance |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Receivables [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loans and Allowance | LOANS AND ALLOWANCE Loan Portfolio and Credit Quality The Corporation's primary lending focus is small business and middle market commercial, commercial real estate and residential real estate, which results in portfolio diversification. The following tables show the composition of the loan portfolio and credit quality characteristics by collateral classification, excluding loans held for sale. Loans held for sale at March 31, 2021 and December 31, 2020, were $4.4 million and $4.0 million, respectively. The following table illustrates the composition of the Corporation’s loan portfolio by loan class for the periods indicated:
As of March 31, 2021, the Corporation had $741.7 million of Paycheck Protection Program ("PPP") loans compared to the December 31, 2020 balance of $667.1 million. PPP loans are included in the commercial and industrial loan class. Additional details of the PPP are included in The CARES Act and the Paycheck Protection Program section of the "COVID-19 UPDATE" section of Management’s Discussion and Analysis of Financial Condition and Results of Operations included on this Form 10-Q. Credit Quality As part of the ongoing monitoring of the credit quality of the Corporation's loan portfolio, management tracks certain credit quality indicators including trends related to: (i) the level of criticized commercial loans, (ii) net charge-offs, (iii) non-performing loans, (iv) covenant failures and (v) the general national and local economic conditions. The Corporation utilizes a risk grading of pass, special mention, substandard, doubtful and loss to assess the overall credit quality of large commercial loans. All large commercial credit grades are reviewed at a minimum of once a year for pass grade loans. Loans with grades below pass are reviewed more frequently depending on the grade. A description of the general characteristics of these grades is as follows: •Pass - Loans that are considered to be of acceptable credit quality. •Special Mention - Loans which possess some credit deficiency or potential weakness, which deserves close attention. If left uncorrected, these potential weaknesses may result in deterioration of the repayment prospects for the asset or in the Corporation's credit position at some future date. Special mention assets are not adversely classified and do not expose the Corporation to sufficient risk to warrant adverse classification. •Substandard - A substandard loan is inadequately protected by the current net worth and paying capacity of the obligor or of the collateral pledged, if any. Assets so classified have a well-defined weakness that jeopardizes the liquidation of the debt. They are characterized by the distinct possibility that the Corporation will sustain some loss if the deficiencies are not corrected. •Doubtful - Loans that have all of the weaknesses of those classified as Substandard. However, based on currently existing facts, conditions and values, these weaknesses make full collection of principal highly questionable and improbable. •Loss – Loans that are considered uncollectible and of such little value that continuing to carry them as an asset is not warranted. Loans will be classified as Loss when it is neither practical or desirable to defer writing off or reserving all or a portion of a basically worthless asset, even though partial recovery may be possible at some time in the future. The following tables summarize the risk grading of the Corporation’s loan portfolio by loan class and by year of origination for the years indicated. Consumer loans are not risk graded. For the purposes of this disclosure the consumer loans are classified in the following manner: loans that are less than 30 days past due are Pass, loans 30-89 days past due are Special Mention and loans greater than 89 days past due are Substandard. The entire balance of a loan is considered delinquent if the minimum payment contractually required to be made is not received by the specified due date. Loans that evidenced deterioration of credit quality since origination and it was probable, at acquisition, that all contractually required payments would not be collected are included in the applicable categories below. Outstanding loan balances as of March 31, 2021 with an origination year of 2021 and 2020 include PPP loans of $293.1 million and $448.6 million, respectively.
At March 31, 2021, 30-59 Days Past Due loans totaled $55.6 million, an increase of $36.0 million from December 31, 2020. The primary increase was in the commercial real estate, non-owner occupied segment and is related to four relationships. Three of the relationships are multi-family units totaling $24.1 million and the fourth relationship is a hotel totaling $21.0 million. At March 31, 2021, the 60-89 Days Past Due category totaled $3.0 million, a decrease of $8.2 million from December 31, 2020. The primary decrease was related to a $5.0 million commercial and industrial loan that was current as of March 31, 2021. The 90 Days or More Past Due bucket totaled $47.4 million at March 31, 2021, an increase of $5.4 million from December 31, 2020. The primary increase was related to a $13.0 million nursing home loan within the commercial real estate, non-owner occupied segment, that was current at December 31, 2020, but has moved into the 90+ Days Past Due bucket. This was offset by a $3.7 million loan within the same segment that was 90+ Days Past Due at December 31, 2020, but has since paid off. The tables below show a past due aging of the Corporation’s loan portfolio, by loan class, for the years indicated:
Loans are reclassified to a non-accruing status when, in management’s judgment, the collateral value and financial condition of the borrower do not justify accruing interest. All unpaid accrued interest is reversed against earnings when considered uncollectible and at the time accrual is discontinued. Payments subsequently received on non-accrual loans are applied to principal. A loan is returned to accrual status when principal and interest are no longer past due and collectability is probable, typically after a minimum of six consecutive months of performance. The following table summarizes the Corporation’s non-accrual loans by loan class for the periods indicated:
There was no interest income recognized on non-accrual loans for the three months ended March 31, 2021 and 2020, respectively. Determining fair value for collateral dependent loans requires obtaining a current independent appraisal of the collateral and applying a discount factor, which includes selling costs if applicable, to the value. The fair value of real estate is generally based on appraisals by qualified licensed appraisers. The appraisers typically determine the value of the real estate by utilizing an income or market valuation approach. If an appraisal is not available, the fair value may be determined by using a cash flow analysis. Fair value on other collateral such as business assets is typically ascertained by assessing, either singularly or some combination of, asset appraisals, accounts receivable aging reports, inventory listings and or customer financial statements. Both appraised values and values based on borrower’s financial information are discounted as considered appropriate based on age and quality of the information and current market conditions. The following table presents the amortized cost basis of collateral dependent loans, which are individually evaluated to determine expected credit losses:
As detailed in NOTE 1. GENERAL of these Notes to Consolidated Condensed Financial Statements, the Bank's banking regulators issued guidance in March 2020 encouraging financial institutions to work prudently with borrowers who are or may be unable to meet their contractual payment obligations due to the effects of COVID-19. Additionally, Section 4013 of the CARES Act had further provided that a qualified loan modification is exempt by law from classification as a troubled debt restructure as defined by GAAP, from the period beginning March 1, 2020 until the earlier of December 31, 2020 or the date that is 60 days after the date on which the national emergency concerning the COVID-19 outbreak under the National Emergencies Act (50 U.S.C. 1601 et seq.) terminates. In accordance with that guidance, the Bank has offered short-term modifications made in response to COVID-19 to borrowers who were current and otherwise not past due. These included short-term, 180 days or less, modifications in the form of payment deferrals, fee waivers, extensions of repayment terms, or other delays in payment that are insignificant. The Consolidated Appropriations Act, 2021 extended the expiration date for COVID-related loan modifications exempt from troubled debt restructuring classification until the earlier of January 1, 2022, or 60 days after the termination of the national emergency. Details of the Corporation's modifications are included in the "LOAN QUALITY" section of Management’s Discussion and Analysis of Financial Condition and Results of Operations included on this Form 10-Q. In certain loan restructuring situations, the Corporation may grant a concession to a debtor experiencing financial difficulty, resulting in a troubled debt restructuring. A concession is deemed to be granted when, as a result of the restructuring, the Corporation does not expect to collect all original amounts due, including interest accrued at the original contract rate. If the payment of principal at original maturity is primarily dependent on the value of collateral, the current value of the collateral is considered in determining whether the principal will be repaid. The following tables summarize troubled debt restructures in the Corporation's loan portfolio that occurred during the three months ended March 31, 2021. No troubled debt restructures in the Corporation's loan portfolio occurred in the three months ended March 31, 2020.
Loans secured by 1- 4 family residential real estate made up 64 percent of the post-modification balances of the troubled debt restructured loans that occurred during the three months ending March 31, 2021. The following tables summarize troubled debt restructures that occurred during the twelve months ended March 31, 2021 and 2020, that subsequently defaulted during the period indicated and remained in default at period end. For purposes of this schedule, a loan is considered in default if it is 30-days or more past due.
Commercial troubled debt restructured loans risk graded special mention, substandard, doubtful and loss are individually evaluated for apparent loss and may result in a specific reserve allocation in the allowance for credit loss. Commercial troubled debt restructures that aren't individually evaluated for a specific reserve are included in the calculation of allowance for credit losses through the loan segment loss analysis. For all consumer loan modifications, an evaluation to identify if a troubled debt restructure has occurred is performed prior to making the modification. Any subsequent deterioration is addressed through the charge-off process or through a specific reserve allocation included in the allowance for credit loss. Consumer troubled debt restructures that are not individually evaluated for a specific reserve are included in the calculation of the allowance for credit losses through the loan segment loss analysis. Consumer loans secured by residential real estate properties for which formal foreclosure proceedings are in process totaled $3.3 million and $507,000 at March 31, 2021 and March 31, 2020, respectively. Allowance for Credit Losses on Loans The Allowance for Credit Losses on Loans ("ACL - Loans") is a valuation account that is deducted from the amortized cost basis of loans to present the net amount expected to be collected on loans over the contractual term. The ACL - Loans is adjusted by the provision for credit losses, which is reported in earnings, and reduced by charge offs for loans, net or recoveries. Provision for credit losses on loans reflects the totality of actions taken on all loans for a particular period including any necessary increases or decreases in the allowance related to changes in credit loss expectations associated with specific loans or pools of loans. Loans are charged off against the allowance when the uncollectibility of the loan is confirmed. Expected recoveries do not exceed the aggregate of amounts previously charged off and expected to be charged off. The allowance represents the Corporation’s best estimate of current expected credit losses on loans using relevant available information, from internal and external sources, related to past events, current conditions, and reasonable and supportable forecasts. Historical credit loss experience provides the basis for the estimation of expected credit losses. The current expected credit loss ("CECL") calculation is performed and evaluated quarterly and losses are estimated over the expected life of the loan. The level of the allowance for credit losses is believed to be adequate to absorb all expected future losses inherent in the loan portfolio at the measurement date. In calculating the allowance for credit losses, the loan portfolio was pooled into ten loan segments with similar risk characteristics. Common characteristics include the type or purpose of the loan, underlying collateral and historical/expected credit loss patterns. In developing the loan segments, the Corporation analyzed the degree of correlation in how loans within each portfolio respond when subjected to varying economic conditions and scenarios as well as other portfolio stress factors. The expected credit losses are measured over the life of each loan segment utilizing the Probability of Default / Loss Given Default methodology combined with economic forecast models to estimate the current expected credit loss inherent in the loan portfolio. This approach is also leveraged to estimate the expected credit losses associated with unfunded loan commitments incorporating expected utilization rates. The Corporation sub-segmented certain commercial portfolios by risk level and certain consumer portfolios by delinquency status where appropriate. The Corporation utilized a four-quarter reasonable and supportable economic forecast period followed by a six-quarter, straight-line reversion period to the historical macroeconomic mean for the remaining life of the loans. Econometric modeling was performed using historical default rates and a selection of economic forecast scenarios published by Moody’s to develop a range of estimated credit losses for which to determine the best credit loss estimate within. Macroeconomic factors utilized in the modeling process include the national unemployment rate, BBB US corporate index, CRE price index and the home price index. The Corporation qualitatively adjusts model results for risk factors that are not inherently considered in the quantitative modeling process, but are nonetheless relevant in assessing the expected credit losses within the loan portfolio. These adjustments may increase or decrease the estimate of expected credit losses based upon the assessed level of risk for each qualitative factor. The various risks that may be considered in making qualitative adjustments include, among other things, the impact of (i) changes in the nature and volume of the loan portfolio, (ii) changes in the existence, growth and effect of any concentrations in credit, (iii) changes in lending policies and procedures, including changes in underwriting standards and practices for collections, write-offs, and recoveries, (iv) changes in the quality of the credit review function, (v) changes in the experience, ability and depth of lending management and staff, and (vi) other environmental factors such as regulatory, legal and technological considerations, as well as competition. In some cases, management may determine that an individual loan exhibits unique risk characteristics which differentiate the loan from other loans within the loan segments. In such cases, the loans are evaluated for expected credit losses on an individual basis and excluded from the collective evaluation. Specific reserve allocations of the allowance for credit losses are determined by analyzing the borrower’s ability to repay amounts owed, collateral deficiencies, the relative risk grade of the loan and economic conditions affecting the borrower’s industry, among other things. A loan is considered to be collateral dependent when, based upon management's assessment, the borrower is experiencing financial difficulty and repayment is expected to be provided substantially through the operation or sale of the collateral. In such cases, expected credit losses are based on the fair value of the collateral at the measurement date, adjusted for estimated selling costs if satisfaction of the loan depends on the sale of the collateral. The fair value of collateral supporting collateral dependent loans is evaluated on a quarterly basis. No allowance for credit losses has been recognized for PPP loans as such loans are fully guaranteed by the Small Business Administration ("SBA"). The risk characteristics of the Corporation’s portfolio segments are as follows: Commercial Commercial lending is primarily based on the identified cash flows of the borrower and secondarily on the underlying collateral provided by the borrower. The cash flows of borrowers, however, may not be as expected and the collateral securing these loans may fluctuate in value. Most commercial loans are secured by the tangible assets being financed such as equipment or real estate or other business assets such as accounts receivable or inventory and may incorporate a personal guarantee. Other loans may be unsecured, secured but under-collateralized or otherwise made on the basis of the enterprise value of an organization. In the case of loans secured by accounts receivable, the availability of funds for the repayment of these loans may be substantially dependent on the ability of the borrower to collect amounts due from its customers. Commercial real estate Commercial real estate loans are viewed primarily as cash flow loans and secondarily as loans secured by real estate. Commercial real estate lending typically involves higher loan principal amounts and the repayment of these loans is generally dependent on the successful operation of the property securing the loan or the business conducted on the property securing the loan. The Corporation monitors commercial real estate loans based on collateral and risk grade criteria, as well as the levels of owner-occupied versus non-owner occupied loans. Construction Construction loans are underwritten utilizing a combination of tools and techniques including feasibility and market studies, independent appraisals and appraisal reviews, absorption and interest rate sensitivity analysis as well as the financial analysis of the developer and all guarantors. Construction loans are monitored by either in house or third party inspectors limiting advances to a percentage of costs or stabilized project value. These loans frequently involve the disbursement of significant funds with the repayment dependent upon the successful completion and, where necessary, the future stabilization of the project. The predominant inherent risk of this portfolio is associated with the borrower's ability to successfully complete a project on time, within budget and stabilize the projected as originally projected. Consumer and Residential With respect to residential loans that are secured by 1-4 family residences, which are typically owner occupied, the Corporation generally establishes a maximum loan-to-value ratio and requires private mortgage insurance if that ratio is exceeded. Home equity loans are secured by a subordinate interest in 1-4 family residences, and consumer loans are secured by consumer assets such as automobiles or recreational vehicles. Some consumer loans, such as small installment loans and certain lines of credit, are unsecured. Repayment of these loans is primarily dependent on the personal income and credit rating of the borrowers and can also be impacted by changes in property values. Risk is mitigated by the fact that the loans are of smaller individual amounts and spread over a large number of borrowers. The following tables summarize changes in the allowance for credit losses by loan segment for the three months ended March 31, 2021:
Allowance for Loan Losses under prior GAAP ("Incurred Loss Model") Prior to the adoption of ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments on January 1, 2021, the Corporation maintained an allowance for loan losses in accordance with the incurred loss model as disclosed in the Corporation's 2020 Annual Report on Form 10-K. The following tables summarize changes in the allowance for loan losses by loan segment for the three months ended March 31, 2020:
The table below shows the Corporation’s allowance for loan losses under the incurred loss model and loan portfolio by loan segment as of the periods indicated.
The following tables show the composition of the Corporation’s impaired loans, related allowance under the incurred loss model and interest income recognized while impaired by loan class as of the periods indicated:
Off-Balance Sheet Arrangements, Commitments And Contingencies In the normal course of business, the Corporation has entered into off-balance sheet financial instruments which include commitments to extend credit and standby letters of credit. Commitments to extend credit are usually the result of lines of credit granted to existing borrowers under agreements that the total outstanding indebtedness will not exceed a specific amount during the term of the indebtedness. Typical borrowers are commercial concerns that use lines of credit to supplement their treasury management functions, and thus their total outstanding indebtedness may fluctuate during any time period based on the seasonality of their business and the resultant timing for their cash flows. Other typical lines of credit are related to home equity loans granted to customers. Commitments to extend credit generally have fixed expiration dates or other termination clauses that may require a fee. Standby letters of credit are generally issued on behalf of an applicant (the Corporation’s customer) to a specifically named beneficiary and are the result of a particular business arrangement that exists between the applicant and the beneficiary. Standby letters of credit have fixed expiration dates and are usually for terms of two years or less unless terminated beforehand due to criteria specified in the standby letter of credit. The standby letter of credit would permit the beneficiary to obtain payment from the Corporation under certain prescribed circumstances. Subsequently, the Corporation would seek reimbursement from the applicant pursuant to the terms of the standby letter of credit. The Corporation typically follows the same credit policies and underwriting practices when making these commitments as it does for on-balance sheet instruments. Each customer’s creditworthiness is typically evaluated on a case-by-case basis, and the amount of collateral obtained, if any, is based on management’s credit evaluation of the customer. Collateral held varies but may include cash, real estate, marketable securities, accounts receivable, inventory, equipment and personal property. The contractual amounts of these commitments are not reflected in the consolidated financial statements and only amounts drawn upon would be reflected in the future. Since many of the commitments are expected to expire without being drawn upon, the contractual amounts do not necessarily represent future cash requirements. However, should the commitments be drawn upon and should the Corporation’s customers default on their resulting obligation to the Corporation, the maximum exposure to credit loss, without consideration of collateral, is represented by the contractual amount of those commitments. Financial instruments with off-balance sheet risk were as follows:
The adoption of the CECL methodology for measuring credit losses, as discussed more fully in the Allowance for Credit Loss on Loans section of this Note, and in NOTE 1. GENERAL of these Notes to Consolidated Condensed Financial Statements, increased the opening balance of our accrual for off-balance sheet commitments at adoption by $20.5 million, which is reported in Other Liabilities as of March 31, 2021 in the CONSOLIDATED CONDENSED BALANCE SHEETS. The following table details activity in the allowance for credit losses on off-balance sheet commitments:
|
Other Intangibles |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Goodwill and Intangible Assets Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other Intangibles | OTHER INTANGIBLES Core deposit intangibles are recorded on the acquisition date of an entity. The carrying basis and accumulated amortization of recognized core deposit intangibles are noted below.
The core deposit intangibles are being amortized primarily on an accelerated basis over their estimated useful lives, generally over a period of ten years. Intangible asset amortization expense for the three months ended March 31, 2021 was $1.4 million compared to $1.5 million for the three months ended March 31, 2020. Estimated future amortization expense is summarized as follows:
|
Derivative Financial Instruments |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Derivative Financial Instruments | DERIVATIVE FINANCIAL INSTRUMENTS Risk Management Objective of Using Derivatives The Corporation is exposed to certain risks arising from both its business operations and economic conditions. The Corporation principally manages its exposures to a wide variety of business and operational risks through management of its core business activities. The Corporation manages economic risks, including interest rate, liquidity, and credit risk, primarily by managing the amount, sources, and duration of its assets and liabilities and through the use of derivative financial instruments. Specifically, the Corporation enters into derivative financial instruments to manage exposures that arise from business activities that result in the receipt or payment of future known and uncertain cash amounts, the value of which are determined by interest rates. The Corporation’s derivative financial instruments are used to manage differences in the amount, timing, and duration of the Corporation’s known or expected cash payments principally related to certain variable-rate liabilities. The Corporation also has derivatives that are a result of a service the Corporation provides to certain qualifying customers, and, therefore, are not used to manage interest rate risk in the Corporation’s assets or liabilities. The Corporation manages a matched book with respect to its derivative instruments offered as a part of this service to its customers in order to minimize its net risk exposure resulting from such transactions. Cash Flow Hedges of Interest Rate Risk The Corporation’s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish these objectives, the Corporation primarily uses interest rate swaps and interest rate caps as part of its interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the payment of fixed amounts to a counterparty in exchange for the Corporation receiving variable payments over the life of the agreements without exchange of the underlying notional amount. Interest rate caps designated as cash flow hedges involve the receipt of variable amounts from a counterparty if interest rates rise above the strike rate on the contract in exchange for an up-front premium. As of March 31, 2021 and December 31, 2020, the Corporation had four interest rate swaps with a notional amount of $60.0 million that were designated as cash flow hedges. The effective portion of changes in the fair value of derivatives designated and that qualify as cash flow hedges is recorded in accumulated other comprehensive income and is subsequently reclassified into earnings in the period that the hedged forecasted transaction affects earnings. During the first quarter of 2021, $26.0 million of the interest rate swaps were used to hedge the variable cash outflows (LIBOR-based) associated with existing trust preferred securities when the outflows converted from a fixed rate to variable rate in September 2012. In addition, $10.0 million of interest rate swaps were used to hedge the variable cash outflows (LIBOR-based) associated with one Federal Home Loan Bank advances. Finally, the remaining $24.0 million of interest rate swaps were used to hedge the variable cash outflows (Ameribor-based) associated with a brokered deposit originated in December 2020. The ineffective portion of the change in fair value of the derivatives is recognized directly in earnings. During the three months ended March 31, 2021 and 2020, the Corporation did not recognize any ineffectiveness. Amounts reported in accumulated other comprehensive income related to derivatives will be reclassified to interest expense as interest payments are made on the Corporation's variable-rate liabilities. During the next twelve months, the Corporation expects to reclassify $1.0 million from accumulated other comprehensive income to interest expense. Non-designated Hedges The Corporation does not use derivatives for trading or speculative purposes. Derivatives not designated as hedges are not speculative and result from a service the Corporation provides to certain customers. The Corporation executes interest rate swaps with commercial banking customers to facilitate their respective risk management strategies. Those interest rate swaps are simultaneously hedged by offsetting interest rate swaps that the Corporation executes with a third party, such that the Corporation minimizes its net risk exposure resulting from such transactions. As the interest rate swaps associated with this program do not meet the strict hedge accounting requirements, changes in the fair value of both the customer swaps and the offsetting swaps are recognized directly in earnings. As of March 31, 2021 and December 31, 2020, the notional amount of customer-facing swaps was approximately $972.7 million and $985.0 million, respectively. These amounts are offset with third party counterparties, as described above. Fair Values of Derivative Instruments on the Balance Sheet The table below presents the fair value of the Corporation’s derivative financial instruments, as well as their classification on the Balance Sheet, as of March 31, 2021, and December 31, 2020.
The amount of gain (loss) recognized in other comprehensive income is included in the table below for the periods indicated.
Effect of Derivative Instruments on the Income Statement The Corporation did not recognize any gains or losses from derivative financial instruments in the Consolidated Condensed Statements of Income for the three months ended March 31, 2021 and 2020. The amount of gain (loss) reclassified from other comprehensive income into income is included in the table below for the periods indicated.
The Corporation’s exposure to credit risk occurs because of nonperformance by its counterparties. The counterparties approved by the Corporation are usually financial institutions, which are well capitalized and have credit ratings through Moody’s and/or Standard & Poor’s at or above investment grade. The Corporation’s control of such risk is through quarterly financial reviews, comparing mark-to-market values with policy limitations, credit ratings and collateral pledging. Credit-risk-related Contingent Features The Corporation has agreements with certain of its derivative counterparties that contain a provision where if the Corporation fails to maintain its status as a well or adequately capitalized institution, then the Corporation could be required to terminate or fully collateralize all outstanding derivative contracts. Additionally, the Corporation has agreements with certain of its derivative counterparties that contain a provision where if the Corporation defaults on any of its indebtedness, including default where repayment of the indebtedness has not been accelerated by the lender, then the Corporation could also be declared in default on its derivative obligations. As of March 31, 2021, the termination value of derivatives in a net liability position related to these agreements was $36.7 million. As of March 31, 2021, the Corporation has minimum collateral posting thresholds with certain of its derivative counterparties and has posted collateral of $62.8 million. While the Corporation did not breach any of these provisions as of March 31, 2021, if it had, the Corporation could have been required to settle its obligations under the agreements at their termination value.
|
Disclosures About Fair Value of Assets and Liabilities |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Disclosures About Fair Value of Assets and Liabilities | DISCLOSURES ABOUT FAIR VALUE OF ASSETS AND LIABILITIES The Corporation used fair value measurements to record fair value adjustments to certain assets and liabilities and to determine fair value disclosures. The accounting guidance defines fair value, establishes a framework for measuring fair value and expands disclosures about fair value measurements. ASC 820 applies only when other guidance requires or permits assets or liabilities to be measured at fair value; it does not expand the use of fair value in any new circumstances. As defined in ASC 820, fair value is the price to sell an asset or transfer a liability in an orderly transaction between market participants. It represents an exit price at the measurement date. Market participants are buyers and sellers, who are independent, knowledgeable, and willing and able to transact in the principal (or most advantageous) market for the asset or liability being measured. Current market conditions, including imbalances between supply and demand, are considered in determining fair value. The Corporation values its assets and liabilities in the principal market where it sells the particular asset or transfers the liability with the greatest volume and level of activity. In the absence of a principal market, the valuation is based on the most advantageous market for the asset or liability (i.e., the market where the asset could be sold or the liability transferred at a price that maximizes the amount to be received for the asset or minimizes the amount to be paid to transfer the liability). Valuation inputs refer to the assumptions market participants would use in pricing a given asset or liability. Inputs can be observable or unobservable. Observable inputs are those assumptions which market participants would use in pricing the particular asset or liability. These inputs are based on market data and are obtained from a source independent of the Corporation. Unobservable inputs are assumptions based on the Corporation’s own information or estimate of assumptions used by market participants in pricing the asset or liability. Unobservable inputs are based on the best and most current information available on the measurement date. All inputs, whether observable or unobservable, are ranked in accordance with a prescribed fair value hierarchy which gives the highest ranking to quoted prices (unadjusted) in active markets for identical assets or liabilities (Level 1) and the lowest ranking to unobservable inputs for which there is little or no market activity (Level 3). Fair values for assets or liabilities classified as Level 2 are based on one or a combination of the following factors: (i) quoted prices for similar assets; (ii) observable inputs for the asset or liability, such as interest rates or yield curves; or (iii) inputs derived principally from or corroborated by observable market data. The level in the fair value hierarchy within which the fair value measurement in its entirety falls is determined based on the lowest level input that is significant to the fair value measurement in its entirety. The Corporation considers an input to be significant if it drives 10 percent or more of the total fair value of a particular asset or liability. RECURRING MEASUREMENTS Assets and liabilities are considered to be measured at fair value on a recurring basis if fair value is measured regularly (i.e., daily, weekly, monthly or quarterly). Recurring valuation occurs at a minimum on the measurement date. Assets and liabilities are considered to be measured at fair value on a nonrecurring basis if the fair value measurement of the instrument does not necessarily result in a change in the amount recorded on the balance sheet. Generally, nonrecurring valuation is the result of the application of other accounting pronouncements which require assets or liabilities to be assessed for impairment or recorded at the lower of cost or fair value. The fair value of assets or liabilities transferred in or out of Level 3 is measured on the transfer date, with any additional changes in fair value subsequent to the transfer considered to be realized or unrealized gains or losses. Following is a description of the valuation methodologies used for instruments measured at fair value on a recurring basis and recognized in the accompanying balance sheets, as well as the general classification of such instruments pursuant to the valuation hierarchy. Investment Securities Where quoted prices are available in an active market, securities are classified within Level 1 of the valuation hierarchy. The Corporation currently has no securities classified within Level 1 of the hierarchy. Where significant observable inputs, other than Level 1 quoted prices, are available, securities are classified within Level 2 of the valuation hierarchy. Level 2 securities include U.S. treasury securities, government-sponsored agency and mortgage-backed securities, state and municipal securities and corporate obligations securities. In certain cases where Level 1 or Level 2 inputs are not available, securities are classified within Level 3 of the hierarchy and include state and municipal securities, government-sponsored mortgage-backed securities and corporate obligations securities. Level 3 fair value for securities was determined using a discounted cash flow model that incorporated market estimates of interest rates and volatility in markets that have not been active. Third party vendors compile prices from various sources and may apply such techniques as matrix pricing to determine the value of identical or similar investment securities (Level 2). Matrix pricing is a mathematical technique widely used in the banking industry to value investment securities without relying exclusively on quoted prices for specific investment securities but rather relying on the investment securities’ relationship to other benchmark quoted investment securities. Any investment security not valued based upon the methods above are considered Level 3. Interest Rate Derivative Agreements See information regarding the Corporation’s interest rate derivative products in NOTE 5. DERIVATIVE FINANCIAL INSTRUMENTS of these Notes to Consolidated Condensed Financial Statements. The following table presents the fair value measurements of assets and liabilities recognized in the accompanying balance sheets measured at fair value on a recurring basis and the level within the ASC 820 fair value hierarchy in which the fair value measurements fall at March 31, 2021, and December 31, 2020.
There were no gains or losses included in earnings that were attributable to the changes in unrealized gains or losses related to assets or liabilities held at March 31, 2021 or December 31, 2020. Level 3 Reconciliation The following is a reconciliation of the beginning and ending balances of recurring fair value measurements recognized in the accompanying balance sheets using significant unobservable Level 3 inputs for the three months ended March 31, 2021 and 2020.
Transfers Between Levels There were no transfers in or out of Level 3 for the three months ended March 31, 2021 and 2020. Nonrecurring Measurements Following is a description of valuation methodologies used for instruments measured at fair value on a non-recurring basis and recognized in the accompanying balance sheets, as well as the general classification of such instruments pursuant to the valuation hierarchy for March 31, 2021, and December 31, 2020.
Impaired Loans (collateral dependent) Loans for which it is probable that the Corporation will not collect all principal and interest due according to contractual terms are measured for impairment. Allowable methods for determining the amount of impairment include estimating fair value of the collateral for collateral dependent loans. If the impaired loan is identified as collateral dependent, then the fair value method of measuring the amount of impairment is utilized. This method requires obtaining a current independent appraisal of the collateral and applying a discount factor to the value. A portion of the allowance for loan losses is allocated to impaired loans if the value of such loans is deemed to be less than the unpaid balance. If these allocations cause the allowance for loan losses to increase, such increase is reported as a component of the provision for loan losses. Loan losses are charged against the allowance when management believes the uncollectability of the loan is confirmed. During 2020 and 2021, certain impaired loans were partially charged off or re-evaluated. Impaired loans that are collateral dependent are classified within Level 3 of the fair value hierarchy when impairment is determined using the fair value method. Other Real Estate Owned The fair value for impaired loans and other real estate owned is measured based on the value of the collateral securing those loans or real estate and is determined using several methods. The fair value of real estate is generally determined based on appraisals by qualified licensed appraisers. The appraisers typically determine the value of the real estate by utilizing an income or market valuation approach. If an appraisal is not available, the fair value may be determined by using a discounted cash flow analysis. Fair value on other collateral such as business assets is typically ascertained by assessing, either singularly or some combination of, asset appraisals, accounts receivable aging reports, inventory listings and/or customer financial statements. Both appraised values and values based on borrower’s financial information are discounted as considered appropriate based on age and quality of the information and current market conditions. Unobservable (Level 3) Inputs The following table presents quantitative information about unobservable inputs used in recurring and nonrecurring Level 3 fair value measurements, other than goodwill, at March 31, 2021 and December 31, 2020.
The following is a discussion of the sensitivity of significant unobservable inputs, the interrelationships between those inputs and other unobservable inputs used in recurring fair value measurement and how those inputs might magnify or mitigate the effect of changes in the unobservable inputs on the fair value measurement. State and Municipal Securities, Corporate Obligations and U.S. Government-sponsored Mortgage-Backed Securities The significant unobservable inputs used in the fair value measurement of the Corporation's state and municipal securities, corporate obligations and U.S. Government-sponsored mortgage-backed securities are premiums for unrated securities and marketability discounts. Significant increases or decreases in either of those inputs in isolation would result in a significantly lower or higher fair value measurement. Generally, changes in either of those inputs will not affect the other input. Fair Value of Financial Instruments The following table presents estimated fair values of the Corporation’s financial instruments and the level within the fair value hierarchy in which the fair value measurements fall at March 31, 2021, and December 31, 2020.
|
Transfers Accounted for as Secured Borrowings |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Transfers and Servicing [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Transfers Accounted for as Secured Borrowings | TRANSFERS ACCOUNTED FOR AS SECURED BORROWINGS The collateral pledged for all repurchase agreements that are accounted for as secured borrowings as of March 31, 2021 and December 31, 2020 were:
|
Accumulated Other Comprehensive Income (Loss) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Equity [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accumulated Other Comprehensive Income (Loss) | ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) The following table summarizes the changes in the balances of each component of accumulated other comprehensive income (loss), net of tax, as of March 31, 2021 and 2020:
The following table presents the reclassification adjustments out of accumulated other comprehensive income (loss) that were included in net income in the Consolidated Condensed Statements of Income for the three months ended March 31, 2021 and 2020.
(1) For additional detail related to unrealized gains (losses) on available for sale securities and related amounts reclassified from accumulated other comprehensive income see NOTE 2. INVESTMENT SECURITIES of these Notes to Consolidated Condensed Financial Statements. (2) For additional detail related to unrealized gains (losses) on cash flow hedges and related amounts reclassified from accumulated other comprehensive income see NOTE 5. DERIVATIVE FINANCIAL INSTRUMENTS of these Notes to Consolidated Condensed Financial Statements.
|
Share-Based Compensation |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share-based Payment Arrangement [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share-Based Compensation | SHARE-BASED COMPENSATION Stock options and RSAs have been issued to directors, officers and other management employees under the Corporation's 2009 Long-term Equity Incentive Plan, the 2019 Long-term Equity Incentive Plan, and the Equity Compensation Plan for Non-Employee Directors. The stock options, which have a ten year life, become 100 percent vested based on time ranging from one year to two years and are fully exercisable when vested. Option exercise prices equal the Corporation's common stock closing price on NASDAQ on the date of grant. The RSAs issued to employees and non-employee directors provide for the issuance of shares of the Corporation's common stock at no cost to the holder and generally vest after 3 years. The RSAs vest only if the employee is actively employed by the Corporation on the vesting date and, therefore, any unvested shares are forfeited. For non-employee directors, the RSAs vest only if the non-employee director remains as an active board member on the vesting date and, therefore, any unvested shares are forfeited. The RSAs for employees and non-employee directors are either immediately vested at retirement, disability or death, or, continue to vest after retirement, disability or death, depending on the plan under which the shares were granted. The Corporation’s 2019 ESPP provides eligible employees of the Corporation and its subsidiaries an opportunity to purchase shares of common stock of the Corporation through quarterly offerings financed by payroll deductions. The price of the stock to be paid by the employees shall be equal to 85 percent of the average of the closing price of the Corporation’s common stock on each trading day during the offering period. However, in no event shall such purchase price be less than the lesser of an amount equal to 85 percent of the market price of the Corporation’s stock on the offering date or an amount equal to 85 percent of the market value on the date of purchase. Common stock purchases are made quarterly and are paid through advance payroll deductions up to a calendar year maximum of $25,000. Compensation expense related to unvested share-based awards is recorded by recognizing the unamortized grant date fair value of these awards over the remaining service periods of those awards, with no change in historical reported fair values and earnings. Awards are valued at fair value in accordance with provisions of share-based compensation guidance and are recognized on a straight-line basis over the service periods of each award. To complete the exercise of vested stock options, RSA’s and ESPP options, the Corporation generally issues new shares from its authorized but unissued share pool. Share-based compensation for the three months ended March 31, 2021 was $1,190,000 compared to $1,220,000 for the three months ended March 31, 2020. Share-based compensation has been recognized as a component of salaries and benefits expense in the accompanying Consolidated Condensed Statements of Income. Share-based compensation expense recognized in the Consolidated Condensed Statements of Income is based on awards ultimately expected to vest and is reduced for estimated forfeitures. Share-based compensation guidance requires forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods, if actual forfeitures differ from those estimates. Pre-vesting forfeitures were estimated to be approximately 0.5 percent for the three months ended March 31, 2021, based on historical experience. The following table summarizes the components of the Corporation's share-based compensation awards recorded as an expense and the income tax benefit of such awards.
As of March 31, 2021, unrecognized compensation expense related to RSAs was $8.4 million and is expected to be recognized over a weighted-average period of 2.01 years. The Corporation did not have any unrecognized compensation expense related to stock options as of March 31, 2021. Stock option activity under the Corporation's stock option plans as of March 31, 2021 and changes during the three months ended March 31, 2021, were as follows:
The aggregate intrinsic value in the table above represents the total pre-tax intrinsic value (the difference between the Corporation's closing stock price on the last trading day of the first three months of 2021 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their stock options on March 31, 2021. The amount of aggregate intrinsic value will change based on the fair market value of the Corporation's common stock. The aggregate intrinsic value of stock options exercised during the three months ended March 31, 2021 and 2020 was $453,000 and $36,000, respectively. Cash receipts of stock options exercised during this same period were $171,000 and $7,000, respectively. The following table summarizes information on unvested RSAs outstanding as of March 31, 2021:
The grant date fair value of ESPP options was estimated to be approximately $75,000 at the beginning of the January 1, 2021 quarterly offering period. The ESPP options vested during the three months ending March 31, 2021, leaving no unrecognized compensation expense related to unvested ESPP options at March 31, 2021.
|
Income Tax |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Income Tax Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Income Tax | INCOME TAX The following table summarizes the major components creating differences between income taxes at the federal statutory and the effective tax rate recorded in the consolidated statements of income for the three months ended March 31, 2021 and 2020:
|
Net Income Per Share |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Net Income Per Share | NET INCOME PER SHARE Basic net income per share is computed by dividing net income by the weighted-average shares outstanding during the reporting period. Diluted net income per share is computed by dividing net income by the combination of the weighted-average shares outstanding during the reporting period and all potentially dilutive common shares. Potentially dilutive common shares include stock options and RSAs issued under the Corporation's share-based compensation plans. Potentially dilutive common shares are excluded from the computation of diluted earnings per share in the periods where the effect would be antidilutive. The following table reconciles basic and diluted net income per share for the three months ended March 31, 2021 and 2020.
|
General Litigation and Regulatory Examinations |
3 Months Ended |
---|---|
Mar. 31, 2021 | |
Commitments and Contingencies Disclosure [Abstract] | |
General Litigation and Regulatory Examinations | GENERAL LITIGATION AND REGULATORY EXAMINATIONS The Corporation is subject to claims and lawsuits that arise primarily in the ordinary course of business. Additionally, the Corporation is subject to periodic examinations by various regulatory agencies. It is the general opinion of management that the disposition or ultimate resolution of such claims, lawsuits, and examinations will not have a material adverse effect on the consolidated financial position, results of operations and cash flow of the Corporation.
|
Subsequent Event |
3 Months Ended |
---|---|
Mar. 31, 2021 | |
Subsequent Events [Abstract] | |
Subsequent Event | SUBSEQUENT EVENTOn April 1, 2021, the Bank closed its acquisition of Hoosier Trust Company, an Indiana trust company (“Hoosier”), pursuant to which Hoosier merged with and into the Bank. The consideration paid to the shareholders of Hoosier at closing was $3,225,000 in cash. |
General (Policies) |
3 Months Ended |
---|---|
Mar. 31, 2021 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Recent Accounting Changes Adopted in 2021 and New Accounting Pronouncements Not Yet Adopted | Recent Accounting Changes Adopted In 2021 The Corporation continually monitors potential accounting pronouncements and the following pronouncements have been deemed to have the most applicability to the Corporation's financial statements: FASB Accounting Standards Updates No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments Summary - The FASB issued Accounting Standards Update (ASU) No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. This new guidance replaces the previous "incurred loss" model for measuring credit losses with an "expected life of loan loss" model, referred to as the CECL model. Under the CECL model, certain financial assets carried at amortized cost, such as loans held for investment and held-to-maturity debt securities, are required to be presented at the net amount expected to be collected. The measurement of expected credit losses is based on information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. This measurement takes place at the time the financial asset is first added to the balance sheet and periodically thereafter. This differs significantly from the “incurred loss” model, which delayed recognition until it is probable a loss had been incurred. The Corporation developed models that satisfy the requirements of the new standard which are governed by a system of internal controls and a cross-functional working group consisting of accounting, finance, and credit administration personnel. The loan portfolio was pooled into ten loan segments with similar risk characteristics for which the probability of default/loss given default methodology was applied. The Corporation utilized a one-year economic forecast period then reverted to historical macroeconomic levels for the remaining life of the portfolio. A baseline macroeconomic scenario, along with other scenarios, were used to develop a range of estimated credit losses for which to determine the best estimate within. The ASU was effective for SEC filers for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. Pursuant to the CARES Act and the related joint statement of federal banking regulators (which also became effective as of March 27, 2020), and consistent with guidance from the SEC and FASB, the Corporation elected to delay implementation of ASU No. 2016-13, which was set to expire on December 31, 2020. However, the CAA (as discussed above) extended the temporary relief from CECL compliance to the earlier of the first day of the fiscal year that begins after the date on which the national emergency concerning COVID-19 terminates, or January 1, 2022. The Corporation elected to delay implementation of CECL following the approval of the CARES Act and, with the enactment of the CAA, the Corporation elected to adopt CECL on January 1, 2021. This allows the Corporation to utilize the CECL standard for the entire year of 2021, while its 2020 financial statements were prepared under the incurred loss model. As of the adoption and day one measurement date of January 1, 2021, the Corporation recorded a one-time cumulative-effect adjustment to retained earnings, net of income taxes, on the consolidated balance sheet of $68.0 million. The allowance increased 57 percent from December 31, 2020, or $74.1 million, because it covered expected credit losses over the life of the loan portfolio, which approximates four years, and it included an allowance on all purchased loans that were previously excluded from the allowance for loan losses calculation. CECL also requires the establishment of a reserve for potential losses from unfunded commitments that is recorded in other liabilities, separate from allowance for credit losses, which was approximately $20.5 million. An allowance for credit losses of $245,000 was recorded on the state and municipal securities classified as held to maturity based on applying the long-term historical credit loss rate, as published by Moody’s, for similarly rated securities. FASB Accounting Standards Updates No. 2019-11 - Codification Improvements to (Topic 326): Financial Instruments - Credit Losses Summary - The FASB issued ASU No. 2019-11, Codification Improvements to Topic 326, Financial Instruments - Credit Losses in order to address issues raised by stakeholders during the implementation of ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses of Financial Instruments. Among other narrow-scope improvements, the new ASU clarifies guidance around how to report expected recoveries. “Expected recoveries” describes a situation in which an organization recognizes a full or partial write-off of the amortized cost basis of a financial asset, but then later determines that the amount written off, or a portion of that amount, will in fact be recovered. While applying the credit losses standard, stakeholders questioned whether expected recoveries were permitted on assets that had already shown credit deterioration at the time of purchase (also known as PCD assets). In response to this question, the ASU permits organizations to record expected recoveries on PCD assets. In addition to other narrow technical improvements, the ASU also reinforces existing guidance that prohibits organizations from recording negative allowances for available-for-sale debt securities. The ASU includes effective dates and transition requirements that vary depending on whether or not an entity has already adopted ASU No. 2016-13. As discussed above, pursuant to the CARES Act, the Corporation elected to defer the adoption of CECL. Additionally, the 2021 Consolidated Appropriations Act ("CAA"), signed into law on December 27, 2020, amended the CARES Act by extending the temporary relief from CECL compliance to the earlier of the first day of the fiscal year that begins after the date on which the national emergency concerning COVID-19 terminates, or January 1, 2022. The Corporation elected to delay implementation of CECL following the approval of the CARES Act and, with the enactment of the CAA, the Corporation elected to adopt CECL on January 1, 2021. The adoption of this standard did not have a significant effect on the Corporation’s consolidated financial statements or disclosures. Accounting Standards Update No. 2019-12 - Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes Summary - The FASB issued ASU No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which is expected to reduce cost and complexity related to the accounting for income taxes. The ASU removes specific exceptions to the general principles in Topic 740 in Generally Accepted Accounting Principles (GAAP). It eliminates the need for an organization to analyze whether the following apply in a given period: • Exception to the incremental approach for intraperiod tax allocation; • Exceptions to accounting for basis differences when there are ownership changes in foreign investments; and • Exception in interim period income tax accounting for year-to-date losses that exceed anticipated losses. The ASU also improves financial statement preparers’ application of income tax-related guidance and simplifies GAAP for: • Franchise taxes that are partially based on income; • Transactions with a government that result in a step up in the tax basis of goodwill • Separate financial statements of legal entities that are not subject to tax; and • Enacted changes in tax laws in interim periods. The ASU is part of the FASB’s simplification initiative to make narrow-scope simplifications and improvements to accounting standards through a series of short-term projects. For public business entities, the ASU is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. Early adoption of the ASU was permitted. The Corporation adopted this standard on January 1, 2021 and adoption of this standard did not have a significant effect on the Corporation's consolidated financial statements or disclosures. New Accounting Pronouncements Not Yet Adopted FASB Accounting Standards Updates - No. 2020-04 - Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting Summary - The FASB issued ASU No. 2020-04 to provide temporary optional guidance to ease the potential burden in accounting for reference rate reform. LIBOR and other interbank offered rates are widely used benchmarks or reference rates in the United States and globally. Trillions of dollars in loans, derivatives, and other financial contracts reference LIBOR, the benchmark interest rate banks use to make short-term loans to each other. With global capital markets expected to move away from LIBOR and other interbank offered rates and move toward rates that are more observable or transaction based and less susceptible to manipulation, the FASB launched a broad project in late 2018 to address potential accounting challenges expected to arise from the transition. The new guidance provides optional expedients and exceptions for applying generally accepted accounting principles to contract modifications and hedging relationships, subject to meeting certain criteria, that reference LIBOR or another reference rate expected to be discontinued. The ASU is intended to help stakeholders during the global market-wide reference rate transition period. Entities may apply this ASU as of the beginning of an interim period that includes the March 12, 2020 issuance date of the ASU, through December 31, 2022. The Corporation expects to adopt the practical expedients included in the ASU prior to December 31, 2022. The Corporation is implementing a transition plan to identify and modify its loans and other financial instruments with attributes that are either directly or indirectly influenced by LIBOR. The Corporation is assessing ASU 2020-04 and its impact on the Corporation's transition away from LIBOR for its loans and other financial instruments. FASB Accounting Standards Updates - Accounting Standards Update No. 2021-01 - Reference Rate Reform (Topic 848): Scope Summary - The FASB has published ASU 2021-01, Reference Rate Reform. ASU 2021-01 clarifies that certain optional expedients and exceptions in Topic 848 for contract modifications and hedge accounting apply to derivatives that are affected by the discounting transition. The ASU also amends the expedients and exceptions in Topic 848 to capture the incremental consequences of the scope clarification and to tailor the existing guidance to derivative instruments affected by the discounting transition. An entity may elect to apply the amendments in this Update on a full retrospective basis as of any date from the beginning of an interim period that includes or is subsequent to March 12, 2020, or on a prospective basis to new modifications from any date within an interim period that includes or is subsequent to the date of the issuance of a final Update, up to the date that financial statements are available to be issued. If an entity elects to apply any of the amendments in this Update for an eligible hedging relationship, any adjustments as a result of those elections must be reflected as of the date the entity applies the election. The amendments in this Update do not apply to contract modifications made after December 31, 2022, new hedging relationships entered into after December 31, 2022, and existing hedging relationships evaluated for effectiveness in periods after December 31, 2022, except for hedging relationships existing as of December 31, 2022, that apply certain optional expedients in which the accounting effects are recorded through the end of the hedging relationship (including periods after December 31, 2022). The Corporation is assessing ASU 2021-01 and its impact on the Corporation's transition away from LIBOR for its loans and other financial instruments.
|
General (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of changes in accounting principles | The following table details the impact of the adoption of CECL on the Corporation's balance sheet as of January 1, 2021.
|
Investment Securities (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investments, Debt and Equity Securities [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of amortized cost, gross unrealized gains, gross unrealized losses and approximate fair value of investment securities | The following table summarizes the amortized cost, gross unrealized gains and losses and approximate fair value of investment securities available for sale as of March 31, 2021 and December 31, 2020.
The following table summarizes the amortized cost, gross unrealized gains and losses, approximate fair value and allowance for credit losses on investment securities held to maturity as of March 31, 2021 and December 31, 2020.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of amortized cost of investment securities held to maturity aggregated by credit quality indicator | The following table summarizes the amortized cost of investment securities held to maturity at March 31, 2021, aggregated by credit quality indicator.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of allowance for credit losses on investment securities held to maturity | The following table details activity in the allowance for credit losses on investment securities held to maturity during the three months ended March 31, 2021.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of investment securities with unrealized losses, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position | The following tables summarize, as of March 31, 2021 and December 31, 2020, investment securities available for sale in an unrealized loss position for which an allowance for credit losses has not been recorded, aggregated by security type and length of time in a continuous unrealized loss position.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of investments in debt and equity securities reported in the financial statements at an amount less than their historical cost | Certain investment securities available for sale are reported in the financial statements at an amount less than their historical cost as indicated in the table below.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of amortized cost and fair value of available for sale securities and held to maturity securities | The amortized cost and fair value of investment securities available for sale and held to maturity at March 31, 2021 and December 31, 2020, by contractual maturity are shown below. Expected maturities will differ from contractual maturities because issuers may have the right to call or prepay obligations with or without call or prepayment penalties. Securities not due at a single maturity are shown separately.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of gross gains on sales and redemptions of available for sale securities | Gross gains on the sales and redemptions of investment securities available for sale for the three months ended March 31, 2021 and 2020 are shown below.
|
Loans and Allowance (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Receivables [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of composition of loan portfolio by loan class | The following table illustrates the composition of the Corporation’s loan portfolio by loan class for the periods indicated:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of credit quality of loan portfolio by loan class | The following tables summarize the risk grading of the Corporation’s loan portfolio by loan class and by year of origination for the years indicated. Consumer loans are not risk graded. For the purposes of this disclosure the consumer loans are classified in the following manner: loans that are less than 30 days past due are Pass, loans 30-89 days past due are Special Mention and loans greater than 89 days past due are Substandard. The entire balance of a loan is considered delinquent if the minimum payment contractually required to be made is not received by the specified due date. Loans that evidenced deterioration of credit quality since origination and it was probable, at acquisition, that all contractually required payments would not be collected are included in the applicable categories below. Outstanding loan balances as of March 31, 2021 with an origination year of 2021 and 2020 include PPP loans of $293.1 million and $448.6 million, respectively.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of changes in allowance for loan losses | The following tables summarize changes in the allowance for credit losses by loan segment for the three months ended March 31, 2021:
Allowance for Loan Losses under prior GAAP ("Incurred Loss Model") Prior to the adoption of ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments on January 1, 2021, the Corporation maintained an allowance for loan losses in accordance with the incurred loss model as disclosed in the Corporation's 2020 Annual Report on Form 10-K. The following tables summarize changes in the allowance for loan losses by loan segment for the three months ended March 31, 2020:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of past due aging of loan portfolio by loan class | The tables below show a past due aging of the Corporation’s loan portfolio, by loan class, for the years indicated:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of non-accrual loans by loan class | The following table summarizes the Corporation’s non-accrual loans by loan class for the periods indicated:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of amortized cost basis of collateral dependent loans | The following table presents the amortized cost basis of collateral dependent loans, which are individually evaluated to determine expected credit losses:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedules of troubled debt restructurings | The following tables summarize troubled debt restructures in the Corporation's loan portfolio that occurred during the three months ended March 31, 2021. No troubled debt restructures in the Corporation's loan portfolio occurred in the three months ended March 31, 2020.
The following tables summarize troubled debt restructures that occurred during the twelve months ended March 31, 2021 and 2020, that subsequently defaulted during the period indicated and remained in default at period end. For purposes of this schedule, a loan is considered in default if it is 30-days or more past due.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of allowance for credit losses and loan portfolio by loan segment | The table below shows the Corporation’s allowance for loan losses under the incurred loss model and loan portfolio by loan segment as of the periods indicated.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of composition of impaired loans by loan class | The following tables show the composition of the Corporation’s impaired loans, related allowance under the incurred loss model and interest income recognized while impaired by loan class as of the periods indicated:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of financial instruments with off-balance sheet risk | Financial instruments with off-balance sheet risk were as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of allowance for credit losses, off-balance sheet | The following table details activity in the allowance for credit losses on off-balance sheet commitments:
|
Other Intangibles (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Goodwill and Intangible Assets Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of core deposit intangibles | The carrying basis and accumulated amortization of recognized core deposit intangibles are noted below.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of estimated future amortization expense | Estimated future amortization expense is summarized as follows:
|
Derivative Financial Instruments (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of fair value of derivative financial instruments and their classification on Balance Sheet | The table below presents the fair value of the Corporation’s derivative financial instruments, as well as their classification on the Balance Sheet, as of March 31, 2021, and December 31, 2020.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of amount of gain (loss) recognized in other comprehensive income | The amount of gain (loss) recognized in other comprehensive income is included in the table below for the periods indicated.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of amount of gain (loss) reclassified from other comprehensive income | The amount of gain (loss) reclassified from other comprehensive income into income is included in the table below for the periods indicated.
|
Disclosures About Fair Value of Assets and Liabilities (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of fair value measurements of assets and liabilities recognized in Consolidated Condensed Balance Sheets measured at fair value | The following table presents the fair value measurements of assets and liabilities recognized in the accompanying balance sheets measured at fair value on a recurring basis and the level within the ASC 820 fair value hierarchy in which the fair value measurements fall at March 31, 2021, and December 31, 2020.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of reconciliation of beginning and ending balances of recurring fair value measurements recognized in Consolidated Condensed Balance Sheets using significant unobservable Level 3 inputs | The following is a reconciliation of the beginning and ending balances of recurring fair value measurements recognized in the accompanying balance sheets using significant unobservable Level 3 inputs for the three months ended March 31, 2021 and 2020.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of description of valuation methodologies used for instruments measured at fair value on a non-recurring basis and recognized in Consolidated Condensed Balance Sheets | Following is a description of valuation methodologies used for instruments measured at fair value on a non-recurring basis and recognized in the accompanying balance sheets, as well as the general classification of such instruments pursuant to the valuation hierarchy for March 31, 2021, and December 31, 2020.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of unobservable inputs used in recurring and nonrecurring Level 3 fair value measurements other than goodwill | The following table presents quantitative information about unobservable inputs used in recurring and nonrecurring Level 3 fair value measurements, other than goodwill, at March 31, 2021 and December 31, 2020.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of estimated fair values of financial instruments | The following table presents estimated fair values of the Corporation’s financial instruments and the level within the fair value hierarchy in which the fair value measurements fall at March 31, 2021, and December 31, 2020.
|
Transfers Accounted for as Secured Borrowings (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Transfers and Servicing [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of collateral pledged for all repurchase agreements accounted for as secured borrowings | The collateral pledged for all repurchase agreements that are accounted for as secured borrowings as of March 31, 2021 and December 31, 2020 were:
|
Accumulated Other Comprehensive Income (Loss) (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Equity [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of accumulated other comprehensive income (loss) | The following table summarizes the changes in the balances of each component of accumulated other comprehensive income (loss), net of tax, as of March 31, 2021 and 2020:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of reclassification out of accumulated other comprehensive income (loss) | The following table presents the reclassification adjustments out of accumulated other comprehensive income (loss) that were included in net income in the Consolidated Condensed Statements of Income for the three months ended March 31, 2021 and 2020.
(1) For additional detail related to unrealized gains (losses) on available for sale securities and related amounts reclassified from accumulated other comprehensive income see NOTE 2. INVESTMENT SECURITIES of these Notes to Consolidated Condensed Financial Statements. (2) For additional detail related to unrealized gains (losses) on cash flow hedges and related amounts reclassified from accumulated other comprehensive income see NOTE 5. DERIVATIVE FINANCIAL INSTRUMENTS of these Notes to Consolidated Condensed Financial Statements.
|
Share-Based Compensation (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share-based Payment Arrangement [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of components of share-based compensation awards | The following table summarizes the components of the Corporation's share-based compensation awards recorded as an expense and the income tax benefit of such awards.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of stock option activity under stock option plans | Stock option activity under the Corporation's stock option plans as of March 31, 2021 and changes during the three months ended March 31, 2021, were as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of unvested RSAs outstanding | The following table summarizes information on unvested RSAs outstanding as of March 31, 2021:
|
Income Tax (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Income Tax Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of reconciliation of Federal Statutory to actual tax expense | The following table summarizes the major components creating differences between income taxes at the federal statutory and the effective tax rate recorded in the consolidated statements of income for the three months ended March 31, 2021 and 2020:
|
Net Income Per Share (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of basic and diluted net income per share | The following table reconciles basic and diluted net income per share for the three months ended March 31, 2021 and 2020.
|
General - Narrative (Details) - USD ($) $ in Thousands |
Jan. 01, 2021 |
Mar. 31, 2021 |
Dec. 31, 2020 |
Mar. 31, 2020 |
Dec. 31, 2019 |
||||
---|---|---|---|---|---|---|---|---|---|
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | |||||||||
Retained earnings | $ 755,877 | $ 788,578 | |||||||
Allowance for credit losses - Loans | 201,082 | [1] | 130,648 | [1] | $ 99,454 | $ 80,284 | |||
Allowance for credit losses on unfunded loan commitments | 20,500 | 0 | |||||||
Allowance for credit losses | 245 | 0 | |||||||
State and municipal | |||||||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | |||||||||
Allowance for credit losses | 245 | 0 | |||||||
Cumulative effect of ASC 326 adoption | |||||||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | |||||||||
Retained earnings | $ (68,040) | ||||||||
Percent of increase in allowance | 57.00% | ||||||||
Allowance for credit losses - Loans | $ 74,055 | 74,055 | |||||||
Life of loan portfolio | 4 years | ||||||||
Allowance for credit losses on unfunded loan commitments | $ 20,500 | 20,500 | 20,500 | ||||||
Cumulative effect of ASC 326 adoption | State and municipal | |||||||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | |||||||||
Allowance for credit losses | $ 245 | $ 245 | |||||||
|
General - Schedule of Changes in Accounting Principles (Details) - USD ($) $ in Thousands |
Mar. 31, 2021 |
Jan. 01, 2021 |
Dec. 31, 2020 |
Mar. 31, 2020 |
Dec. 31, 2019 |
||||
---|---|---|---|---|---|---|---|---|---|
Assets: | |||||||||
Held to maturity securities | $ 1,295,534 | $ 1,227,668 | |||||||
Loans | 9,318,228 | 9,243,174 | |||||||
Less: Allowance for credit losses - loans | (201,082) | [1] | (130,648) | [1] | $ (99,454) | $ (80,284) | |||
Net loans | 9,117,146 | 9,112,526 | |||||||
Tax asset, deferred and receivable | 40,163 | 12,340 | |||||||
Liabilities: | |||||||||
Allowance for credit losses on unfunded loan commitments | 20,500 | 0 | |||||||
Stockholder's Equity: | |||||||||
Retained earnings | 755,877 | 788,578 | |||||||
Impact of CECL Adoption | |||||||||
Assets: | |||||||||
Held to maturity securities | $ (245) | ||||||||
Loans | 4,776 | ||||||||
Less: Allowance for credit losses - loans | (74,055) | (74,055) | |||||||
Net loans | (69,279) | ||||||||
Tax asset, deferred and receivable | 21,984 | ||||||||
Liabilities: | |||||||||
Allowance for credit losses on unfunded loan commitments | $ 20,500 | 20,500 | 20,500 | ||||||
Stockholder's Equity: | |||||||||
Retained earnings | (68,040) | ||||||||
January 1, 2021 Post-CECL Adoption | |||||||||
Assets: | |||||||||
Held to maturity securities | 1,227,423 | ||||||||
Loans | 9,247,950 | ||||||||
Less: Allowance for credit losses - loans | (204,703) | $ (204,703) | |||||||
Net loans | 9,043,247 | ||||||||
Tax asset, deferred and receivable | 34,324 | ||||||||
Liabilities: | |||||||||
Allowance for credit losses on unfunded loan commitments | 20,500 | ||||||||
Stockholder's Equity: | |||||||||
Retained earnings | $ 720,538 | ||||||||
|
Investment Securities - Amortized Cost and Approximate Fair Value of Securities (Details) - USD ($) $ in Thousands |
Mar. 31, 2021 |
Dec. 31, 2020 |
---|---|---|
Available for sale securities | ||
Amortized Cost | $ 2,343,573 | $ 1,807,389 |
Gross Unrealized Gains | 81,181 | 112,079 |
Gross Unrealized Losses | 19,186 | 349 |
Fair Value | 2,405,568 | 1,919,119 |
Held to maturity securities | ||
Amortized Cost | 1,295,534 | 1,227,668 |
Allowance for Credit Losses | 245 | 0 |
Net Carrying Amount | 1,295,289 | 1,227,668 |
Gross Unrealized Gains | 35,004 | 52,877 |
Gross Unrealized Losses | 11,758 | 252 |
Fair Value | 1,318,780 | 1,280,293 |
U.S. Treasury | ||
Available for sale securities | ||
Amortized Cost | 1,000 | |
Gross Unrealized Gains | 0 | |
Gross Unrealized Losses | 0 | |
Fair Value | 1,000 | |
U.S. Government-sponsored agency securities | ||
Available for sale securities | ||
Amortized Cost | 11,504 | 2,380 |
Gross Unrealized Gains | 40 | 50 |
Gross Unrealized Losses | 163 | 0 |
Fair Value | 11,381 | 2,430 |
Held to maturity securities | ||
Amortized Cost | 60,676 | 31,087 |
Allowance for Credit Losses | 0 | 0 |
Net Carrying Amount | 60,676 | 31,087 |
Gross Unrealized Gains | 1 | 10 |
Gross Unrealized Losses | 1,553 | 113 |
Fair Value | 59,124 | 30,984 |
State and municipal | ||
Available for sale securities | ||
Amortized Cost | 1,301,378 | 1,168,711 |
Gross Unrealized Gains | 67,438 | 89,420 |
Gross Unrealized Losses | 2,654 | 246 |
Fair Value | 1,366,162 | 1,257,885 |
Held to maturity securities | ||
Amortized Cost | 624,553 | 619,927 |
Allowance for Credit Losses | 245 | 0 |
Net Carrying Amount | 624,308 | 619,927 |
Gross Unrealized Gains | 23,154 | 34,978 |
Gross Unrealized Losses | 3,389 | 32 |
Fair Value | 644,318 | 654,873 |
U.S. Government-sponsored mortgage-backed securities | ||
Available for sale securities | ||
Amortized Cost | 1,025,660 | 632,267 |
Gross Unrealized Gains | 13,550 | 22,505 |
Gross Unrealized Losses | 16,347 | 103 |
Fair Value | 1,022,863 | 654,669 |
Held to maturity securities | ||
Amortized Cost | 608,805 | 575,154 |
Allowance for Credit Losses | 0 | 0 |
Net Carrying Amount | 608,805 | 575,154 |
Gross Unrealized Gains | 11,849 | 17,889 |
Gross Unrealized Losses | 6,816 | 107 |
Fair Value | 613,838 | 592,936 |
Corporate obligations | ||
Available for sale securities | ||
Amortized Cost | 4,031 | 4,031 |
Gross Unrealized Gains | 153 | 104 |
Gross Unrealized Losses | 22 | 0 |
Fair Value | 4,162 | 4,135 |
Foreign investment | ||
Held to maturity securities | ||
Amortized Cost | 1,500 | 1,500 |
Allowance for Credit Losses | 0 | 0 |
Net Carrying Amount | 1,500 | 1,500 |
Gross Unrealized Gains | 0 | 0 |
Gross Unrealized Losses | 0 | 0 |
Fair Value | $ 1,500 | $ 1,500 |
Investment Securities - Narrative (Details) $ in Thousands |
Mar. 31, 2021
USD ($)
instrument
|
Dec. 31, 2020
USD ($)
|
---|---|---|
Schedule of Available for sale Securities and Held to maturity Securities [Line Items] | ||
Accrued interest on investment securities | $ 20,600 | |
Allowance for credit losses | 245 | $ 0 |
Gross unrealized losses | 19,186 | 349 |
Carrying value of securities pledged as collateral | 999,200 | 890,000 |
Securities sold under repurchase agreements | 178,200 | 167,300 |
State and municipal | ||
Schedule of Available for sale Securities and Held to maturity Securities [Line Items] | ||
Allowance for credit losses | 245 | 0 |
Gross unrealized losses | $ 2,654 | 246 |
Number of securities in unrealized loss positions | instrument | 108 | |
U.S. Government-sponsored mortgage-backed securities | ||
Schedule of Available for sale Securities and Held to maturity Securities [Line Items] | ||
Allowance for credit losses | $ 0 | 0 |
Gross unrealized losses | $ 16,347 | 103 |
Number of securities in unrealized loss positions | instrument | 55 | |
U.S. Government-sponsored agency securities | ||
Schedule of Available for sale Securities and Held to maturity Securities [Line Items] | ||
Allowance for credit losses | $ 0 | 0 |
Gross unrealized losses | $ 163 | 0 |
Number of securities in unrealized loss positions | instrument | 2 | |
Corporate obligations | ||
Schedule of Available for sale Securities and Held to maturity Securities [Line Items] | ||
Gross unrealized losses | $ 22 | $ 0 |
Number of securities in unrealized loss positions | instrument | 1 |
Investment Securities - Amortized Cost of Investment Securities Held to Maturity (Details) - USD ($) $ in Thousands |
Mar. 31, 2021 |
Dec. 31, 2020 |
---|---|---|
Schedule of Held-to-maturity Securities [Line Items] | ||
Held to maturity securities | $ 1,295,534 | $ 1,227,668 |
Aaa | ||
Schedule of Held-to-maturity Securities [Line Items] | ||
Held to maturity securities | 109,365 | |
Aa1 | ||
Schedule of Held-to-maturity Securities [Line Items] | ||
Held to maturity securities | 84,954 | |
Aa2 | ||
Schedule of Held-to-maturity Securities [Line Items] | ||
Held to maturity securities | 107,436 | |
Aa3 | ||
Schedule of Held-to-maturity Securities [Line Items] | ||
Held to maturity securities | 72,969 | |
A1 | ||
Schedule of Held-to-maturity Securities [Line Items] | ||
Held to maturity securities | 65,578 | |
A2 | ||
Schedule of Held-to-maturity Securities [Line Items] | ||
Held to maturity securities | 19,074 | |
A3 | ||
Schedule of Held-to-maturity Securities [Line Items] | ||
Held to maturity securities | 1,065 | |
Baa2 | ||
Schedule of Held-to-maturity Securities [Line Items] | ||
Held to maturity securities | 528 | |
Non-rated | ||
Schedule of Held-to-maturity Securities [Line Items] | ||
Held to maturity securities | 834,565 | |
State and municipal | ||
Schedule of Held-to-maturity Securities [Line Items] | ||
Held to maturity securities | 624,553 | $ 619,927 |
State and municipal | Aaa | ||
Schedule of Held-to-maturity Securities [Line Items] | ||
Held to maturity securities | 48,689 | |
State and municipal | Aa1 | ||
Schedule of Held-to-maturity Securities [Line Items] | ||
Held to maturity securities | 84,954 | |
State and municipal | Aa2 | ||
Schedule of Held-to-maturity Securities [Line Items] | ||
Held to maturity securities | 107,436 | |
State and municipal | Aa3 | ||
Schedule of Held-to-maturity Securities [Line Items] | ||
Held to maturity securities | 72,969 | |
State and municipal | A1 | ||
Schedule of Held-to-maturity Securities [Line Items] | ||
Held to maturity securities | 65,578 | |
State and municipal | A2 | ||
Schedule of Held-to-maturity Securities [Line Items] | ||
Held to maturity securities | 19,074 | |
State and municipal | A3 | ||
Schedule of Held-to-maturity Securities [Line Items] | ||
Held to maturity securities | 1,065 | |
State and municipal | Baa2 | ||
Schedule of Held-to-maturity Securities [Line Items] | ||
Held to maturity securities | 528 | |
State and municipal | Non-rated | ||
Schedule of Held-to-maturity Securities [Line Items] | ||
Held to maturity securities | 224,260 | |
Other | ||
Schedule of Held-to-maturity Securities [Line Items] | ||
Held to maturity securities | 670,981 | |
Other | Aaa | ||
Schedule of Held-to-maturity Securities [Line Items] | ||
Held to maturity securities | 60,676 | |
Other | Aa1 | ||
Schedule of Held-to-maturity Securities [Line Items] | ||
Held to maturity securities | 0 | |
Other | Aa2 | ||
Schedule of Held-to-maturity Securities [Line Items] | ||
Held to maturity securities | 0 | |
Other | Aa3 | ||
Schedule of Held-to-maturity Securities [Line Items] | ||
Held to maturity securities | 0 | |
Other | A1 | ||
Schedule of Held-to-maturity Securities [Line Items] | ||
Held to maturity securities | 0 | |
Other | A2 | ||
Schedule of Held-to-maturity Securities [Line Items] | ||
Held to maturity securities | 0 | |
Other | A3 | ||
Schedule of Held-to-maturity Securities [Line Items] | ||
Held to maturity securities | 0 | |
Other | Baa2 | ||
Schedule of Held-to-maturity Securities [Line Items] | ||
Held to maturity securities | 0 | |
Other | Non-rated | ||
Schedule of Held-to-maturity Securities [Line Items] | ||
Held to maturity securities | $ 610,305 |
Investment Securities - Allowance for Credit Losses on Investment Securities Held to Maturity (Details) $ in Thousands |
3 Months Ended |
---|---|
Mar. 31, 2021
USD ($)
| |
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Roll Forward] | |
Beginning balance | $ 0 |
Ending balance | 245 |
State and municipal | |
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Roll Forward] | |
Beginning balance | 0 |
Provision for credit loss | 0 |
Securities charged off | 0 |
Recoveries on securities | 0 |
Ending balance | 245 |
State and municipal | Cumulative effect of ASC 326 adoption | |
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Roll Forward] | |
Beginning balance | 245 |
Ending balance | $ 245 |
Investment Securities - Investments' Gross Unrealized Losses and Fair Value Aggregated by Investment Category and Length of Time in Continuous Unrealized Loss Position (Details) - USD ($) $ in Thousands |
Mar. 31, 2021 |
Dec. 31, 2020 |
---|---|---|
Fair Value | ||
Less than 12 Months | $ 789,968 | $ 15,019 |
12 Months or Longer | 0 | 0 |
Total | 789,968 | 15,019 |
Gross Unrealized Losses | ||
Less than 12 Months | 19,186 | 349 |
12 Months or Longer | 0 | 0 |
Total | 19,186 | 349 |
U.S. Government-sponsored agency securities | ||
Fair Value | ||
Less than 12 Months | 9,837 | |
12 Months or Longer | 0 | |
Total | 9,837 | |
Gross Unrealized Losses | ||
Less than 12 Months | 163 | |
12 Months or Longer | 0 | |
Total | 163 | |
State and municipal | ||
Fair Value | ||
Less than 12 Months | 172,655 | 5,368 |
12 Months or Longer | 0 | 0 |
Total | 172,655 | 5,368 |
Gross Unrealized Losses | ||
Less than 12 Months | 2,654 | 246 |
12 Months or Longer | 0 | 0 |
Total | 2,654 | 246 |
U.S. Government-sponsored mortgage-backed securities | ||
Fair Value | ||
Less than 12 Months | 606,498 | 9,651 |
12 Months or Longer | 0 | 0 |
Total | 606,498 | 9,651 |
Gross Unrealized Losses | ||
Less than 12 Months | 16,347 | 103 |
12 Months or Longer | 0 | 0 |
Total | 16,347 | $ 103 |
Corporate obligations | ||
Fair Value | ||
Less than 12 Months | 978 | |
12 Months or Longer | 0 | |
Total | 978 | |
Gross Unrealized Losses | ||
Less than 12 Months | 22 | |
12 Months or Longer | 0 | |
Total | $ 22 |
Investment Securities - Investments in Debt and Equity Securities Reported Less than Historical Cost (Details) - Investments reported at less than historical cost - USD ($) $ in Thousands |
Mar. 31, 2021 |
Dec. 31, 2020 |
---|---|---|
Schedule of Investments [Line Items] | ||
Historical cost | $ 809,154 | $ 15,368 |
Fair value | 789,968 | 15,019 |
Gross unrealized losses | $ 19,186 | $ 349 |
Percent of the Corporation's investments available for sale | 21.40% | 0.50% |
Investment Securities - Amortized Cost and Fair Value of Available for Sale Securities and Held to Maturity Securities by Contractual Maturity (Details) - USD ($) $ in Thousands |
Mar. 31, 2021 |
Dec. 31, 2020 |
---|---|---|
Amortized Cost | ||
Due in one year or less | $ 2,062 | $ 1,349 |
Due after one through five years | 4,781 | 5,545 |
Due after five through ten years | 92,598 | 70,777 |
Due after ten years | 1,218,472 | 1,097,451 |
Total debt securities with a single maturity date | 1,317,913 | 1,175,122 |
Total investment securities | 2,343,573 | 1,807,389 |
Fair Value | ||
Due in one year or less | 2,071 | 1,353 |
Due after one through five years | 4,960 | 5,764 |
Due after five through ten years | 96,882 | 75,223 |
Due after ten years | 1,278,792 | 1,182,110 |
Total debt securities with a single maturity date | 1,382,705 | 1,264,450 |
Total investment securities | 2,405,568 | 1,919,119 |
Amortized Cost | ||
Due in one year or less | 9,056 | 9,712 |
Due after one through five years | 23,116 | 22,241 |
Due after five through ten years | 151,103 | 115,408 |
Due after ten years | 503,454 | 505,153 |
Total debt securities with a single maturity date | 686,729 | 652,514 |
Total investment securities | 1,295,534 | 1,227,668 |
Fair Value | ||
Due in one year or less | 9,068 | 9,755 |
Due after one through five years | 24,084 | 23,190 |
Due after five through ten years | 154,819 | 121,333 |
Due after ten years | 516,971 | 533,079 |
Total debt securities with a single maturity date | 704,942 | 687,357 |
Investment securities held to maturity | 1,318,780 | 1,280,293 |
U.S. Government-sponsored mortgage-backed securities | ||
Amortized Cost | ||
Without single maturity date | 1,025,660 | 632,267 |
Total investment securities | 1,025,660 | 632,267 |
Fair Value | ||
Without single maturity date | 1,022,863 | 654,669 |
Total investment securities | 1,022,863 | 654,669 |
Amortized Cost | ||
Without single maturity date | 608,805 | 575,154 |
Total investment securities | 608,805 | 575,154 |
Fair Value | ||
Without single maturity date | 613,838 | 592,936 |
Investment securities held to maturity | $ 613,838 | $ 592,936 |
Investment Securities - Gross Gains on Sales and Redemptions of Available for Sale Securities (Details) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Mar. 31, 2021 |
Mar. 31, 2020 |
|
Sales and redemptions of investment securities available for sale: | ||
Gross gains | $ 2,076 | $ 4,612 |
Gross losses | 277 | 0 |
Net gains on sales and redemptions of investment securities available for sale | $ 1,799 | $ 4,612 |
Loans and Allowance - Narrative (Details) - USD ($) |
3 Months Ended | |||
---|---|---|---|---|
Mar. 31, 2021 |
Mar. 31, 2020 |
Jan. 01, 2021 |
Dec. 31, 2020 |
|
Receivables [Abstract] | ||||
Loans held for sale | $ 4,430,000 | $ 3,966,000 | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Loans | 9,318,228,000 | 9,243,174,000 | ||
Interest income recognized on non-accrual loans | 0 | $ 0 | ||
Allowance for credit losses on unfunded loan commitments | 20,500,000 | 0 | ||
Cumulative effect of ASC 326 adoption | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Loans | $ 4,776,000 | |||
Allowance for credit losses on unfunded loan commitments | 20,500,000 | $ 20,500,000 | 20,500,000 | |
Commercial real estate, non-owner occupied | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Loans | 2,178,832,000 | 2,220,949,000 | ||
Commercial and industrial loans | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Loans | 2,876,212,000 | 2,776,699,000 | ||
Residential Real Estate | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Loans | $ 1,239,925,000 | 1,234,741,000 | ||
Percentage of troubled debt restructured loans | 6400.00% | |||
Mortgage loans with formal foreclosure proceedings | $ 3,300,000 | $ 507,000 | ||
PPP loans | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Loans | 741,700,000 | 667,100,000 | ||
30-59 Days Past Due | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Past due | 55,622,000 | 19,638,000 | ||
Increase (decrease) in past due loans | (36,000,000.0) | |||
30-59 Days Past Due | Commercial real estate, non-owner occupied | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Past due | 45,942,000 | 2,525,000 | ||
30-59 Days Past Due | Commercial and industrial loans | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Past due | 4,545,000 | 5,866,000 | ||
30-59 Days Past Due | Residential Real Estate | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Past due | 1,582,000 | 3,269,000 | ||
30-59 Days Past Due | Multifamily | Commercial real estate, non-owner occupied | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Past due | 24,100,000 | |||
30-59 Days Past Due | Hotel | Commercial real estate, non-owner occupied | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Past due | 21,000,000.0 | |||
60-89 Days Past Due | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Past due | 2,978,000 | 11,187,000 | ||
Increase (decrease) in past due loans | 8,200,000 | |||
60-89 Days Past Due | Commercial real estate, non-owner occupied | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Past due | 434,000 | 2,109,000 | ||
60-89 Days Past Due | Commercial and industrial loans | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Past due | 19,000 | 6,571,000 | ||
Increase (decrease) in past due loans | (5,000,000.0) | |||
60-89 Days Past Due | Residential Real Estate | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Past due | 377,000 | 1,429,000 | ||
90 Days or More Past Due | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Past due | 47,390,000 | 41,950,000 | ||
Increase (decrease) in past due loans | (5,400,000) | |||
90 Days or More Past Due | Commercial real estate, non-owner occupied | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Past due | 38,353,000 | 31,634,000 | ||
Increase (decrease) in past due loans | 3,700,000 | |||
90 Days or More Past Due | Commercial and industrial loans | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Past due | 1,212,000 | 2,789,000 | ||
90 Days or More Past Due | Residential Real Estate | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Past due | 3,493,000 | $ 3,264,000 | ||
90 Days or More Past Due | Nursing Home | Commercial real estate, non-owner occupied | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Increase (decrease) in past due loans | $ (13,000,000.0) |
Loans and Allowance - Composition of Loan Portfolio by Loan Class (Details) - USD ($) $ in Thousands |
Mar. 31, 2021 |
Dec. 31, 2020 |
---|---|---|
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | $ 9,318,228 | $ 9,243,174 |
Commercial and industrial loans | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 2,876,212 | 2,776,699 |
Agricultural land, production and other loans to farmers | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 245,631 | 281,884 |
Construction | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 541,224 | 484,723 |
Commercial real estate, non-owner occupied | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 2,178,832 | 2,220,949 |
Commercial real estate, owner occupied | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 950,038 | 958,501 |
Residential Real Estate | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 1,239,925 | 1,234,741 |
Home equity | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 482,229 | 508,259 |
Individuals' loans for household and other personal expenditures | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 126,387 | 129,479 |
Public finance and other commercial loans | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | $ 677,750 | $ 647,939 |
Loans and Allowance - Credit Quality of Loan Portfolio by Loan Class (Details) - USD ($) $ in Thousands |
Mar. 31, 2021 |
Dec. 31, 2020 |
---|---|---|
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
2021 | $ 923,091 | |
2020 | 3,744,372 | |
2019 | 1,208,586 | |
2018 | 677,245 | |
2017 | 502,173 | |
Prior | 906,900 | |
Revolving loans amortized cost basis | 1,355,861 | |
Loans | 9,318,228 | $ 9,243,174 |
Commercial Pass | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Loans | 7,000,298 | |
Commercial Special Mention | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Loans | 334,989 | |
Commercial Substandard | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Loans | 234,712 | |
Commercial Doubtful | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Loans | 0 | |
Commercial Loss | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Loans | 0 | |
Consumer Performing | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Loans | 1,666,062 | |
Consumer Non-Performing | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Loans | 7,113 | |
PPP loans | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
2021 | 293,100 | |
2020 | 448,600 | |
Loans | 741,700 | 667,100 |
Commercial and industrial loans | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
2021 | 461,373 | |
2020 | 1,157,272 | |
2019 | 273,425 | |
2018 | 129,457 | |
2017 | 49,876 | |
Prior | 67,813 | |
Revolving loans amortized cost basis | 736,996 | |
Loans | 2,876,212 | 2,776,699 |
Commercial and industrial loans | Pass | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
2021 | 451,747 | |
2020 | 1,101,622 | |
2019 | 265,685 | |
2018 | 121,416 | |
2017 | 47,101 | |
Prior | 64,093 | |
Revolving loans amortized cost basis | 634,146 | |
Loans | 2,685,810 | |
Commercial and industrial loans | Special Mention | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
2021 | 7,735 | |
2020 | 50,704 | |
2019 | 1,421 | |
2018 | 7,435 | |
2017 | 2,306 | |
Prior | 2,326 | |
Revolving loans amortized cost basis | 29,255 | |
Loans | 101,182 | |
Commercial and industrial loans | Substandard | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
2021 | 1,891 | |
2020 | 4,946 | |
2019 | 6,319 | |
2018 | 606 | |
2017 | 469 | |
Prior | 1,394 | |
Revolving loans amortized cost basis | 73,595 | |
Loans | 89,220 | |
Commercial and industrial loans | Commercial Pass | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Loans | 2,562,077 | |
Commercial and industrial loans | Commercial Special Mention | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Loans | 117,503 | |
Commercial and industrial loans | Commercial Substandard | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Loans | 97,119 | |
Commercial and industrial loans | Commercial Doubtful | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Loans | 0 | |
Commercial and industrial loans | Commercial Loss | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Loans | 0 | |
Commercial and industrial loans | Consumer Performing | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Loans | 0 | |
Commercial and industrial loans | Consumer Non-Performing | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Loans | 0 | |
Agricultural land, production and other loans to farmers | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
2021 | 22,721 | |
2020 | 63,357 | |
2019 | 26,396 | |
2018 | 14,140 | |
2017 | 9,538 | |
Prior | 53,870 | |
Revolving loans amortized cost basis | 55,609 | |
Loans | 245,631 | 281,884 |
Agricultural land, production and other loans to farmers | Pass | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
2021 | 22,570 | |
2020 | 58,620 | |
2019 | 26,146 | |
2018 | 11,864 | |
2017 | 8,821 | |
Prior | 49,646 | |
Revolving loans amortized cost basis | 45,626 | |
Loans | 223,293 | |
Agricultural land, production and other loans to farmers | Special Mention | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
2021 | 151 | |
2020 | 621 | |
2019 | 186 | |
2018 | 2,151 | |
2017 | 0 | |
Prior | 3,347 | |
Revolving loans amortized cost basis | 8,824 | |
Loans | 15,280 | |
Agricultural land, production and other loans to farmers | Substandard | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
2021 | 0 | |
2020 | 4,116 | |
2019 | 64 | |
2018 | 125 | |
2017 | 717 | |
Prior | 877 | |
Revolving loans amortized cost basis | 1,159 | |
Loans | 7,058 | |
Agricultural land, production and other loans to farmers | Commercial Pass | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Loans | 243,991 | |
Agricultural land, production and other loans to farmers | Commercial Special Mention | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Loans | 26,835 | |
Agricultural land, production and other loans to farmers | Commercial Substandard | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Loans | 9,885 | |
Agricultural land, production and other loans to farmers | Commercial Doubtful | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Loans | 0 | |
Agricultural land, production and other loans to farmers | Commercial Loss | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Loans | 0 | |
Agricultural land, production and other loans to farmers | Consumer Performing | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Loans | 1,173 | |
Agricultural land, production and other loans to farmers | Consumer Non-Performing | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Loans | 0 | |
Construction | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
2021 | 65,191 | |
2020 | 218,970 | |
2019 | 165,903 | |
2018 | 68,879 | |
2017 | 3,104 | |
Prior | 1,963 | |
Revolving loans amortized cost basis | 17,214 | |
Loans | 541,224 | 484,723 |
Construction | Pass | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
2021 | 60,800 | |
2020 | 208,852 | |
2019 | 165,903 | |
2018 | 68,816 | |
2017 | 3,104 | |
Prior | 1,945 | |
Revolving loans amortized cost basis | 17,184 | |
Loans | 526,604 | |
Construction | Special Mention | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
2021 | 0 | |
2020 | 10,118 | |
2019 | 0 | |
2018 | 63 | |
2017 | 0 | |
Prior | 0 | |
Revolving loans amortized cost basis | 30 | |
Loans | 10,211 | |
Construction | Substandard | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
2021 | 4,391 | |
2020 | 0 | |
2019 | 0 | |
2018 | 0 | |
2017 | 0 | |
Prior | 18 | |
Revolving loans amortized cost basis | 0 | |
Loans | 4,409 | |
Construction | Commercial Pass | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Loans | 446,846 | |
Construction | Commercial Special Mention | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Loans | 10,445 | |
Construction | Commercial Substandard | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Loans | 5,549 | |
Construction | Commercial Doubtful | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Loans | 0 | |
Construction | Commercial Loss | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Loans | 0 | |
Construction | Consumer Performing | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Loans | 21,763 | |
Construction | Consumer Non-Performing | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Loans | 120 | |
Commercial real estate, non-owner occupied | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
2021 | 103,508 | |
2020 | 1,141,062 | |
2019 | 313,326 | |
2018 | 238,546 | |
2017 | 149,787 | |
Prior | 205,899 | |
Revolving loans amortized cost basis | 26,704 | |
Loans | 2,178,832 | 2,220,949 |
Commercial real estate, non-owner occupied | Pass | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
2021 | 93,726 | |
2020 | 933,226 | |
2019 | 275,343 | |
2018 | 225,971 | |
2017 | 141,947 | |
Prior | 196,284 | |
Revolving loans amortized cost basis | 25,454 | |
Loans | 1,891,951 | |
Commercial real estate, non-owner occupied | Special Mention | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
2021 | 9,544 | |
2020 | 169,291 | |
2019 | 13,242 | |
2018 | 990 | |
2017 | 0 | |
Prior | 112 | |
Revolving loans amortized cost basis | 1,250 | |
Loans | 194,429 | |
Commercial real estate, non-owner occupied | Substandard | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
2021 | 238 | |
2020 | 38,545 | |
2019 | 24,741 | |
2018 | 11,585 | |
2017 | 7,840 | |
Prior | 9,503 | |
Revolving loans amortized cost basis | 0 | |
Loans | 92,452 | |
Commercial real estate, non-owner occupied | Commercial Pass | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Loans | 1,979,827 | |
Commercial real estate, non-owner occupied | Commercial Special Mention | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Loans | 160,304 | |
Commercial real estate, non-owner occupied | Commercial Substandard | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Loans | 80,818 | |
Commercial real estate, non-owner occupied | Commercial Doubtful | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Loans | 0 | |
Commercial real estate, non-owner occupied | Commercial Loss | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Loans | 0 | |
Commercial real estate, non-owner occupied | Consumer Performing | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Loans | 0 | |
Commercial real estate, non-owner occupied | Consumer Non-Performing | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Loans | 0 | |
Commercial real estate, owner occupied | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
2021 | 56,880 | |
2020 | 510,636 | |
2019 | 124,777 | |
2018 | 61,356 | |
2017 | 63,552 | |
Prior | 92,959 | |
Revolving loans amortized cost basis | 39,878 | |
Loans | 950,038 | 958,501 |
Commercial real estate, owner occupied | Pass | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
2021 | 51,710 | |
2020 | 481,355 | |
2019 | 122,017 | |
2018 | 57,531 | |
2017 | 60,587 | |
Prior | 89,802 | |
Revolving loans amortized cost basis | 39,729 | |
Loans | 902,731 | |
Commercial real estate, owner occupied | Special Mention | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
2021 | 45 | |
2020 | 10,174 | |
2019 | 2,606 | |
2018 | 1,646 | |
2017 | 2,242 | |
Prior | 1,178 | |
Revolving loans amortized cost basis | 149 | |
Loans | 18,040 | |
Commercial real estate, owner occupied | Substandard | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
2021 | 5,079 | |
2020 | 19,107 | |
2019 | 154 | |
2018 | 2,179 | |
2017 | 723 | |
Prior | 1,979 | |
Revolving loans amortized cost basis | 0 | |
Loans | 29,221 | |
Commercial real estate, owner occupied | Commercial Pass | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Loans | 907,566 | |
Commercial real estate, owner occupied | Commercial Special Mention | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Loans | 17,641 | |
Commercial real estate, owner occupied | Commercial Substandard | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Loans | 33,294 | |
Commercial real estate, owner occupied | Commercial Doubtful | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Loans | ||
Commercial real estate, owner occupied | Commercial Loss | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
2021 | 46 | |
2020 | 0 | |
2019 | 0 | |
2018 | 0 | |
2017 | 0 | |
Prior | 0 | |
Revolving loans amortized cost basis | 0 | |
Loans | 46 | |
Commercial real estate, owner occupied | Consumer Performing | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Loans | 0 | |
Commercial real estate, owner occupied | Consumer Non-Performing | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Loans | 0 | |
Residential Real Estate | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
2021 | 171,943 | |
2020 | 402,246 | |
2019 | 148,975 | |
2018 | 103,570 | |
2017 | 89,154 | |
Prior | 320,071 | |
Revolving loans amortized cost basis | 3,966 | |
Loans | 1,239,925 | 1,234,741 |
Residential Real Estate | Pass | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
2021 | 171,109 | |
2020 | 398,112 | |
2019 | 148,457 | |
2018 | 101,627 | |
2017 | 88,700 | |
Prior | 314,130 | |
Revolving loans amortized cost basis | 3,873 | |
Loans | 1,226,008 | |
Residential Real Estate | Special Mention | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
2021 | 349 | |
2020 | 982 | |
2019 | 0 | |
2018 | 588 | |
2017 | 82 | |
Prior | 1,313 | |
Revolving loans amortized cost basis | 93 | |
Loans | 3,407 | |
Residential Real Estate | Substandard | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
2021 | 485 | |
2020 | 3,152 | |
2019 | 518 | |
2018 | 1,355 | |
2017 | 372 | |
Prior | 4,628 | |
Revolving loans amortized cost basis | 0 | |
Loans | 10,510 | |
Residential Real Estate | Commercial Pass | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Loans | 199,338 | |
Residential Real Estate | Commercial Special Mention | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Loans | 2,261 | |
Residential Real Estate | Commercial Substandard | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Loans | 7,058 | |
Residential Real Estate | Commercial Doubtful | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Loans | 0 | |
Residential Real Estate | Commercial Loss | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Loans | 0 | |
Residential Real Estate | Consumer Performing | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Loans | 1,020,687 | |
Residential Real Estate | Consumer Non-Performing | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Loans | 5,397 | |
Home equity | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
2021 | 3,076 | |
2020 | 20,274 | |
2019 | 2,577 | |
2018 | 2,943 | |
2017 | 1,915 | |
Prior | 5,339 | |
Revolving loans amortized cost basis | 446,105 | |
Loans | 482,229 | 508,259 |
Home equity | Pass | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
2021 | 2,673 | |
2020 | 20,032 | |
2019 | 2,577 | |
2018 | 2,930 | |
2017 | 1,786 | |
Prior | 5,085 | |
Revolving loans amortized cost basis | 442,166 | |
Loans | 477,249 | |
Home equity | Special Mention | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
2021 | 0 | |
2020 | 91 | |
2019 | 0 | |
2018 | 0 | |
2017 | 0 | |
Prior | 59 | |
Revolving loans amortized cost basis | 2,588 | |
Loans | 2,738 | |
Home equity | Substandard | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
2021 | 403 | |
2020 | 151 | |
2019 | 0 | |
2018 | 13 | |
2017 | 129 | |
Prior | 195 | |
Revolving loans amortized cost basis | 1,351 | |
Loans | 2,242 | |
Home equity | Commercial Pass | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Loans | 12,714 | |
Home equity | Commercial Special Mention | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Loans | 0 | |
Home equity | Commercial Substandard | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Loans | 989 | |
Home equity | Commercial Doubtful | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Loans | 0 | |
Home equity | Commercial Loss | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Loans | 0 | |
Home equity | Consumer Performing | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Loans | 492,999 | |
Home equity | Consumer Non-Performing | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Loans | 1,557 | |
Individuals' loans for household and other personal expenditures | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
2021 | 16,786 | |
2020 | 38,747 | |
2019 | 24,363 | |
2018 | 18,517 | |
2017 | 4,391 | |
Prior | 7,583 | |
Revolving loans amortized cost basis | 16,000 | |
Loans | 126,387 | 129,479 |
Individuals' loans for household and other personal expenditures | Pass | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
2021 | 16,786 | |
2020 | 38,678 | |
2019 | 24,201 | |
2018 | 18,482 | |
2017 | 4,383 | |
Prior | 7,550 | |
Revolving loans amortized cost basis | 15,996 | |
Loans | 126,076 | |
Individuals' loans for household and other personal expenditures | Special Mention | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
2021 | 0 | |
2020 | 68 | |
2019 | 75 | |
2018 | 35 | |
2017 | 8 | |
Prior | 33 | |
Revolving loans amortized cost basis | 4 | |
Loans | 223 | |
Individuals' loans for household and other personal expenditures | Substandard | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
2021 | 0 | |
2020 | 1 | |
2019 | 87 | |
2018 | 0 | |
2017 | 0 | |
Prior | 0 | |
Revolving loans amortized cost basis | 0 | |
Loans | 88 | |
Individuals' loans for household and other personal expenditures | Commercial Pass | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Loans | 0 | |
Individuals' loans for household and other personal expenditures | Commercial Special Mention | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Loans | 0 | |
Individuals' loans for household and other personal expenditures | Commercial Substandard | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Loans | 0 | |
Individuals' loans for household and other personal expenditures | Commercial Doubtful | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Loans | 0 | |
Individuals' loans for household and other personal expenditures | Commercial Loss | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Loans | 0 | |
Individuals' loans for household and other personal expenditures | Consumer Performing | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Loans | 129,440 | |
Individuals' loans for household and other personal expenditures | Consumer Non-Performing | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Loans | 39 | |
Public finance and other commercial loans | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
2021 | 21,613 | |
2020 | 191,808 | |
2019 | 128,844 | |
2018 | 39,837 | |
2017 | 130,856 | |
Prior | 151,403 | |
Revolving loans amortized cost basis | 13,389 | |
Loans | 677,750 | 647,939 |
Public finance and other commercial loans | Pass | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
2021 | 21,613 | |
2020 | 191,808 | |
2019 | 128,844 | |
2018 | 39,837 | |
2017 | 130,856 | |
Prior | 151,403 | |
Revolving loans amortized cost basis | 13,389 | |
Loans | $ 677,750 | |
Public finance and other commercial loans | Commercial Pass | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Loans | 647,939 | |
Public finance and other commercial loans | Commercial Special Mention | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Loans | 0 | |
Public finance and other commercial loans | Commercial Substandard | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Loans | 0 | |
Public finance and other commercial loans | Commercial Doubtful | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Loans | 0 | |
Public finance and other commercial loans | Commercial Loss | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Loans | 0 | |
Public finance and other commercial loans | Consumer Performing | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Loans | 0 | |
Public finance and other commercial loans | Consumer Non-Performing | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Loans | $ 0 |
Loans and Allowance - Past Due Aging of Loan Portfolio by Loan Class (Details) - USD ($) $ in Thousands |
Mar. 31, 2021 |
Dec. 31, 2020 |
---|---|---|
Financing Receivable, Past Due [Line Items] | ||
Current | $ 9,212,238 | $ 9,170,399 |
Loans | 9,318,228 | 9,243,174 |
Commercial and industrial loans | ||
Financing Receivable, Past Due [Line Items] | ||
Current | 2,870,436 | 2,761,473 |
Loans | 2,876,212 | 2,776,699 |
Agricultural land, production and other loans to farmers | ||
Financing Receivable, Past Due [Line Items] | ||
Current | 244,403 | 280,615 |
Loans | 245,631 | 281,884 |
Construction | ||
Financing Receivable, Past Due [Line Items] | ||
Current | 540,648 | 484,706 |
Loans | 541,224 | 484,723 |
Commercial real estate, non-owner occupied | ||
Financing Receivable, Past Due [Line Items] | ||
Current | 2,094,103 | 2,184,681 |
Loans | 2,178,832 | 2,220,949 |
Commercial real estate, owner occupied | ||
Financing Receivable, Past Due [Line Items] | ||
Current | 946,423 | 951,561 |
Loans | 950,038 | 958,501 |
Residential Real Estate | ||
Financing Receivable, Past Due [Line Items] | ||
Current | 1,234,473 | 1,226,779 |
Loans | 1,239,925 | 1,234,741 |
Home equity | ||
Financing Receivable, Past Due [Line Items] | ||
Current | 477,927 | 503,596 |
Loans | 482,229 | 508,259 |
Individuals' loans for household and other personal expenditures | ||
Financing Receivable, Past Due [Line Items] | ||
Current | 126,075 | 129,049 |
Loans | 126,387 | 129,479 |
Public finance and other commercial loans | ||
Financing Receivable, Past Due [Line Items] | ||
Current | 677,750 | 647,939 |
Loans | 677,750 | 647,939 |
30-59 Days Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Past Due | 55,622 | 19,638 |
30-59 Days Past Due | Commercial and industrial loans | ||
Financing Receivable, Past Due [Line Items] | ||
Past Due | 4,545 | 5,866 |
30-59 Days Past Due | Agricultural land, production and other loans to farmers | ||
Financing Receivable, Past Due [Line Items] | ||
Past Due | 114 | 146 |
30-59 Days Past Due | Construction | ||
Financing Receivable, Past Due [Line Items] | ||
Past Due | 560 | 0 |
30-59 Days Past Due | Commercial real estate, non-owner occupied | ||
Financing Receivable, Past Due [Line Items] | ||
Past Due | 45,942 | 2,525 |
30-59 Days Past Due | Commercial real estate, owner occupied | ||
Financing Receivable, Past Due [Line Items] | ||
Past Due | 792 | 4,854 |
30-59 Days Past Due | Residential Real Estate | ||
Financing Receivable, Past Due [Line Items] | ||
Past Due | 1,582 | 3,269 |
30-59 Days Past Due | Home equity | ||
Financing Receivable, Past Due [Line Items] | ||
Past Due | 1,906 | 2,644 |
30-59 Days Past Due | Individuals' loans for household and other personal expenditures | ||
Financing Receivable, Past Due [Line Items] | ||
Past Due | 181 | 334 |
30-59 Days Past Due | Public finance and other commercial loans | ||
Financing Receivable, Past Due [Line Items] | ||
Past Due | 0 | 0 |
60-89 Days Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Past Due | 2,978 | 11,187 |
60-89 Days Past Due | Commercial and industrial loans | ||
Financing Receivable, Past Due [Line Items] | ||
Past Due | 19 | 6,571 |
60-89 Days Past Due | Agricultural land, production and other loans to farmers | ||
Financing Receivable, Past Due [Line Items] | ||
Past Due | 0 | 226 |
60-89 Days Past Due | Construction | ||
Financing Receivable, Past Due [Line Items] | ||
Past Due | 0 | 17 |
60-89 Days Past Due | Commercial real estate, non-owner occupied | ||
Financing Receivable, Past Due [Line Items] | ||
Past Due | 434 | 2,109 |
60-89 Days Past Due | Commercial real estate, owner occupied | ||
Financing Receivable, Past Due [Line Items] | ||
Past Due | 1,096 | 180 |
60-89 Days Past Due | Residential Real Estate | ||
Financing Receivable, Past Due [Line Items] | ||
Past Due | 377 | 1,429 |
60-89 Days Past Due | Home equity | ||
Financing Receivable, Past Due [Line Items] | ||
Past Due | 1,010 | 559 |
60-89 Days Past Due | Individuals' loans for household and other personal expenditures | ||
Financing Receivable, Past Due [Line Items] | ||
Past Due | 42 | 96 |
60-89 Days Past Due | Public finance and other commercial loans | ||
Financing Receivable, Past Due [Line Items] | ||
Past Due | 0 | 0 |
90 Days or More Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Past Due | 47,390 | 41,950 |
Loans > 90 Days or More Past Due And Accruing | 1,093 | 746 |
90 Days or More Past Due | Commercial and industrial loans | ||
Financing Receivable, Past Due [Line Items] | ||
Past Due | 1,212 | 2,789 |
Loans > 90 Days or More Past Due And Accruing | 0 | 594 |
90 Days or More Past Due | Agricultural land, production and other loans to farmers | ||
Financing Receivable, Past Due [Line Items] | ||
Past Due | 1,114 | 897 |
Loans > 90 Days or More Past Due And Accruing | 0 | 0 |
90 Days or More Past Due | Construction | ||
Financing Receivable, Past Due [Line Items] | ||
Past Due | 16 | 0 |
Loans > 90 Days or More Past Due And Accruing | 0 | 0 |
90 Days or More Past Due | Commercial real estate, non-owner occupied | ||
Financing Receivable, Past Due [Line Items] | ||
Past Due | 38,353 | 31,634 |
Loans > 90 Days or More Past Due And Accruing | 0 | 0 |
90 Days or More Past Due | Commercial real estate, owner occupied | ||
Financing Receivable, Past Due [Line Items] | ||
Past Due | 1,727 | 1,906 |
Loans > 90 Days or More Past Due And Accruing | 1,032 | 0 |
90 Days or More Past Due | Residential Real Estate | ||
Financing Receivable, Past Due [Line Items] | ||
Past Due | 3,493 | 3,264 |
Loans > 90 Days or More Past Due And Accruing | 0 | 133 |
90 Days or More Past Due | Home equity | ||
Financing Receivable, Past Due [Line Items] | ||
Past Due | 1,386 | 1,460 |
Loans > 90 Days or More Past Due And Accruing | 60 | 19 |
90 Days or More Past Due | Individuals' loans for household and other personal expenditures | ||
Financing Receivable, Past Due [Line Items] | ||
Past Due | 89 | 0 |
Loans > 90 Days or More Past Due And Accruing | 1 | 0 |
90 Days or More Past Due | Public finance and other commercial loans | ||
Financing Receivable, Past Due [Line Items] | ||
Past Due | 0 | 0 |
Loans > 90 Days or More Past Due And Accruing | $ 0 | $ 0 |
Loans and Allowance - Summary of Non-Accrual Loans by Loan Class (Details) - USD ($) $ in Thousands |
Mar. 31, 2021 |
Dec. 31, 2020 |
---|---|---|
Financing Receivable, Past Due [Line Items] | ||
Non-Accrual Loans | $ 57,923 | $ 61,471 |
Non-Accrual Loans with no Allowance for Credit Losses | 5,548 | |
Commercial and industrial loans | ||
Financing Receivable, Past Due [Line Items] | ||
Non-Accrual Loans | 1,671 | 2,329 |
Non-Accrual Loans with no Allowance for Credit Losses | 786 | |
Agricultural land, production and other loans to farmers | ||
Financing Receivable, Past Due [Line Items] | ||
Non-Accrual Loans | 1,220 | 1,012 |
Non-Accrual Loans with no Allowance for Credit Losses | 561 | |
Construction | ||
Financing Receivable, Past Due [Line Items] | ||
Non-Accrual Loans | 18 | 123 |
Non-Accrual Loans with no Allowance for Credit Losses | 0 | |
Commercial real estate, non-owner occupied | ||
Financing Receivable, Past Due [Line Items] | ||
Non-Accrual Loans | 44,143 | 46,316 |
Non-Accrual Loans with no Allowance for Credit Losses | 1,853 | |
Commercial real estate, owner occupied | ||
Financing Receivable, Past Due [Line Items] | ||
Non-Accrual Loans | 1,760 | 3,040 |
Non-Accrual Loans with no Allowance for Credit Losses | 1,513 | |
Residential Real Estate | ||
Financing Receivable, Past Due [Line Items] | ||
Non-Accrual Loans | 6,336 | 6,517 |
Non-Accrual Loans with no Allowance for Credit Losses | 835 | |
Home equity | ||
Financing Receivable, Past Due [Line Items] | ||
Non-Accrual Loans | 2,650 | 2,095 |
Non-Accrual Loans with no Allowance for Credit Losses | 0 | |
Individuals' loans for household and other personal expenditures | ||
Financing Receivable, Past Due [Line Items] | ||
Non-Accrual Loans | 125 | $ 39 |
Non-Accrual Loans with no Allowance for Credit Losses | $ 0 |
Loans and Allowance - Amortized Cost Basis Of Collateral Dependent Loans (Details) - USD ($) $ in Thousands |
Mar. 31, 2021 |
Dec. 31, 2020 |
Mar. 31, 2020 |
Dec. 31, 2019 |
||||
---|---|---|---|---|---|---|---|---|
Financing Receivable, Allowance for Credit Loss [Line Items] | ||||||||
Loans | $ 55,276 | |||||||
Allowance on Collateral Dependent Loans | 201,082 | [1] | $ 130,648 | [1] | $ 99,454 | $ 80,284 | ||
Commercial and industrial loans | ||||||||
Financing Receivable, Allowance for Credit Loss [Line Items] | ||||||||
Loans | 2,202 | |||||||
Agricultural land, production and other loans to farmers | ||||||||
Financing Receivable, Allowance for Credit Loss [Line Items] | ||||||||
Loans | 780 | |||||||
Commercial real estate, non-owner occupied | ||||||||
Financing Receivable, Allowance for Credit Loss [Line Items] | ||||||||
Loans | 45,188 | |||||||
Commercial real estate, owner occupied | ||||||||
Financing Receivable, Allowance for Credit Loss [Line Items] | ||||||||
Loans | 3,539 | |||||||
Residential Real Estate | ||||||||
Financing Receivable, Allowance for Credit Loss [Line Items] | ||||||||
Loans | 3,113 | |||||||
Allowance on Collateral Dependent Loans | 0 | 0 | 17,364 | 14,569 | ||||
Home equity | ||||||||
Financing Receivable, Allowance for Credit Loss [Line Items] | ||||||||
Loans | 452 | |||||||
Individuals' loans for household and other personal expenditures | ||||||||
Financing Receivable, Allowance for Credit Loss [Line Items] | ||||||||
Loans | 2 | |||||||
Allowance on Collateral Dependent Loans | 0 | $ 0 | $ 5,752 | $ 4,035 | ||||
Commercial Real Estate | ||||||||
Financing Receivable, Allowance for Credit Loss [Line Items] | ||||||||
Loans | 49,507 | |||||||
Commercial Real Estate | Commercial and industrial loans | ||||||||
Financing Receivable, Allowance for Credit Loss [Line Items] | ||||||||
Loans | 0 | |||||||
Commercial Real Estate | Agricultural land, production and other loans to farmers | ||||||||
Financing Receivable, Allowance for Credit Loss [Line Items] | ||||||||
Loans | 780 | |||||||
Commercial Real Estate | Commercial real estate, non-owner occupied | ||||||||
Financing Receivable, Allowance for Credit Loss [Line Items] | ||||||||
Loans | 45,188 | |||||||
Commercial Real Estate | Commercial real estate, owner occupied | ||||||||
Financing Receivable, Allowance for Credit Loss [Line Items] | ||||||||
Loans | 3,539 | |||||||
Commercial Real Estate | Residential Real Estate | ||||||||
Financing Receivable, Allowance for Credit Loss [Line Items] | ||||||||
Loans | 0 | |||||||
Commercial Real Estate | Home equity | ||||||||
Financing Receivable, Allowance for Credit Loss [Line Items] | ||||||||
Loans | 0 | |||||||
Commercial Real Estate | Individuals' loans for household and other personal expenditures | ||||||||
Financing Receivable, Allowance for Credit Loss [Line Items] | ||||||||
Loans | 0 | |||||||
Residential Real Estate | ||||||||
Financing Receivable, Allowance for Credit Loss [Line Items] | ||||||||
Loans | 3,565 | |||||||
Residential Real Estate | Commercial and industrial loans | ||||||||
Financing Receivable, Allowance for Credit Loss [Line Items] | ||||||||
Loans | 0 | |||||||
Residential Real Estate | Agricultural land, production and other loans to farmers | ||||||||
Financing Receivable, Allowance for Credit Loss [Line Items] | ||||||||
Loans | 0 | |||||||
Residential Real Estate | Commercial real estate, non-owner occupied | ||||||||
Financing Receivable, Allowance for Credit Loss [Line Items] | ||||||||
Loans | 0 | |||||||
Residential Real Estate | Commercial real estate, owner occupied | ||||||||
Financing Receivable, Allowance for Credit Loss [Line Items] | ||||||||
Loans | 0 | |||||||
Residential Real Estate | Residential Real Estate | ||||||||
Financing Receivable, Allowance for Credit Loss [Line Items] | ||||||||
Loans | 3,113 | |||||||
Residential Real Estate | Home equity | ||||||||
Financing Receivable, Allowance for Credit Loss [Line Items] | ||||||||
Loans | 452 | |||||||
Residential Real Estate | Individuals' loans for household and other personal expenditures | ||||||||
Financing Receivable, Allowance for Credit Loss [Line Items] | ||||||||
Loans | 0 | |||||||
Other | ||||||||
Financing Receivable, Allowance for Credit Loss [Line Items] | ||||||||
Loans | 2,204 | |||||||
Other | Commercial and industrial loans | ||||||||
Financing Receivable, Allowance for Credit Loss [Line Items] | ||||||||
Loans | 2,202 | |||||||
Other | Agricultural land, production and other loans to farmers | ||||||||
Financing Receivable, Allowance for Credit Loss [Line Items] | ||||||||
Loans | 0 | |||||||
Other | Commercial real estate, non-owner occupied | ||||||||
Financing Receivable, Allowance for Credit Loss [Line Items] | ||||||||
Loans | 0 | |||||||
Other | Commercial real estate, owner occupied | ||||||||
Financing Receivable, Allowance for Credit Loss [Line Items] | ||||||||
Loans | 0 | |||||||
Other | Residential Real Estate | ||||||||
Financing Receivable, Allowance for Credit Loss [Line Items] | ||||||||
Loans | 0 | |||||||
Other | Home equity | ||||||||
Financing Receivable, Allowance for Credit Loss [Line Items] | ||||||||
Loans | 0 | |||||||
Other | Individuals' loans for household and other personal expenditures | ||||||||
Financing Receivable, Allowance for Credit Loss [Line Items] | ||||||||
Loans | 2 | |||||||
Collateral Dependent | ||||||||
Financing Receivable, Allowance for Credit Loss [Line Items] | ||||||||
Allowance on Collateral Dependent Loans | 5,994 | |||||||
Collateral Dependent | Commercial and industrial loans | ||||||||
Financing Receivable, Allowance for Credit Loss [Line Items] | ||||||||
Allowance on Collateral Dependent Loans | 0 | |||||||
Collateral Dependent | Agricultural land, production and other loans to farmers | ||||||||
Financing Receivable, Allowance for Credit Loss [Line Items] | ||||||||
Allowance on Collateral Dependent Loans | 0 | |||||||
Collateral Dependent | Commercial real estate, non-owner occupied | ||||||||
Financing Receivable, Allowance for Credit Loss [Line Items] | ||||||||
Allowance on Collateral Dependent Loans | 5,561 | |||||||
Collateral Dependent | Commercial real estate, owner occupied | ||||||||
Financing Receivable, Allowance for Credit Loss [Line Items] | ||||||||
Allowance on Collateral Dependent Loans | 0 | |||||||
Collateral Dependent | Residential Real Estate | ||||||||
Financing Receivable, Allowance for Credit Loss [Line Items] | ||||||||
Allowance on Collateral Dependent Loans | 356 | |||||||
Collateral Dependent | Home equity | ||||||||
Financing Receivable, Allowance for Credit Loss [Line Items] | ||||||||
Allowance on Collateral Dependent Loans | 77 | |||||||
Collateral Dependent | Individuals' loans for household and other personal expenditures | ||||||||
Financing Receivable, Allowance for Credit Loss [Line Items] | ||||||||
Allowance on Collateral Dependent Loans | $ 0 | |||||||
|
Loans and Allowance - Summary of Troubled Debt Restructurings by Modification Type (Details) |
3 Months Ended |
---|---|
Mar. 31, 2021
USD ($)
| |
Accounts, Notes, Loans and Financing Receivable [Line Items] | |
Pre- Modification Recorded Balance | $ 973,000 |
Post - Modification Recorded Balance | $ 975,000 |
Number of Loans | 9 |
Commercial and industrial loans | |
Accounts, Notes, Loans and Financing Receivable [Line Items] | |
Pre- Modification Recorded Balance | $ 348,000 |
Post - Modification Recorded Balance | $ 348,000 |
Number of Loans | 2 |
Residential Real Estate | |
Accounts, Notes, Loans and Financing Receivable [Line Items] | |
Pre- Modification Recorded Balance | $ 625,000 |
Post - Modification Recorded Balance | $ 627,000 |
Number of Loans | 7 |
Term Modification | |
Accounts, Notes, Loans and Financing Receivable [Line Items] | |
Modification Recorded Balance | $ 731,000 |
Term Modification | Commercial and industrial loans | |
Accounts, Notes, Loans and Financing Receivable [Line Items] | |
Modification Recorded Balance | 348,000 |
Term Modification | Residential Real Estate | |
Accounts, Notes, Loans and Financing Receivable [Line Items] | |
Modification Recorded Balance | 383,000 |
Rate Modification | |
Accounts, Notes, Loans and Financing Receivable [Line Items] | |
Modification Recorded Balance | 126,000 |
Rate Modification | Commercial and industrial loans | |
Accounts, Notes, Loans and Financing Receivable [Line Items] | |
Modification Recorded Balance | 0 |
Rate Modification | Residential Real Estate | |
Accounts, Notes, Loans and Financing Receivable [Line Items] | |
Modification Recorded Balance | 126,000 |
Combination | |
Accounts, Notes, Loans and Financing Receivable [Line Items] | |
Modification Recorded Balance | 118,000 |
Combination | Commercial and industrial loans | |
Accounts, Notes, Loans and Financing Receivable [Line Items] | |
Modification Recorded Balance | 0 |
Combination | Residential Real Estate | |
Accounts, Notes, Loans and Financing Receivable [Line Items] | |
Modification Recorded Balance | $ 118,000 |
Loans and Allowance - Schedule of Modified Loans (Details) $ in Thousands |
3 Months Ended | |
---|---|---|
Mar. 31, 2021
USD ($)
loan
|
Mar. 31, 2020
USD ($)
loan
|
|
Financing Receivable, Troubled Debt Restructuring [Line Items] | ||
Number of Loans | loan | 7 | 1 |
Recorded Balance | $ | $ 290 | $ 22 |
Residential Real Estate | ||
Financing Receivable, Troubled Debt Restructuring [Line Items] | ||
Number of Loans | loan | 5 | 1 |
Recorded Balance | $ | $ 197 | $ 22 |
Residential | ||
Financing Receivable, Troubled Debt Restructuring [Line Items] | ||
Number of Loans | loan | 1 | |
Recorded Balance | $ | $ 2 | |
Home equity | ||
Financing Receivable, Troubled Debt Restructuring [Line Items] | ||
Number of Loans | loan | 1 | |
Recorded Balance | $ | $ 91 |
Loans and Allowance - Changes in Allowance for Loan Losses by Loan Segment (Details) - USD ($) $ in Thousands |
3 Months Ended | ||||
---|---|---|---|---|---|
Mar. 31, 2021 |
Mar. 31, 2020 |
||||
Allowance for Loan and Lease Losses [Roll Forward] | |||||
Beginning balance | $ 130,648 | [1] | $ 80,284 | ||
Provision for credit losses - loans | 0 | 19,752 | |||
Recoveries on loans | 694 | 673 | |||
Loans charged off | (4,315) | (1,255) | |||
Ending balance | 201,082 | [1] | 99,454 | ||
Previously reported | |||||
Allowance for Loan and Lease Losses [Roll Forward] | |||||
Beginning balance | 130,648 | ||||
Credit risk reclassifications | |||||
Allowance for Loan and Lease Losses [Roll Forward] | |||||
Beginning balance | 0 | ||||
Cumulative effect of ASC 326 adoption | |||||
Allowance for Loan and Lease Losses [Roll Forward] | |||||
Beginning balance | 74,055 | ||||
Adjusted balance | |||||
Allowance for Loan and Lease Losses [Roll Forward] | |||||
Beginning balance | 204,703 | ||||
Commercial | |||||
Allowance for Loan and Lease Losses [Roll Forward] | |||||
Beginning balance | 47,115 | 32,902 | |||
Provision for credit losses - loans | (932) | 5,701 | |||
Recoveries on loans | 188 | 443 | |||
Loans charged off | (673) | (615) | |||
Ending balance | 65,722 | 38,431 | |||
Commercial | Previously reported | |||||
Allowance for Loan and Lease Losses [Roll Forward] | |||||
Beginning balance | 47,115 | ||||
Commercial | Credit risk reclassifications | |||||
Allowance for Loan and Lease Losses [Roll Forward] | |||||
Beginning balance | 0 | ||||
Commercial | Cumulative effect of ASC 326 adoption | |||||
Allowance for Loan and Lease Losses [Roll Forward] | |||||
Beginning balance | 20,024 | ||||
Commercial | Adjusted balance | |||||
Allowance for Loan and Lease Losses [Roll Forward] | |||||
Beginning balance | 67,139 | ||||
Commercial Real Estate | |||||
Allowance for Loan and Lease Losses [Roll Forward] | |||||
Beginning balance | 40,786 | 28,778 | |||
Provision for credit losses - loans | (1,701) | 9,194 | |||
Recoveries on loans | 164 | 118 | |||
Loans charged off | (3,313) | (183) | |||
Ending balance | 70,861 | 37,907 | |||
Commercial Real Estate | Previously reported | |||||
Allowance for Loan and Lease Losses [Roll Forward] | |||||
Beginning balance | 51,070 | ||||
Commercial Real Estate | Credit risk reclassifications | |||||
Allowance for Loan and Lease Losses [Roll Forward] | |||||
Beginning balance | (10,284) | ||||
Commercial Real Estate | Cumulative effect of ASC 326 adoption | |||||
Allowance for Loan and Lease Losses [Roll Forward] | |||||
Beginning balance | 34,925 | ||||
Commercial Real Estate | Adjusted balance | |||||
Allowance for Loan and Lease Losses [Roll Forward] | |||||
Beginning balance | 75,711 | ||||
Construction | |||||
Allowance for Loan and Lease Losses [Roll Forward] | |||||
Beginning balance | 10,284 | ||||
Provision for credit losses - loans | 1,095 | ||||
Recoveries on loans | 0 | ||||
Loans charged off | (2) | ||||
Ending balance | 20,182 | ||||
Construction | Previously reported | |||||
Allowance for Loan and Lease Losses [Roll Forward] | |||||
Beginning balance | 0 | ||||
Construction | Credit risk reclassifications | |||||
Allowance for Loan and Lease Losses [Roll Forward] | |||||
Beginning balance | 10,284 | ||||
Construction | Cumulative effect of ASC 326 adoption | |||||
Allowance for Loan and Lease Losses [Roll Forward] | |||||
Beginning balance | 8,805 | ||||
Construction | Adjusted balance | |||||
Allowance for Loan and Lease Losses [Roll Forward] | |||||
Beginning balance | 19,089 | ||||
Consumer | |||||
Allowance for Loan and Lease Losses [Roll Forward] | |||||
Beginning balance | 0 | 4,035 | |||
Provision for credit losses - loans | 0 | 1,924 | |||
Recoveries on loans | 0 | 42 | |||
Loans charged off | 0 | (249) | |||
Ending balance | 0 | 5,752 | |||
Consumer | Previously reported | |||||
Allowance for Loan and Lease Losses [Roll Forward] | |||||
Beginning balance | 9,648 | ||||
Consumer | Credit risk reclassifications | |||||
Allowance for Loan and Lease Losses [Roll Forward] | |||||
Beginning balance | (9,648) | ||||
Consumer | Cumulative effect of ASC 326 adoption | |||||
Allowance for Loan and Lease Losses [Roll Forward] | |||||
Beginning balance | 0 | ||||
Consumer | Adjusted balance | |||||
Allowance for Loan and Lease Losses [Roll Forward] | |||||
Beginning balance | 0 | ||||
Residential Real Estate | |||||
Allowance for Loan and Lease Losses [Roll Forward] | |||||
Beginning balance | 0 | 14,569 | |||
Provision for credit losses - loans | 0 | 2,933 | |||
Recoveries on loans | 0 | 70 | |||
Loans charged off | 0 | (208) | |||
Ending balance | 0 | $ 17,364 | |||
Residential Real Estate | Previously reported | |||||
Allowance for Loan and Lease Losses [Roll Forward] | |||||
Beginning balance | 22,815 | ||||
Residential Real Estate | Credit risk reclassifications | |||||
Allowance for Loan and Lease Losses [Roll Forward] | |||||
Beginning balance | (22,815) | ||||
Residential Real Estate | Cumulative effect of ASC 326 adoption | |||||
Allowance for Loan and Lease Losses [Roll Forward] | |||||
Beginning balance | 0 | ||||
Residential Real Estate | Adjusted balance | |||||
Allowance for Loan and Lease Losses [Roll Forward] | |||||
Beginning balance | 0 | ||||
Consumer & Residential | |||||
Allowance for Loan and Lease Losses [Roll Forward] | |||||
Beginning balance | 32,463 | ||||
Provision for credit losses - loans | 1,538 | ||||
Recoveries on loans | 342 | ||||
Loans charged off | (327) | ||||
Ending balance | 44,317 | ||||
Consumer & Residential | Previously reported | |||||
Allowance for Loan and Lease Losses [Roll Forward] | |||||
Beginning balance | 0 | ||||
Consumer & Residential | Credit risk reclassifications | |||||
Allowance for Loan and Lease Losses [Roll Forward] | |||||
Beginning balance | 32,463 | ||||
Consumer & Residential | Cumulative effect of ASC 326 adoption | |||||
Allowance for Loan and Lease Losses [Roll Forward] | |||||
Beginning balance | 10,301 | ||||
Consumer & Residential | Adjusted balance | |||||
Allowance for Loan and Lease Losses [Roll Forward] | |||||
Beginning balance | $ 42,764 | ||||
|
Loans and Allowance - Allowance for Credit Losses and Loan Portfolio by Loan Segment (Details) $ in Thousands |
Dec. 31, 2020
USD ($)
|
---|---|
Allowance Balances: | |
Individually evaluated for impairment | $ 12,901 |
Collectively evaluated for impairment | 117,747 |
Total Allowance for Loan Losses | 130,648 |
Loan Balances: | |
Individually evaluated for impairment | 56,156 |
Collectively evaluated for impairment | 9,180,857 |
Financing Receivable, Evaluated for Impairment | 9,243,174 |
Loans acquired with deteriorated credit quality | |
Loan Balances: | |
Financing Receivable, Evaluated for Impairment | 6,161 |
Commercial | |
Allowance Balances: | |
Individually evaluated for impairment | 223 |
Collectively evaluated for impairment | 46,892 |
Total Allowance for Loan Losses | 47,115 |
Loan Balances: | |
Individually evaluated for impairment | 1,258 |
Collectively evaluated for impairment | 3,505,863 |
Financing Receivable, Evaluated for Impairment | 3,507,698 |
Commercial | Loans acquired with deteriorated credit quality | |
Loan Balances: | |
Financing Receivable, Evaluated for Impairment | 577 |
Commercial Real Estate | |
Allowance Balances: | |
Individually evaluated for impairment | 12,246 |
Collectively evaluated for impairment | 38,824 |
Total Allowance for Loan Losses | 51,070 |
Loan Balances: | |
Individually evaluated for impairment | 51,605 |
Collectively evaluated for impairment | 3,805,808 |
Financing Receivable, Evaluated for Impairment | 3,862,997 |
Commercial Real Estate | Loans acquired with deteriorated credit quality | |
Loan Balances: | |
Financing Receivable, Evaluated for Impairment | 5,584 |
Consumer | |
Allowance Balances: | |
Individually evaluated for impairment | 0 |
Collectively evaluated for impairment | 9,648 |
Total Allowance for Loan Losses | 9,648 |
Loan Balances: | |
Individually evaluated for impairment | 2 |
Collectively evaluated for impairment | 129,477 |
Financing Receivable, Evaluated for Impairment | 129,479 |
Residential | |
Allowance Balances: | |
Individually evaluated for impairment | 432 |
Collectively evaluated for impairment | 22,383 |
Total Allowance for Loan Losses | 22,815 |
Loan Balances: | |
Individually evaluated for impairment | 3,291 |
Collectively evaluated for impairment | 1,739,709 |
Financing Receivable, Evaluated for Impairment | 1,743,000 |
Residential | Loans acquired with deteriorated credit quality | |
Loan Balances: | |
Financing Receivable, Evaluated for Impairment | $ 0 |
Loans and Allowance - Incurred loss model and interest income recognized while impaired by loan class (Details) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Mar. 31, 2020 |
Dec. 31, 2020 |
|
Unpaid Principal Balance | ||
Impaired loans with no related allowance | $ 9,101 | |
Impaired loans with related allowance | 49,513 | |
Total Impaired Loans | 58,614 | |
Recorded Investment | ||
Impaired loans with no related allowance | 7,813 | |
Impaired loans with related allowance | 48,343 | |
Total Impaired Loans | 56,156 | |
Related Allowance | 12,901 | |
Average Recorded Investment | ||
Impaired loans with no related allowance | $ 8,834 | |
Impaired loans with related allowance | 4,973 | |
Total Impaired Loans | 13,807 | |
Interest Income Recognized | ||
Impaired loans with no related allowance | 38 | |
Impaired loans with related allowance | 22 | |
Total Impaired Loans | 60 | |
Commercial and industrial loans | ||
Unpaid Principal Balance | ||
Impaired loans with no related allowance | 1,059 | |
Impaired loans with related allowance | 268 | |
Recorded Investment | ||
Impaired loans with no related allowance | 991 | |
Impaired loans with related allowance | 268 | |
Related Allowance | 223 | |
Average Recorded Investment | ||
Impaired loans with no related allowance | 905 | |
Interest Income Recognized | ||
Impaired loans with no related allowance | 0 | |
Agricultural land, production and other loans to farmers | ||
Unpaid Principal Balance | ||
Impaired loans with related allowance | 640 | |
Recorded Investment | ||
Impaired loans with related allowance | 562 | |
Related Allowance | 3 | |
Commercial real estate, non-owner occupied | ||
Unpaid Principal Balance | ||
Impaired loans with no related allowance | 4,958 | |
Impaired loans with related allowance | 44,016 | |
Recorded Investment | ||
Impaired loans with no related allowance | 4,694 | |
Impaired loans with related allowance | 43,715 | |
Related Allowance | 11,686 | |
Construction | ||
Average Recorded Investment | ||
Impaired loans with no related allowance | 1,015 | |
Interest Income Recognized | ||
Impaired loans with no related allowance | 0 | |
Commercial and farmland | ||
Unpaid Principal Balance | ||
Impaired loans with no related allowance | 2,125 | |
Impaired loans with related allowance | 2,061 | |
Recorded Investment | ||
Impaired loans with no related allowance | 1,310 | |
Impaired loans with related allowance | 1,323 | |
Related Allowance | 557 | |
Average Recorded Investment | ||
Impaired loans with no related allowance | 6,852 | |
Impaired loans with related allowance | 2,400 | |
Interest Income Recognized | ||
Impaired loans with no related allowance | 37 | |
Residential Real Estate | ||
Unpaid Principal Balance | ||
Impaired loans with no related allowance | 957 | |
Impaired loans with related allowance | 2,041 | |
Recorded Investment | ||
Impaired loans with no related allowance | 816 | |
Impaired loans with related allowance | 2,014 | |
Related Allowance | 352 | |
Average Recorded Investment | ||
Impaired loans with no related allowance | 59 | |
Impaired loans with related allowance | 2,180 | |
Interest Income Recognized | ||
Impaired loans with no related allowance | 1 | |
Impaired loans with related allowance | 19 | |
Individuals' loans for household and other personal expenditures | ||
Unpaid Principal Balance | ||
Impaired loans with no related allowance | 2 | |
Recorded Investment | ||
Impaired loans with no related allowance | 2 | |
Average Recorded Investment | ||
Impaired loans with no related allowance | 3 | |
Interest Income Recognized | ||
Impaired loans with no related allowance | 0 | |
Home equity | ||
Unpaid Principal Balance | ||
Impaired loans with related allowance | 487 | |
Recorded Investment | ||
Impaired loans with related allowance | 461 | |
Related Allowance | $ 80 | |
Average Recorded Investment | ||
Impaired loans with related allowance | 393 | |
Interest Income Recognized | ||
Impaired loans with related allowance | $ 3 |
Loans and Allowance - Amounts of Commitments (Details) - USD ($) $ in Thousands |
Mar. 31, 2021 |
Dec. 31, 2020 |
---|---|---|
Loan commitments to extend credit | ||
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items] | ||
Amounts of commitments | $ 3,657,931 | $ 3,443,514 |
Standby letters of credit | ||
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items] | ||
Amounts of commitments | $ 33,610 | $ 29,555 |
Loans and Allowance - Allowance for Credit Losses, Off-balance Sheet (Details) $ in Thousands |
3 Months Ended |
---|---|
Mar. 31, 2021
USD ($)
| |
Off-Balance Sheet, Credit Loss, Liability [Roll Forward] | |
Balances, December 31, 2020 | $ 0 |
Provision for credit losses | 0 |
Balances, March 31, 2021 | 20,500 |
Cumulative effect of ASC 326 adoption | |
Off-Balance Sheet, Credit Loss, Liability [Roll Forward] | |
Balances, December 31, 2020 | 20,500 |
Balances, March 31, 2021 | $ 20,500 |
Other Intangibles- Schedule of Core Deposit Intangibles (Details) - USD ($) $ in Thousands |
Mar. 31, 2021 |
Dec. 31, 2020 |
---|---|---|
Goodwill and Intangible Assets Disclosure [Abstract] | ||
Gross carrying amount | $ 102,396 | $ 102,396 |
Accumulated amortization | (74,778) | (73,421) |
Total core deposit intangibles | $ 27,618 | $ 28,975 |
Other Intangibles - Narrative (Details) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Mar. 31, 2021 |
Mar. 31, 2020 |
|
Goodwill and Intangible Assets Disclosure [Abstract] | ||
Useful life of core deposit intangibles and other intangibles | 10 years | |
Intangible asset amortization | $ 1,357 | $ 1,514 |
Other Intangibles - Estimated Future Amortization Expense (Details) - USD ($) $ in Thousands |
Mar. 31, 2021 |
Dec. 31, 2020 |
---|---|---|
Amortization Expense | ||
2021 | $ 4,072 | |
2022 | 5,027 | |
2023 | 4,827 | |
2024 | 4,241 | |
2025 | 3,526 | |
After 2025 | 5,925 | |
Total core deposit intangibles | $ 27,618 | $ 28,975 |
Derivative Financial Instruments - Narrative (Details) $ in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2021
USD ($)
interest_rate_swap
|
Dec. 31, 2020
USD ($)
interest_rate_swap
|
|
Derivative [Line Items] | ||
Estimated amount to be transferred from accumulated other comprehensive income to earnings | $ 1.0 | |
Termination value of derivatives in a net liability position | 36.7 | |
Derivative collateral posted | 62.8 | |
Not Designated as Hedging Instrument | ||
Derivative [Line Items] | ||
Notional amount of interest rate derivatives | $ 972.7 | $ 985.0 |
Cash Flow Hedging | Interest rate swap | ||
Derivative [Line Items] | ||
Number of interest rate derivatives held | interest_rate_swap | 4 | 4 |
Notional amount of interest rate derivatives | $ 60.0 | $ 60.0 |
Cash Flow Hedging | Interest rate swap | Trust Preferred Debt | ||
Derivative [Line Items] | ||
Notional amount of interest rate derivatives | 26.0 | |
Cash Flow Hedging | Interest rate swap | Federal Home Loan Bank Advances | ||
Derivative [Line Items] | ||
Notional amount of interest rate derivatives | 10.0 | |
Cash Flow Hedging | Interest rate swap | Brokered Deposit | ||
Derivative [Line Items] | ||
Notional amount of interest rate derivatives | $ 24.0 |
Derivative Financial Instruments - Fair Value of Derivative Financial Instruments and Their Classification on Balance Sheet (Details) - Interest rate contracts - USD ($) $ in Thousands |
Mar. 31, 2021 |
Dec. 31, 2020 |
---|---|---|
Derivatives designated as hedging instruments | Other Assets | ||
Derivatives, Fair Value [Line Items] | ||
Asset Derivatives | $ 0 | $ 0 |
Derivatives designated as hedging instruments | Other Liabilities | ||
Derivatives, Fair Value [Line Items] | ||
Liability Derivatives | 1,708 | 2,018 |
Derivatives not designated as hedging instruments | Other Assets | ||
Derivatives, Fair Value [Line Items] | ||
Asset Derivatives | 48,576 | 74,335 |
Derivatives not designated as hedging instruments | Other Liabilities | ||
Derivatives, Fair Value [Line Items] | ||
Liability Derivatives | $ 48,576 | $ 74,335 |
Derivative Financial Instruments - Effect of Derivative Financial Instruments on Other Comprehensive Income (Details) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Mar. 31, 2021 |
Mar. 31, 2020 |
|
Derivative [Line Items] | ||
Unrealized holding gain (loss) arising during the period | $ 58 | $ (1,314) |
Designated as Hedging Instrument | Cash Flow Hedging | Interest Rate Products | ||
Derivative [Line Items] | ||
Unrealized holding gain (loss) arising during the period | $ 58 | $ (1,314) |
Derivative Financial Instruments - Effect of Derivative Financial Instruments on Income Statement (Details) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Mar. 31, 2021 |
Mar. 31, 2020 |
|
Derivative [Line Items] | ||
Amount of Gain (Loss) Reclassed from Other Comprehensive Income into Income (Effective Portion) | $ (252) | $ (125) |
Interest rate contracts | Derivatives designated as hedging instruments | Interest Expense | ||
Derivative [Line Items] | ||
Amount of Gain (Loss) Reclassed from Other Comprehensive Income into Income (Effective Portion) | $ (252) | $ (125) |
Disclosures About Fair Value of Assets and Liabilities - Fair Value Measurements of Assets and Liabilities Measured at Fair Value on Recurring Basis (Details) - USD ($) $ in Thousands |
Mar. 31, 2021 |
Dec. 31, 2020 |
---|---|---|
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Investment securities available for sale | $ 2,405,568 | $ 1,919,119 |
Quoted Prices in Active Markets for Identical Assets (Level 1) | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Investment securities available for sale | 0 | 0 |
Significant Other Observable Inputs (Level 2) | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Investment securities available for sale | 2,403,422 | 1,916,640 |
Significant Unobservable Inputs (Level 3) | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Investment securities available for sale | 2,146 | 2,479 |
Recurring | Interest rate swap liability | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Interest rate swap liability | 50,284 | 76,353 |
Recurring | U.S. Treasury | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Investment securities available for sale | 1,000 | |
Recurring | U.S. Government-sponsored agency securities | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Investment securities available for sale | 11,381 | 2,430 |
Recurring | State and municipal | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Investment securities available for sale | 1,366,162 | 1,257,885 |
Recurring | U.S. Government-sponsored mortgage-backed securities | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Investment securities available for sale | 1,022,863 | 654,669 |
Recurring | Corporate obligations | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Investment securities available for sale | 4,162 | 4,135 |
Recurring | Interest rate swap asset | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Interest rate swap asset | 48,576 | 74,335 |
Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | Interest rate swap liability | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Interest rate swap liability | 0 | 0 |
Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | U.S. Treasury | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Investment securities available for sale | 0 | |
Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | U.S. Government-sponsored agency securities | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Investment securities available for sale | 0 | 0 |
Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | State and municipal | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Investment securities available for sale | 0 | 0 |
Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | U.S. Government-sponsored mortgage-backed securities | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Investment securities available for sale | 0 | 0 |
Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | Corporate obligations | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Investment securities available for sale | 0 | 0 |
Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | Interest rate swap asset | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Interest rate swap asset | 0 | 0 |
Recurring | Significant Other Observable Inputs (Level 2) | Interest rate swap liability | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Interest rate swap liability | 50,284 | 76,353 |
Recurring | Significant Other Observable Inputs (Level 2) | U.S. Treasury | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Investment securities available for sale | 1,000 | |
Recurring | Significant Other Observable Inputs (Level 2) | U.S. Government-sponsored agency securities | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Investment securities available for sale | 11,381 | 2,430 |
Recurring | Significant Other Observable Inputs (Level 2) | State and municipal | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Investment securities available for sale | 1,364,051 | 1,255,441 |
Recurring | Significant Other Observable Inputs (Level 2) | U.S. Government-sponsored mortgage-backed securities | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Investment securities available for sale | 1,022,859 | 654,665 |
Recurring | Significant Other Observable Inputs (Level 2) | Corporate obligations | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Investment securities available for sale | 4,131 | 4,104 |
Recurring | Significant Other Observable Inputs (Level 2) | Interest rate swap asset | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Interest rate swap asset | 48,576 | 74,335 |
Recurring | Significant Unobservable Inputs (Level 3) | Interest rate swap liability | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Interest rate swap liability | 0 | 0 |
Recurring | Significant Unobservable Inputs (Level 3) | U.S. Treasury | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Investment securities available for sale | 0 | |
Recurring | Significant Unobservable Inputs (Level 3) | U.S. Government-sponsored agency securities | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Investment securities available for sale | 0 | 0 |
Recurring | Significant Unobservable Inputs (Level 3) | State and municipal | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Investment securities available for sale | 2,111 | 2,444 |
Recurring | Significant Unobservable Inputs (Level 3) | U.S. Government-sponsored mortgage-backed securities | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Investment securities available for sale | 4 | 4 |
Recurring | Significant Unobservable Inputs (Level 3) | Corporate obligations | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Investment securities available for sale | 31 | 31 |
Recurring | Significant Unobservable Inputs (Level 3) | Interest rate swap asset | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Interest rate swap asset | $ 0 | $ 0 |
Disclosures About Fair Value of Assets and Liabilities - Reconciliation of Beginning and Ending Balances of Recurring Fair Value Measurements using Significant Unobservable Level 3 Inputs (Details) - Recurring - Available for Sale Securities - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Mar. 31, 2021 |
Mar. 31, 2020 |
|
Available for Sale Securities | ||
Balance at beginning of the period | $ 2,479 | $ 2,893 |
Included in other comprehensive income | (60) | (20) |
Principal payments | (273) | (344) |
Ending balance | $ 2,146 | $ 2,529 |
Disclosures About Fair Value of Assets and Liabilities - Valuation Methodologies Used for Instruments Measured at Fair Value on Non-Recurring Basis (Details) - Nonrecurring - USD ($) $ in Thousands |
Mar. 31, 2021 |
Dec. 31, 2020 |
---|---|---|
Collateral dependent loans | Fair Value | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Asset fair value | $ 40,698 | $ 37,250 |
Collateral dependent loans | Quoted Prices in Active Markets for Identical Assets (Level 1) | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Asset fair value | 0 | 0 |
Collateral dependent loans | Significant Other Observable Inputs (Level 2) | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Asset fair value | 0 | 0 |
Collateral dependent loans | Significant Unobservable Inputs (Level 3) | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Asset fair value | 40,698 | 37,250 |
Other real estate owned | Fair Value | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Asset fair value | 185 | 544 |
Other real estate owned | Quoted Prices in Active Markets for Identical Assets (Level 1) | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Asset fair value | 0 | 0 |
Other real estate owned | Significant Other Observable Inputs (Level 2) | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Asset fair value | 0 | 0 |
Other real estate owned | Significant Unobservable Inputs (Level 3) | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Asset fair value | $ 185 | $ 544 |
Disclosures About Fair Value of Assets and Liabilities - Unobservable Inputs Used in Recurring and Nonrecurring Level 3 Fair Value Measurements Other Than Goodwill (Details) - Significant Unobservable Inputs (Level 3) $ in Thousands |
3 Months Ended | 12 Months Ended |
---|---|---|
Mar. 31, 2021
USD ($)
|
Dec. 31, 2020
USD ($)
|
|
Discounted cash flow | State and municipal securities | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Fair Value | $ 2,111 | $ 2,444 |
Discounted cash flow | State and municipal securities | Minimum | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Maturity/Call date | 1 month | 1 month |
US Muni BQ curve | A- | A- |
Discounted cash flow | State and municipal securities | Maximum | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Maturity/Call date | 15 years | 15 years |
US Muni BQ curve | BBB- | BBB- |
Discounted cash flow | State and municipal securities | Discount rate | Minimum | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Discount rate | 0.02 | 0.02 |
Discounted cash flow | State and municipal securities | Discount rate | Maximum | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Discount rate | 0.04 | 0.04 |
Discounted cash flow | State and municipal securities | Weighted-average coupon | Weighted-average | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Discount rate | 0.04 | 0.04 |
Discounted cash flow | Corporate obligations and U.S. Government-sponsored mortgage-backed securities | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Fair Value | $ 35 | $ 35 |
Discounted cash flow | Corporate obligations and U.S. Government-sponsored mortgage-backed securities | Weighted-average coupon | Weighted-average | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Discount rate | 0 | 0 |
Discounted cash flow | Corporate obligations and U.S. Government-sponsored mortgage-backed securities | Risk free rate | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Risk free rate | 3 month LIBOR | 3 month LIBOR |
Discounted cash flow | Corporate obligations and U.S. Government-sponsored mortgage-backed securities | Plus premium for illiquidity | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Discount rate | 0.02 | 0.02 |
Collateral based measurements | Collateral dependent loans | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Fair Value | $ 40,698 | $ 37,250 |
Collateral based measurements | Collateral dependent loans | Discount to reflect current market conditions and ultimate collectability | Minimum | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Discount to reflect current market conditions and ultimate collectability | 0 | 0 |
Collateral based measurements | Collateral dependent loans | Discount to reflect current market conditions and ultimate collectability | Maximum | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Discount to reflect current market conditions and ultimate collectability | 0.10 | 0.10 |
Collateral based measurements | Collateral dependent loans | Discount to reflect current market conditions and ultimate collectability | Weighted-average | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Discount to reflect current market conditions and ultimate collectability | 0.04 | 0.06 |
Appraisals | Other real estate owned | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Fair Value | $ 185 | $ 544 |
Appraisals | Other real estate owned | Discount to reflect current market conditions | Minimum | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Other real estate owned | 0 | 0 |
Appraisals | Other real estate owned | Discount to reflect current market conditions | Maximum | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Other real estate owned | 0.72 | 0.30 |
Appraisals | Other real estate owned | Discount to reflect current market conditions | Weighted-average | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Other real estate owned | 0.39 | 0.26 |
Disclosures About Fair Value of Assets and Liabilities - Estimated Fair Values of Financial Instruments (Details) - USD ($) $ in Thousands |
Mar. 31, 2021 |
Dec. 31, 2020 |
---|---|---|
Assets: | ||
Investment securities available for sale | $ 2,405,568 | $ 1,919,119 |
Investment securities held to maturity | 1,318,780 | 1,280,293 |
Loans held for sale | 4,430 | 3,966 |
Quoted Prices in Active Markets for Identical Assets (Level 1) | ||
Assets: | ||
Cash and cash equivalents | 187,901 | 192,896 |
Interest-bearing deposits | 392,806 | 392,305 |
Investment securities available for sale | 0 | 0 |
Investment securities held to maturity | 0 | 0 |
Loans held for sale | 0 | 0 |
Loans | 0 | 0 |
Federal Home Loan Bank stock | 0 | 0 |
Interest rate swap asset | 0 | 0 |
Interest receivable | 0 | 0 |
Liabilities: | ||
Deposits | 11,103,474 | 10,482,865 |
Borrowings: | ||
Securities sold under repurchase agreements | 0 | 0 |
Federal Home Loan Bank advances | 0 | 0 |
Subordinated debentures and other borrowings | 0 | 0 |
Interest rate swap liability | 0 | 0 |
Interest payable | 0 | 0 |
Significant Other Observable Inputs (Level 2) | ||
Assets: | ||
Cash and cash equivalents | 0 | 0 |
Interest-bearing deposits | 0 | 0 |
Investment securities available for sale | 2,403,422 | 1,916,640 |
Investment securities held to maturity | 1,299,944 | 1,260,815 |
Loans held for sale | 4,430 | 3,966 |
Loans | 0 | 0 |
Federal Home Loan Bank stock | 28,736 | 28,736 |
Interest rate swap asset | 48,576 | 74,335 |
Interest receivable | 54,662 | 53,948 |
Liabilities: | ||
Deposits | 847,398 | 878,257 |
Borrowings: | ||
Securities sold under repurchase agreements | 185,716 | 177,097 |
Federal Home Loan Bank advances | 366,179 | 399,991 |
Subordinated debentures and other borrowings | 108,124 | 108,439 |
Interest rate swap liability | 50,284 | 76,353 |
Interest payable | 4,020 | 3,287 |
Significant Unobservable Inputs (Level 3) | ||
Assets: | ||
Cash and cash equivalents | 0 | 0 |
Interest-bearing deposits | 0 | 0 |
Investment securities available for sale | 2,146 | 2,479 |
Investment securities held to maturity | 18,836 | 19,478 |
Loans held for sale | 0 | 0 |
Loans | 9,168,023 | 9,191,628 |
Federal Home Loan Bank stock | 0 | 0 |
Interest rate swap asset | 0 | 0 |
Interest receivable | 0 | 0 |
Liabilities: | ||
Deposits | 0 | 0 |
Borrowings: | ||
Securities sold under repurchase agreements | 0 | 0 |
Federal Home Loan Bank advances | 0 | 0 |
Subordinated debentures and other borrowings | 0 | 0 |
Interest rate swap liability | 0 | 0 |
Interest payable | 0 | 0 |
Carrying Amount | ||
Assets: | ||
Cash and cash equivalents | 187,901 | 192,896 |
Interest-bearing deposits | 392,806 | 392,305 |
Investment securities available for sale | 2,405,568 | 1,919,119 |
Investment securities held to maturity | 1,295,289 | 1,227,668 |
Loans held for sale | 4,430 | 3,966 |
Loans | 9,117,146 | 9,112,526 |
Federal Home Loan Bank stock | 28,736 | 28,736 |
Interest rate swap asset | 48,576 | 74,335 |
Interest receivable | 54,662 | 53,948 |
Liabilities: | ||
Deposits | 11,951,780 | 11,361,610 |
Borrowings: | ||
Securities sold under repurchase agreements | 185,721 | 177,102 |
Federal Home Loan Bank advances | 359,337 | 389,430 |
Subordinated debentures and other borrowings | 118,439 | 118,380 |
Interest rate swap liability | 50,284 | 76,353 |
Interest payable | $ 4,020 | $ 3,287 |
Transfers Accounted for as Secured Borrowings (Details) - U.S. Government-sponsored mortgage-backed securities - USD ($) $ in Thousands |
Mar. 31, 2021 |
Dec. 31, 2020 |
---|---|---|
Assets Sold under Agreements to Repurchase [Line Items] | ||
Collateral pledged for all repurchase agreements accounted for as secured borrowings | $ 185,721 | $ 177,102 |
Overnight and Continuous | ||
Assets Sold under Agreements to Repurchase [Line Items] | ||
Collateral pledged for all repurchase agreements accounted for as secured borrowings | 184,067 | 175,449 |
Up to 30 Days | ||
Assets Sold under Agreements to Repurchase [Line Items] | ||
Collateral pledged for all repurchase agreements accounted for as secured borrowings | 0 | 0 |
30-90 Days | ||
Assets Sold under Agreements to Repurchase [Line Items] | ||
Collateral pledged for all repurchase agreements accounted for as secured borrowings | 1,654 | 1,653 |
Greater Than 90 Days | ||
Assets Sold under Agreements to Repurchase [Line Items] | ||
Collateral pledged for all repurchase agreements accounted for as secured borrowings | $ 0 | $ 0 |
Accumulated Other Comprehensive Income (Loss) - Summary of Changes (Details) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Mar. 31, 2021 |
Mar. 31, 2020 |
|
Accumulated Other Comprehensive Income (Loss) | ||
Beginning balance | $ 1,875,645 | $ 1,786,437 |
Other comprehensive income (loss) before reclassifications | (37,804) | 29,326 |
Amounts reclassified from accumulated other comprehensive income | (1,222) | (3,544) |
Total other comprehensive income (loss), net of tax | (39,026) | 25,782 |
Ending balance | 1,805,856 | 1,777,960 |
Total | ||
Accumulated Other Comprehensive Income (Loss) | ||
Beginning balance | 74,836 | 27,874 |
Ending balance | 35,810 | 53,656 |
Unrealized Gains (Losses) on Securities Available for Sale | ||
Accumulated Other Comprehensive Income (Loss) | ||
Beginning balance | 87,988 | 38,872 |
Other comprehensive income (loss) before reclassifications | (37,850) | 30,364 |
Amounts reclassified from accumulated other comprehensive income | (1,421) | (3,643) |
Total other comprehensive income (loss), net of tax | (39,271) | 26,721 |
Ending balance | 48,717 | 65,593 |
Unrealized Gains (Losses) on Cash Flow Hedges | ||
Accumulated Other Comprehensive Income (Loss) | ||
Beginning balance | (1,594) | (1,141) |
Other comprehensive income (loss) before reclassifications | 46 | (1,038) |
Amounts reclassified from accumulated other comprehensive income | 199 | 99 |
Total other comprehensive income (loss), net of tax | 245 | (939) |
Ending balance | (1,349) | (2,080) |
Unrealized Gains (Losses) on Defined Benefit Plans | ||
Accumulated Other Comprehensive Income (Loss) | ||
Beginning balance | (11,558) | (9,857) |
Other comprehensive income (loss) before reclassifications | 0 | 0 |
Amounts reclassified from accumulated other comprehensive income | 0 | 0 |
Total other comprehensive income (loss), net of tax | 0 | 0 |
Ending balance | $ (11,558) | $ (9,857) |
Accumulated Other Comprehensive Income (Loss) - Reclassifications (Details) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Mar. 31, 2021 |
Mar. 31, 2020 |
|
Reclassification Adjustments out of Accumulated Other Comprehensive Income [Line Items] | ||
Net realized gains on sales of available for sale securities | $ 1,799 | $ 4,612 |
Income tax expense | (8,952) | (3,490) |
Interest expense - subordinated debentures and term loans | 1,657 | 1,945 |
Total reclassifications for the period, net of tax | 49,469 | 34,263 |
Amount Reclassified from Accumulated Other Comprehensive Income (Loss) for the Period | ||
Reclassification Adjustments out of Accumulated Other Comprehensive Income [Line Items] | ||
Total reclassifications for the period, net of tax | 1,222 | 3,544 |
Amount Reclassified from Accumulated Other Comprehensive Income (Loss) for the Period | Unrealized gains (losses) on available for sale securities | ||
Reclassification Adjustments out of Accumulated Other Comprehensive Income [Line Items] | ||
Net realized gains on sales of available for sale securities | 1,799 | 4,612 |
Income tax expense | (378) | (969) |
Total reclassifications for the period, net of tax | 1,421 | 3,643 |
Amount Reclassified from Accumulated Other Comprehensive Income (Loss) for the Period | Unrealized gains (losses) on cash flow hedges | ||
Reclassification Adjustments out of Accumulated Other Comprehensive Income [Line Items] | ||
Income tax expense | 53 | 26 |
Total reclassifications for the period, net of tax | (199) | (99) |
Amount Reclassified from Accumulated Other Comprehensive Income (Loss) for the Period | Unrealized gains (losses) on cash flow hedges | Interest rate contracts | ||
Reclassification Adjustments out of Accumulated Other Comprehensive Income [Line Items] | ||
Interest expense - subordinated debentures and term loans | $ (252) | $ (125) |
Share-Based Compensation - Narrative (Details) - USD ($) |
3 Months Ended | ||
---|---|---|---|
Jan. 01, 2021 |
Mar. 31, 2021 |
Mar. 31, 2020 |
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Percentage of average closing price to be paid by employees | 85.00% | ||
Maximum common stock purchases through advance payroll deductions in a calendar year | $ 25,000 | ||
Share-based compensation | $ 1,190,000 | $ 1,220,000 | |
Forfeiture rate | 0.50% | ||
Unrecognized compensation expense related to stock options | $ 0 | ||
Aggregate intrinsic value of stock options exercised | 453,000 | 36,000 | |
Cash receipts of stock options exercised | $ 171,000 | $ 7,000 | |
Stock Options | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Stock option term | 10 years | ||
Stock options vesting percentage | 100.00% | ||
Stock Options | Minimum | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Vested period | 1 year | ||
Stock Options | Maximum | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Vested period | 2 years | ||
RSAs | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Vested period | 3 years | ||
Unrecognized compensation expense related to RSAs | $ 8,400,000 | ||
Unrecognized compensation expense expected recognition period | 2 years 3 days | ||
ESPP | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Unrecognized compensation expense related to stock options | $ 0 | ||
Grant date fair value of ESPP options | $ 75,000 |
Share-Based Compensation - Components of Awards (Details) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Mar. 31, 2021 |
Mar. 31, 2020 |
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Pre-tax compensation expense | $ 1,190 | $ 1,220 |
Income tax expense (benefit) | (309) | (257) |
Total share-based compensation expense, net of income taxes | 881 | 963 |
Stock and ESPP Options | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Pre-tax compensation expense | 75 | 41 |
Income tax expense (benefit) | (72) | 0 |
Total share-based compensation expense, net of income taxes | 3 | 41 |
Restricted Stock Awards | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Pre-tax compensation expense | 1,115 | 1,179 |
Income tax expense (benefit) | (237) | (257) |
Total share-based compensation expense, net of income taxes | $ 878 | $ 922 |
Share-Based Compensation - Stock Option Activity (Details) |
3 Months Ended |
---|---|
Mar. 31, 2021
USD ($)
$ / shares
shares
| |
Number of Shares | |
Beginning balance (in shares) | shares | 45,800 |
Exercised (in shares) | shares | (14,300) |
Ending balance (in shares) | shares | 31,500 |
Vested and Expected to Vest (in shares) | shares | 31,500 |
Exercisable (in shares) | shares | 31,500 |
Weighted-Average Exercise Price | |
Beginning balance (in dollars per share) | $ / shares | $ 15.00 |
Exercised (in dollars per share) | $ / shares | 11.97 |
Ending balance (in dollars per share) | $ / shares | 16.37 |
Vested and Expected to Vest, Weighted-Average Exercise Price (in dollars per share) | $ / shares | 16.37 |
Exercisable, Weighted-Average Exercise Price (in dollars per share) | $ / shares | $ 16.37 |
Weighted Average Remaining Contractual Term (in Years) | |
Outstanding | 2 years 21 days |
Vested and Expected to Vest | 2 years 21 days |
Exercisable | 2 years 21 days |
Aggregate Intrinsic Value | |
Outstanding | $ | $ 949,155 |
Vested and Expected to Vest | $ | 949,155 |
Exercisable | $ | $ 949,155 |
Share-Based Compensation - Unvested RSAs Outstanding (Details) - RSAs |
3 Months Ended |
---|---|
Mar. 31, 2021
$ / shares
shares
| |
Number of Shares | |
Unvested RSAs, Beginning Balance (in shares) | shares | 357,883 |
Granted (in shares) | shares | 66,913 |
Vested (in shares) | shares | (4,285) |
Forfeited (in shares) | shares | (1,650) |
Unvested RSAs, Ending Balance (in shares) | shares | 418,861 |
Weighted-Average Grant Date Fair Value | |
Unvested RSAs, Beginning Balance (in dollars per share) | $ / shares | $ 36.30 |
Granted (in dollars per share) | $ / shares | 42.39 |
Vested (in dollars per share) | $ / shares | 42.15 |
Forfeited (in dollars per share) | $ / shares | 32.21 |
Unvested RSAs, Ending Balance (in dollars per share) | $ / shares | $ 37.23 |
Income Tax (Details) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Mar. 31, 2021 |
Mar. 31, 2020 |
|
Reconciliation of Federal Statutory to Actual Tax Expense: | ||
Federal statutory income tax at 21% | $ 12,268 | $ 7,928 |
Tax-exempt interest income | (3,706) | (3,022) |
Share-based compensation | (59) | 0 |
Tax-exempt earnings and gains on life insurance | (281) | (286) |
Tax credits | (73) | (61) |
CARES Act - NOL carryback rate differential | 0 | (1,178) |
State Income Tax | 702 | 86 |
Other | 101 | 23 |
Actual Tax Expense | $ 8,952 | $ 3,490 |
Effective Tax Rate | 15.30% | 9.20% |
Net Income Per Share - Reconciliation of Basic and Diluted Net Income Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands |
3 Months Ended | |
---|---|---|
Mar. 31, 2021 |
Mar. 31, 2020 |
|
Net Income | ||
Net income available to common stockholders | $ 49,469 | $ 34,263 |
Diluted net income per share | $ 49,469 | $ 34,263 |
Weighted-Average Shares | ||
Net income available to common stockholders (in shares) | 53,930,200 | 54,732,073 |
Effect of potentially dilutive stock options and restricted stock awards (in shares) | 203,422 | 185,687 |
Diluted net income per share (in shares) | 54,133,622 | 54,917,760 |
Per Share Amount | ||
Net income available to common stockholders (in dollars per share) | $ 0.92 | $ 0.63 |
Diluted net income per share (in dollars per share) | $ 0.91 | $ 0.62 |
Net Income Per Share - Narrative (Details) - shares |
3 Months Ended | |
---|---|---|
Mar. 31, 2021 |
Mar. 31, 2020 |
|
Earnings Per Share [Abstract] | ||
Stock options not included in the earnings per share calculation (in shares) | 0 | 0 |
Subsequent Event (Details) $ in Thousands |
Apr. 01, 2021
USD ($)
|
---|---|
Subsequent event | Hoosier | |
Subsequent Event [Line Items] | |
Cash paid in acquisition | $ 3,225 |
I?=E4\L'H]GK'7OB25]]V7PNX&QVT).F6YV4J >?S[8';M MXJ#P"<'JW>J_(,J_Y0J)%[$>M.8A'5M_:-;
M^I3&/5TF(^R;904'68%S B;%3M0-A)X&U2+95EF3B=HU"^&AX_#OSD*HC2,(
MXOXDZ$9A0+%YL-%!4_0_S$&DW1$3&O5UZ58QI99)B ^Z8J>ND=B4==;4$-Z:
M%5ID!2^2C.<0.^HF:[8RI!MC1ZPKQJRG5[?Q0XM<[*FXZ#D%WXA45"#P6[D6
M2.YA=,V+GP@" >#X+W3:/"!RAMP21L 3C8KSM0H:
M4,'(5]WT\XY\;J9RNC]^!#/:3HN^3NN<1D_X5;0?"$M_)S2A*:+GXNW#DX@<
MMO4RL^=C(2^+;DZN8,F0JU8OR.U2MJ)7S0,Y,U&L>B6[CY'+\.UEN+T,#USF
M!I:]:B9Z(;%;L!Z;V[%F=3^>\HKGU S6+/]<(4?U,W]GRL1/;B?.QVO ""K6*Y2\I^,^\B P4&?@Z2(-8
M& 4]U(Y;@L1VAE0%4UD7!<\A/%M"R])G#M!A1*8Z(W"=G8#O E\+4),<"=P^
MZ"V+83N-[=T+75:&($Y9!;C? #.R]WYZ7NO ON'K$1\-1NW:SF'R#CMOQQN2AYC
M&-BT=1OM@0WV>,\>OY-]!\:#K4_SD+%EFSJVFJS' ARW,AYC.@@V01.!(\W0
M'8>YX53DS#20UH3->!BR;$L7AU+?AU(OS;#\;#LHNZ LNZ^* C/V?@UEBF94
MV6^]B5)A<(6!=61B)BYMJ 8Q
+5;:'+3@CD
M?HB>D8+*/06&)$I[ZM-2=:=OJ/%,1BW755)-T2'8-N513!K(RI]-P=4#HLH-
M0BN*,U9E\97R?B[>81=I 1.A4K(?59%@]4SH;%X=E@+>*A7DYB0MW[?!2'\H
MP](6;Y2_5UR5E ,2J+(KY+Q17O2&*@@I=5\^C'3L'F%V6KKV1>5.?#ES;C68
MA*3B%B2+ VD7971M@PV.))&9KAGF<>O=DY9\;:%-%Y^'!72FU$V11:38*H%0
MDV8;5^KP]F+BTJX[E_:Q=6EOE$L;A-]?9NO]LP
QIU/.DRZWUZ=.CZYE?OZ(+,9Y
M?\:N*SS0K4Q/MDPP%_^2;W?C KAI.>+A[E1^(6CSL#1(NMM+XU??];@][I 3
MG'$'(VY>GO(]5GN\4-H;J80>EKY#SPP=Z-'W/Z'NX>U)&_SA,>^:GS1$9^
MZH2!&UE]Q4\M64H\#N=2&XD\[KNJ)CHH))1Y].K?F7APOFIVS!I7GU\[W)K?
M<[T@